activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	106511	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Br)c3)ccc12)C1CC1		CHEMBL260416	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	106511	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Br)c3)ccc12)C1CC1		CHEMBL260416	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	107703	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CC1		CHEMBL261690	=	IC50	nM	99.0	CHEMBL2850	Homo sapiens	IC50	nM	99.0
	107705	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CCCC1		CHEMBL406644	=	IC50	nM	16.0	CHEMBL2850	Homo sapiens	IC50	nM	16.0
	108797	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccc[nH]3)ccc12)C1CC1		CHEMBL260929	=	IC50	nM	320.0	CHEMBL2850	Homo sapiens	IC50	nM	320.0
	108799	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CCCC1		CHEMBL407980	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	110122	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	nM	4.0
	111581	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	IC50	nM	498.0	CHEMBL2850	Homo sapiens	IC50	nM	498.0
	112983	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1[nH]nc2cc(-c3ccc(O)nc3)ccc12)C1CC1		CHEMBL106060	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	112985	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CC1		CHEMBL260231	=	IC50	nM	39.0	CHEMBL2850	Homo sapiens	IC50	nM	39.0
	114284	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	nM	15.0
	114286	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1		CHEMBL101747	=	IC50	nM	18.0	CHEMBL2850	Homo sapiens	IC50	nM	18.0
	115399	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3cccc(F)c3)ccc12)C1CC1		CHEMBL261660	=	IC50	nM	828.0	CHEMBL2850	Homo sapiens	IC50	nM	828.0
	116836	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccco3)ccc12)C1CC1		CHEMBL421207	=	IC50	nM	50.0	CHEMBL2850	Homo sapiens	IC50	nM	50.0
	118041	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL427909	=	IC50	nM	24.0	CHEMBL2850	Homo sapiens	IC50	nM	24.0
	118043	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	119256	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	IC50	nM	481.0	CHEMBL2850	Homo sapiens	IC50	nM	481.0
	119258	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	121678	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccsc3)ccc12)C1CC1		CHEMBL260928	=	IC50	nM	329.0	CHEMBL2850	Homo sapiens	IC50	nM	329.0
	121680	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	IC50	nM	141.0	CHEMBL2850	Homo sapiens	IC50	nM	141.0
	122918	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	124142	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	125501	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL407981	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	nM	4.0
	125503	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1[nH]nc2cc(-c3ccc4ncccc4c3)ccc12)C1CC1		CHEMBL103099	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	126999	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Cl)c3)ccc12)C1CC1		CHEMBL259838	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	127001	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	129339	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	IC50	nM	12.0	CHEMBL2850	Homo sapiens	IC50	nM	12.0
	130731	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccoc3)ccc12)C1CC1		CHEMBL260243	=	IC50	nM	35.0	CHEMBL2850	Homo sapiens	IC50	nM	35.0
	131961	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1[nH]nc2cc(-c3ccc(F)c(F)c3)ccc12)C1CC1		CHEMBL103112	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	131963	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1[nH]nc2cc(-c3cccc(F)c3F)ccc12)C1CC1		CHEMBL105213	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	133217	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	0.8	CHEMBL2850	Homo sapiens	IC50	nM	0.8
	133242	CHEMBL686313	Inhibition of 10 uM Glycogen synthase kinase-3 alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	Inhibition	%	100.0
	134411	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccc4[nH]ccc4c3)ccc12)C1CC1		CHEMBL261659	=	IC50	nM	42.0	CHEMBL2850	Homo sapiens	IC50	nM	42.0
	138041	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	IC50	nM	250.0	CHEMBL2850	Homo sapiens	IC50	nM	250.0
	138042	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	IC50	nM	75.0	CHEMBL2850	Homo sapiens	IC50	nM	75.0
	138067	CHEMBL686313	Inhibition of 10 uM Glycogen synthase kinase-3 alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	87.0	CHEMBL2850	Homo sapiens	Inhibition	%	87.0
	138068	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	138070	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2cc(-c3cccs3)ccc12)C1CC1		CHEMBL318522	=	IC50	nM	215.0	CHEMBL2850	Homo sapiens	IC50	nM	215.0
	138072	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CCN(Cc2ccccc2)C1		CHEMBL317657	=	IC50	nM	14.0	CHEMBL2850	Homo sapiens	IC50	nM	14.0
	139328	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1[nH]nc2cc(-c3ccccc3F)ccc12)C1CC1		CHEMBL280221	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	nM	1000.0
	144060	CHEMBL686309	Inhibitory concentration against glycogen synthase kinase-3 alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	IC50	nM	8.0	CHEMBL2850	Homo sapiens	IC50	nM	8.0
	144085	CHEMBL686313	Inhibition of 10 uM Glycogen synthase kinase-3 alpha at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	90.0	CHEMBL2850	Homo sapiens	Inhibition	%	90.0
	395345	CHEMBL686315	Inhibition of Glycogen synthase kinase-3 alpha	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	500.0	CHEMBL2850	Homo sapiens	IC50	uM	0.5
	553663	CHEMBL686314	Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL38425	=	cKi	nM	0.19	CHEMBL2850	Homo sapiens	cKi	nM	0.19
	554886	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1n[nH]c2nccc(-c3ccccc3)c12		CHEMBL428968	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	nM	5000.0
	554887	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	IC50	nM	11.0	CHEMBL2850	Homo sapiens	IC50	nM	11.0
	554913	CHEMBL686314	Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1		CHEMBL35785	=	cKi	nM	0.08	CHEMBL2850	Homo sapiens	cKi	nM	0.08
	556011	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncccc12		CHEMBL407374	=	IC50	nM	2345.0	CHEMBL2850	Homo sapiens	IC50	nM	2345.0
	556012	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	557342	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc(F)c3F)cc12		CHEMBL264161	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	557343	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2cnc(-c3ccccc3)cc12		CHEMBL261549	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	558482	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1noc2ncc(-c3ccccc3)cc12		CHEMBL290147	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	nM	5000.0
	559730	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Cn1nc(N)c2cc(-c3ccccc3)cnc21		CHEMBL40835	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	nM	5000.0
	559731	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	nM	4.0
	560777	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc4ccccc34)cc12		CHEMBL260329	=	IC50	nM	241.0	CHEMBL2850	Homo sapiens	IC50	nM	241.0
	561838	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(B3OC(C)(C)C(C)(C)O3)cc12		CHEMBL264162	=	IC50	nM	356.0	CHEMBL2850	Homo sapiens	IC50	nM	356.0
	564308	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	O=C(Nc1n[nH]c2ncc(-c3ccccc3)cc12)C1CCCC1		CHEMBL258483	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	565383	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL288448	=	IC50	nM	291.0	CHEMBL2850	Homo sapiens	IC50	nM	291.0
	566657	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL406701	=	IC50	nM	43.0	CHEMBL2850	Homo sapiens	IC50	nM	43.0
	566658	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	O=C(CCCN1CCCC1)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL261441	=	IC50	nM	11.0	CHEMBL2850	Homo sapiens	IC50	nM	11.0
	569160	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc(F)c3F)cc12		CHEMBL264161	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	570498	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	IC50	nM	250.0	CHEMBL2850	Homo sapiens	IC50	nM	250.0
	570499	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL40493	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	nM	5000.0
	572971	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	IC50	nM	22.0	CHEMBL2850	Homo sapiens	IC50	nM	22.0
	572972	CHEMBL686314	Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	cKi	nM	2.5	CHEMBL2850	Homo sapiens	cKi	nM	2.5
	574132	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc(F)c3)cc12		CHEMBL263907	=	IC50	nM	20.0	CHEMBL2850	Homo sapiens	IC50	nM	20.0
	575349	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3Cl)cc12		CHEMBL407003	=	IC50	nM	27.0	CHEMBL2850	Homo sapiens	IC50	nM	27.0
	576638	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccc(-c4ccccc4)cc3)cc12		CHEMBL261052	=	IC50	nM	851.0	CHEMBL2850	Homo sapiens	IC50	nM	851.0
	579045	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL261439	=	IC50	nM	430.0	CHEMBL2850	Homo sapiens	IC50	nM	430.0
	579046	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1n[nH]c2cnc(-c3ccccc3)cc12		CHEMBL259925	=	IC50	nM	1260.0	CHEMBL2850	Homo sapiens	IC50	nM	1260.0
	579047	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccc4ccccc4c3)cc12		CHEMBL406062	=	IC50	nM	169.0	CHEMBL2850	Homo sapiens	IC50	nM	169.0
	580318	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2cnc(-c3ccccc3)nc12		CHEMBL261661	=	IC50	nM	2697.0	CHEMBL2850	Homo sapiens	IC50	nM	2697.0
	581399	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL408634	=	IC50	nM	530.0	CHEMBL2850	Homo sapiens	IC50	nM	530.0
	581400	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	IC50	nM	250.0	CHEMBL2850	Homo sapiens	IC50	nM	250.0
	581401	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2ccc(-c3ccccc3)cc12		CHEMBL261366	=	IC50	nM	99.0	CHEMBL2850	Homo sapiens	IC50	nM	99.0
	581402	CHEMBL686314	Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12)C1CCCC1		CHEMBL287092	=	cKi	nM	0.11	CHEMBL2850	Homo sapiens	cKi	nM	0.11
	582588	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CC(C)C(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL261596	=	IC50	nM	19.0	CHEMBL2850	Homo sapiens	IC50	nM	19.0
	583857	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL409738	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	nM	7.0
	585181	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	IC50	nM	56.0	CHEMBL2850	Homo sapiens	IC50	nM	56.0
	586365	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	IC50	nM	56.0	CHEMBL2850	Homo sapiens	IC50	nM	56.0
	586391	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCNC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL408809	=	IC50	nM	2810.0	CHEMBL2850	Homo sapiens	IC50	nM	2810.0
	586392	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL406125	=	IC50	nM	9.0	CHEMBL2850	Homo sapiens	IC50	nM	9.0
	587624	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL261127	=	IC50	nM	691.0	CHEMBL2850	Homo sapiens	IC50	nM	691.0
	587625	CHEMBL686314	Binding affinity towards glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL39300	=	cKi	nM	0.95	CHEMBL2850	Homo sapiens	cKi	nM	0.95
	588951	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	CCN1CCN(CCCCC(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL259271	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	590203	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	IC50	nM	18.0	CHEMBL2850	Homo sapiens	IC50	nM	18.0
	591527	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CS(=O)(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL287731	=	IC50	nM	3572.0	CHEMBL2850	Homo sapiens	IC50	nM	3572.0
	591528	CHEMBL686306	Inhibition against human glycogen synthase kinase-3alpha (hGSK-3).	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccncc3)cc12		CHEMBL261264	=	IC50	nM	443.0	CHEMBL2850	Homo sapiens	IC50	nM	443.0
	591529	CHEMBL686307	Inhibition of human glycogen synthase kinase-3alpha (hGSK-3)	B	O=C(CCCN1CCOCC1)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL261518	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	953106	CHEMBL686305	Inhibition of glycogen synthase kinase-3 alpha	B	Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1		CHEMBL296682	=	IC50	nM	900.0	CHEMBL2850	Homo sapiens	IC50	uM	0.9
	1027373	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccccc1	Outside typical range	CHEMBL160968	=	IC50	nM	514000.0	CHEMBL2850	Homo sapiens	IC50	uM	514.0
Not Determined	1027374	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1cccc(C2=C(Nc3ccc(O)c(Cl)c3)C(=O)NC2=O)c1		CHEMBL160951		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1028691	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3ccccc3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL156807	=	IC50	nM	390000.0	CHEMBL2850	Homo sapiens	IC50	uM	390.0
	1028692	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(O)c1	Outside typical range	CHEMBL350435	=	IC50	nM	704000.0	CHEMBL2850	Homo sapiens	IC50	uM	704.0
	1028693	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(O)cc1	Outside typical range	CHEMBL155680	=	IC50	nM	123000.0	CHEMBL2850	Homo sapiens	IC50	uM	123.0
	1028694	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(C(=O)O)c1	Outside typical range	CHEMBL348505	=	IC50	nM	291000.0	CHEMBL2850	Homo sapiens	IC50	uM	291.0
Not Determined	1028695	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cccc(C(=O)O)c1		CHEMBL160241		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1028696	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccc(C2=C(Nc3ccc(Cl)c(C(=O)O)c3)C(=O)NC2=O)cc1		CHEMBL345827		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1028697	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	CSc1ccc(NC2=C(c3ccccc3[N+](=O)[O-])C(=O)NC2=O)cc1		CHEMBL156762		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1030006	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1cccc(Cl)c1		CHEMBL155755		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1030007	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL345348	=	IC50	nM	59000.0	CHEMBL2850	Homo sapiens	IC50	uM	59.0
Not Determined	1031168	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)cc1		CHEMBL345898		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1031169	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2ccc(SC)cc2)C(=O)NC1=O	Outside typical range	CHEMBL349540	=	IC50	nM	110000.0	CHEMBL2850	Homo sapiens	IC50	uM	110.0
Not Determined	1031170	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	CN(C1=C(c2cccc(Cl)c2)C(=O)NC1=O)c1ccccc1		CHEMBL156442		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1031171	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1cccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)c1		CHEMBL156113		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1031172	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc([N+](=O)[O-])cc1		CHEMBL347585		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1032370	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL347134	=	IC50	nM	91000.0	CHEMBL2850	Homo sapiens	IC50	uM	91.0
	1032371	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1	Outside typical range	CHEMBL156563	=	IC50	nM	161000.0	CHEMBL2850	Homo sapiens	IC50	uM	161.0
	1033597	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN1C(=O)C(Nc2ccccc2)=C(c2ccccc2)C1=O		CHEMBL158781	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	uM	5.0
Not Determined	1033598	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccccc1C1=C(N(C)c2ccccc2)C(=O)NC1=O		CHEMBL157034		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1034899	CHEMBL686310	Inhibition of human Glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	IC50	nM	156.0	CHEMBL2850	Homo sapiens	IC50	nM	156.0
	1036294	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	104.0	CHEMBL2850	Homo sapiens	IC50	nM	104.0
	1036295	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(Cl)c1		CHEMBL345801	=	IC50	nM	70000.0	CHEMBL2850	Homo sapiens	IC50	uM	70.0
	1036296	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cccc(O)c1	Outside typical range	CHEMBL155931	=	IC50	nM	251000.0	CHEMBL2850	Homo sapiens	IC50	uM	251.0
	1036297	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(O)c(Cl)c1	Outside typical range	CHEMBL157141	=	IC50	nM	152000.0	CHEMBL2850	Homo sapiens	IC50	uM	152.0
	1036298	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(C(=O)O)c1		CHEMBL159149	=	IC50	nM	79000.0	CHEMBL2850	Homo sapiens	IC50	uM	79.0
Not Determined	1036299	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1cccc(C(=O)O)c1		CHEMBL345114		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1037322	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccccc1C1=C(Nc2ccc(O)cc2)C(=O)NC1=O		CHEMBL160338		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1037323	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3cccc(Cl)c3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL160743	=	IC50	nM	532000.0	CHEMBL2850	Homo sapiens	IC50	uM	532.0
	1037324	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1cccc([N+](=O)[O-])c1	Outside typical range	CHEMBL156153	=	IC50	nM	161000.0	CHEMBL2850	Homo sapiens	IC50	uM	161.0
Not Determined	1038468	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(O)cc1		CHEMBL347702		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1038469	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	CN(C1=C(c2ccccc2[N+](=O)[O-])C(=O)NC1=O)c1ccccc1		CHEMBL156052		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1038470	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1	Outside typical range	CHEMBL156524	=	IC50	nM	1412000.0	CHEMBL2850	Homo sapiens	IC50	uM	1412.0
Not Determined	1039623	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccccc1		CHEMBL156811		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1039624	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccccc1C1=C(Nc2cccc(C(=O)O)c2)C(=O)NC1=O		CHEMBL345836		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1039625	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccccc1Cl	Outside typical range	CHEMBL155967	=	IC50	nM	337000.0	CHEMBL2850	Homo sapiens	IC50	uM	337.0
	1040866	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccccc1	Outside typical range	CHEMBL346371	=	IC50	nM	141000.0	CHEMBL2850	Homo sapiens	IC50	uM	141.0
Not Determined	1040867	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccc(C2=C(Nc3ccc(O)c(Cl)c3)C(=O)NC2=O)cc1		CHEMBL346488		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1040868	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	IC50	nM	93000.0	CHEMBL2850	Homo sapiens	IC50	uM	93.0
Not Determined	1040869	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	CN(C1=C(c2ccccc2Cl)C(=O)NC1=O)c1ccccc1		CHEMBL156969		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1042043	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(O)c1	Outside typical range	CHEMBL158559	=	IC50	nM	236000.0	CHEMBL2850	Homo sapiens	IC50	uM	236.0
	1042044	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3cccc(C(=O)O)c3)C(=O)NC2=O)c1	Outside typical range	CHEMBL346493	=	IC50	nM	195000.0	CHEMBL2850	Homo sapiens	IC50	uM	195.0
Not Determined	1042045	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccccc1C1=C(Nc2ccc(Cl)c(C(=O)O)c2)C(=O)NC1=O		CHEMBL156819		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1042046	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(N(C)c3ccccc3)C(=O)NC2=O)c1	Outside typical range	CHEMBL155904	>	IC50	nM	4500000.0	CHEMBL2850	Homo sapiens	IC50	uM	4500.0
	1043140	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	IC50	nM	94000.0	CHEMBL2850	Homo sapiens	IC50	uM	94.0
	1044707	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(O)c(Cl)c1	Outside typical range	CHEMBL156684	=	IC50	nM	173000.0	CHEMBL2850	Homo sapiens	IC50	uM	173.0
	1045938	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(Cl)c1	Outside typical range	CHEMBL156506	=	IC50	nM	195000.0	CHEMBL2850	Homo sapiens	IC50	uM	195.0
	1045939	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cc(Cl)c(O)c(Cl)c1	Outside typical range	CHEMBL347857	=	IC50	nM	149000.0	CHEMBL2850	Homo sapiens	IC50	uM	149.0
Not Determined	1047086	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL348062		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1047087	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL156960		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1047088	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	IC50	nM	20000.0	CHEMBL2850	Homo sapiens	IC50	uM	20.0
	1047089	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3cccc([N+](=O)[O-])c3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL346996	=	IC50	nM	152000.0	CHEMBL2850	Homo sapiens	IC50	uM	152.0
	1048360	CHEMBL686310	Inhibition of human Glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	IC50	nM	187.0	CHEMBL2850	Homo sapiens	IC50	nM	187.0
	1048361	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(O)c1	Outside typical range	CHEMBL347419	=	IC50	nM	407000.0	CHEMBL2850	Homo sapiens	IC50	uM	407.0
	1048362	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3ccc(Cl)c(C(=O)O)c3)C(=O)NC2=O)c1		CHEMBL349810	=	IC50	nM	85000.0	CHEMBL2850	Homo sapiens	IC50	uM	85.0
	1048363	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN(C1=C(c2ccccc2)C(=O)NC1=O)c1ccccc1	Outside typical range	CHEMBL351334	=	IC50	nM	2613000.0	CHEMBL2850	Homo sapiens	IC50	uM	2613.0
	1049424	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3cc(Cl)c(O)c(Cl)c3)C(=O)NC2=O)cc1		CHEMBL346721	=	IC50	nM	83000.0	CHEMBL2850	Homo sapiens	IC50	uM	83.0
	1049425	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3cccc(C(=O)O)c3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL156218	=	IC50	nM	214000.0	CHEMBL2850	Homo sapiens	IC50	uM	214.0
	1050668	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O	Outside typical range	CHEMBL156263	=	IC50	nM	216000.0	CHEMBL2850	Homo sapiens	IC50	uM	216.0
Not Determined	1050669	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1ccccc1		CHEMBL346056		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1050670	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cccc(Cl)c1	Outside typical range	CHEMBL346066	=	IC50	nM	104000.0	CHEMBL2850	Homo sapiens	IC50	uM	104.0
Not Determined	1051895	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccccc1		CHEMBL158959		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1051896	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1	Outside typical range	CHEMBL347580	=	IC50	nM	694000.0	CHEMBL2850	Homo sapiens	IC50	uM	694.0
Not Determined	1053143	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1cccc(C2=C(Nc3ccc(O)cc3)C(=O)NC2=O)c1		CHEMBL160905		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1053144	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccc(C2=C(Nc3ccc(O)cc3)C(=O)NC2=O)cc1		CHEMBL345864		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1053145	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2ccc(O)c(Cl)c2)C(=O)NC1=O	Outside typical range	CHEMBL157089	=	IC50	nM	139000.0	CHEMBL2850	Homo sapiens	IC50	uM	139.0
	1053146	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3ccc(SC)cc3)C(=O)NC2=O)c1	Outside typical range	CHEMBL158526	=	IC50	nM	203000.0	CHEMBL2850	Homo sapiens	IC50	uM	203.0
	1054288	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(Cl)c1	Outside typical range	CHEMBL351356	=	IC50	nM	301000.0	CHEMBL2850	Homo sapiens	IC50	uM	301.0
	1054289	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)c1	Outside typical range	CHEMBL346829	=	IC50	nM	257000.0	CHEMBL2850	Homo sapiens	IC50	uM	257.0
	1055606	CHEMBL686310	Inhibition of human Glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	IC50	nM	28.0	CHEMBL2850	Homo sapiens	IC50	nM	28.0
	1055607	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2cccc(O)c2)C(=O)NC1=O	Outside typical range	CHEMBL160231	=	IC50	nM	259000.0	CHEMBL2850	Homo sapiens	IC50	uM	259.0
	1055608	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL345212	=	IC50	nM	74000.0	CHEMBL2850	Homo sapiens	IC50	uM	74.0
	1055609	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN(C1=C(c2cccc([N+](=O)[O-])c2)C(=O)NC1=O)c1ccccc1	Outside typical range	CHEMBL156801	=	IC50	nM	1398000.0	CHEMBL2850	Homo sapiens	IC50	uM	1398.0
Not Determined	1056932	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cccc(Cl)c1		CHEMBL155822		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1056933	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3cccc(O)c3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL160829	=	IC50	nM	481000.0	CHEMBL2850	Homo sapiens	IC50	uM	481.0
	1056934	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL422714	=	IC50	nM	58000.0	CHEMBL2850	Homo sapiens	IC50	uM	58.0
	1056935	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3cc(Cl)c(O)c(Cl)c3)C(=O)NC2=O)c1	Outside typical range	CHEMBL157348	=	IC50	nM	142000.0	CHEMBL2850	Homo sapiens	IC50	uM	142.0
	1056936	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3ccc([N+](=O)[O-])cc3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL158835	=	IC50	nM	392000.0	CHEMBL2850	Homo sapiens	IC50	uM	392.0
	1058292	CHEMBL686310	Inhibition of human Glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	IC50	nM	26.0	CHEMBL2850	Homo sapiens	IC50	nM	26.0
	1058293	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1	Potential transcription error	CHEMBL156987	=	IC50	nM	76000.0	CHEMBL2850	Homo sapiens	IC50	uM	76.0
	1058294	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3ccccc3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL434484	=	IC50	nM	404000.0	CHEMBL2850	Homo sapiens	IC50	uM	404.0
	1058295	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccccc1[N+](=O)[O-]	Outside typical range	CHEMBL158719	=	IC50	nM	131000.0	CHEMBL2850	Homo sapiens	IC50	uM	131.0
	1059302	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1	Outside typical range	CHEMBL160937	=	IC50	nM	374000.0	CHEMBL2850	Homo sapiens	IC50	uM	374.0
	1059303	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cccc(O)c1	Outside typical range	CHEMBL351801	=	IC50	nM	1478000.0	CHEMBL2850	Homo sapiens	IC50	uM	1478.0
	1059304	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL158885	=	IC50	nM	52000.0	CHEMBL2850	Homo sapiens	IC50	uM	52.0
	1059305	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN1C(=O)C(Nc2cc(Cl)c(O)c(Cl)c2)=C(c2ccc(Cl)cc2)C1=O		CHEMBL350029	>	IC50	nM	3000.0	CHEMBL2850	Homo sapiens	IC50	uM	3.0
	1059306	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CSc1ccc(NC2=C(c3ccc(Cl)cc3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL351342	=	IC50	nM	529000.0	CHEMBL2850	Homo sapiens	IC50	uM	529.0
	1060612	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccccc1	Outside typical range	CHEMBL347647	=	IC50	nM	216000.0	CHEMBL2850	Homo sapiens	IC50	uM	216.0
Not Determined	1060613	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1cccc(C2=C(Nc3ccccc3)C(=O)NC2=O)c1		CHEMBL156634		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1060614	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccc(Cl)c(C(=O)O)c1	Outside typical range	CHEMBL160251	=	IC50	nM	143000.0	CHEMBL2850	Homo sapiens	IC50	uM	143.0
	1060615	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN(C1=C(c2ccc(Cl)cc2)C(=O)NC1=O)c1ccccc1	Outside typical range	CHEMBL435045	=	IC50	nM	2285000.0	CHEMBL2850	Homo sapiens	IC50	uM	2285.0
Not Determined	1061930	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)cc1		CHEMBL160623		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1061931	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	CN1C(=O)C(Nc2ccc(Cl)c(C(=O)O)c2)=C(c2ccc(Cl)cc2)C1=O		CHEMBL346523	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	uM	5.0
	1063230	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1	Outside typical range	CHEMBL346551	=	IC50	nM	529000.0	CHEMBL2850	Homo sapiens	IC50	uM	529.0
	1063231	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(O)cc1	Outside typical range	CHEMBL156808	=	IC50	nM	317000.0	CHEMBL2850	Homo sapiens	IC50	uM	317.0
	1063232	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2cc(Cl)c(O)c(Cl)c2)C(=O)NC1=O		CHEMBL345800	=	IC50	nM	82000.0	CHEMBL2850	Homo sapiens	IC50	uM	82.0
	1063233	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL347681	=	IC50	nM	71000.0	CHEMBL2850	Homo sapiens	IC50	uM	71.0
	1063234	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(C(=O)O)c1	Outside typical range	CHEMBL350702	=	IC50	nM	136000.0	CHEMBL2850	Homo sapiens	IC50	uM	136.0
	1063235	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(C(=O)O)c1	Outside typical range	CHEMBL347632	=	IC50	nM	186000.0	CHEMBL2850	Homo sapiens	IC50	uM	186.0
	1063236	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1	Outside typical range	CHEMBL160876	=	IC50	nM	109000.0	CHEMBL2850	Homo sapiens	IC50	uM	109.0
Not Determined	1063237	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	COc1ccc(C2=C(N(C)c3ccccc3)C(=O)NC2=O)cc1		CHEMBL160142		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1063238	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1cccc(Cl)c1	Outside typical range	CHEMBL346107	=	IC50	nM	460000.0	CHEMBL2850	Homo sapiens	IC50	uM	460.0
Not Determined	1064471	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccc(O)cc1		CHEMBL348652		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1064472	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cccc(C(=O)O)c1	Outside typical range	CHEMBL345364	=	IC50	nM	134000.0	CHEMBL2850	Homo sapiens	IC50	uM	134.0
Not Determined	1064473	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL158672		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1064474	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccc(C2=C(Nc3ccc(SC)cc3)C(=O)NC2=O)cc1	Outside typical range	CHEMBL160598	=	IC50	nM	243000.0	CHEMBL2850	Homo sapiens	IC50	uM	243.0
Not Determined	1064475	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	CN(C1=C(c2ccc([N+](=O)[O-])cc2)C(=O)NC1=O)c1ccccc1		CHEMBL352011		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1065724	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccccc1		CHEMBL158121		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1065725	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O	Outside typical range	CHEMBL156277	=	IC50	nM	114000.0	CHEMBL2850	Homo sapiens	IC50	uM	114.0
	1065726	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(Cl)c1	Outside typical range	CHEMBL160938	=	IC50	nM	447000.0	CHEMBL2850	Homo sapiens	IC50	uM	447.0
	1065727	CHEMBL686311	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha	B	COc1cccc(C2=C(Nc3cccc(O)c3)C(=O)NC2=O)c1	Outside typical range	CHEMBL160373	=	IC50	nM	472000.0	CHEMBL2850	Homo sapiens	IC50	uM	472.0
Not Determined	1065728	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1cccc(O)c1		CHEMBL435242		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
Not Determined	1065729	CHEMBL686312	Inhibitory concentration was determined against human glycogen synthase kinase-3 alpha; ND means no data	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1ccc(O)cc1		CHEMBL156029		IC50	nM		CHEMBL2850	Homo sapiens	IC50	uM	
	1266470	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	IC50	nM	250.0	CHEMBL2850	Homo sapiens	IC50	nM	250.0
	1267960	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL407981	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	nM	4.0
	1270861	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccccc4)c(Br)cc23)CC1		CHEMBL261882	=	IC50	nM	383.0	CHEMBL2850	Homo sapiens	IC50	nM	383.0
	1271996	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	nM	4.0
	1273177	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Cl)cc12)C1CC1		CHEMBL261883	=	IC50	nM	234.0	CHEMBL2850	Homo sapiens	IC50	nM	234.0
	1279769	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	IC50	nM	56.0	CHEMBL2850	Homo sapiens	IC50	nM	56.0
	1283454	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Cl)cc12)C1CC1		CHEMBL260664	=	IC50	nM	1.0	CHEMBL2850	Homo sapiens	IC50	nM	1.0
	1284719	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	IC50	nM	8.0	CHEMBL2850	Homo sapiens	IC50	nM	8.0
	1285898	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL427909	=	IC50	nM	24.0	CHEMBL2850	Homo sapiens	IC50	nM	24.0
	1287215	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	IC50	nM	1.0	CHEMBL2850	Homo sapiens	IC50	nM	1.0
	1287216	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4cccc(O)c4)ccc23)CC1		CHEMBL407730	=	IC50	nM	21.0	CHEMBL2850	Homo sapiens	IC50	nM	21.0
	1288561	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)ccc12)C1CC1		CHEMBL260344	=	IC50	nM	425.0	CHEMBL2850	Homo sapiens	IC50	nM	425.0
	1289812	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(O)c3)ccc12)C1CC1		CHEMBL260345	=	IC50	nM	8.0	CHEMBL2850	Homo sapiens	IC50	nM	8.0
	1289813	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccccc3O)ccc12)C1CC1		CHEMBL260663	=	IC50	nM	36.0	CHEMBL2850	Homo sapiens	IC50	nM	36.0
	1292596	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL407958	=	IC50	nM	415.0	CHEMBL2850	Homo sapiens	IC50	nM	415.0
	1293903	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	nM	5000.0
	1293904	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	0.8	CHEMBL2850	Homo sapiens	IC50	nM	0.8
	1295310	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	COc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)c1		CHEMBL406620	=	IC50	nM	125.0	CHEMBL2850	Homo sapiens	IC50	nM	125.0
	1295311	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	COc1ccccc1-c1ccc2c(NC(=O)C3CC3)n[nH]c2n1		CHEMBL408979	=	IC50	nM	1593.0	CHEMBL2850	Homo sapiens	IC50	nM	1593.0
	1296648	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	IC50	nM	12.0	CHEMBL2850	Homo sapiens	IC50	nM	12.0
	1299497	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	IC50	nM	75.0	CHEMBL2850	Homo sapiens	IC50	nM	75.0
	1300856	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	Cc1cc2c(NC(=O)C3CC3)n[nH]c2nc1-c1ccc(O)cc1		CHEMBL260662	=	IC50	nM	6.0	CHEMBL2850	Homo sapiens	IC50	nM	6.0
	1300857	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)ccc23)CC1		CHEMBL410926	=	IC50	nM	12.0	CHEMBL2850	Homo sapiens	IC50	nM	12.0
	1306591	CHEMBL686308	Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined	B	N#Cc1cc2c(NC(=O)C3CC3)n[nH]c2nc1-c1ccccc1		CHEMBL261881	=	IC50	nM	87.0	CHEMBL2850	Homo sapiens	IC50	nM	87.0
	1455171	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(CCC)C(N)=O		CHEMBL93836	=	Control	%	80.0	CHEMBL2850	Homo sapiens	Control	%	80.0
	1455174	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(CCC)C(=O)NO		CHEMBL186311	=	Control	%	54.2	CHEMBL2850	Homo sapiens	Control	%	54.2
	1455177	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(CCC)C(=O)OC		CHEMBL186602	=	Control	%	104.5	CHEMBL2850	Homo sapiens	Control	%	104.5
	1455179	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(C)(CCC)C(=O)OC		CHEMBL186603	=	Control	%	99.7	CHEMBL2850	Homo sapiens	Control	%	99.7
	1455181	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CC/C=C(\CCC)C(=O)OC		CHEMBL188008	=	Control	%	61.3	CHEMBL2850	Homo sapiens	Control	%	61.3
	1455183	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CC/C=C(\CCC)C(=O)O		CHEMBL117487	=	Control	%	100.0	CHEMBL2850	Homo sapiens	Control	%	100.0
	1455186	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(C)(CCC)C(=O)O		CHEMBL359977	=	Control	%	67.4	CHEMBL2850	Homo sapiens	Control	%	67.4
	1455189	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	C=CCC(CCC)C(=O)OC		CHEMBL186376	=	Control	%	99.9	CHEMBL2850	Homo sapiens	Control	%	99.9
	1455191	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	C=CCC(CCC)C(=O)OC(C)C		CHEMBL363913	=	Control	%	87.9	CHEMBL2850	Homo sapiens	Control	%	87.9
	1455295	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	C=CCC(CCC)C(=O)O		CHEMBL1367	=	Control	%	99.2	CHEMBL2850	Homo sapiens	Control	%	99.2
	1455599	CHEMBL835983	Inhibitory activity (0.5 mM) against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCC(CC)C(=O)O		CHEMBL184290	=	Control	%	88.3	CHEMBL2850	Homo sapiens	Control	%	88.3
	1455600	CHEMBL835979	Inhibitory activity (4 mM) against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCC(CC)C(=O)O		CHEMBL184290	=	Control	%	88.3	CHEMBL2850	Homo sapiens	Control	%	88.3
	1455604	CHEMBL835982	Inhibitory activity (20 mM) against Glycogen synthase kinase-3 alpha, expressed as percent control	B	[Cl-].[Li+]		CHEMBL69710	=	Control	%	22.1	CHEMBL2850	Homo sapiens	Control	%	22.1
	1455709	CHEMBL835982	Inhibitory activity (20 mM) against Glycogen synthase kinase-3 alpha, expressed as percent control	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Control	%	1.5	CHEMBL2850	Homo sapiens	Control	%	1.5
	1456936	CHEMBL835977	Inhibitory activity against Glycogen synthase kinase-3 alpha, expressed as percent control	B	CCCC(CCC)C(=O)O		CHEMBL109	=	Control	%	100.0	CHEMBL2850	Homo sapiens	Control	%	100.0
	1723245	CHEMBL861301	Inhibition of GSK3alpha	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1723251	CHEMBL861301	Inhibition of GSK3alpha	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1723252	CHEMBL861301	Inhibition of GSK3alpha	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1723253	CHEMBL861301	Inhibition of GSK3alpha	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1723254	CHEMBL861301	Inhibition of GSK3alpha	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1723255	CHEMBL861301	Inhibition of GSK3alpha	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	nM	8900.0
	1734188	CHEMBL862477	Residual activity at human GSK3alpha at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	66.0	CHEMBL2850	Homo sapiens	Activity	%	66.0
	1744458	CHEMBL867317	Inhibition of GSK3alpha	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	8900.0	CHEMBL2850	Homo sapiens	Ki	uM	8.9
	1824571	CHEMBL914318	Inhibition of GSK3 alpha	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2850	Homo sapiens	Ki	uM	10.0
	1824725	CHEMBL914318	Inhibition of GSK3 alpha	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL2850	Homo sapiens	Ki	uM	10.0
	1824798	CHEMBL914318	Inhibition of GSK3 alpha	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL2850	Homo sapiens	Ki	uM	10.0
	1917476	CHEMBL895142	Inhibition of GSK3-alpha at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	3.0	CHEMBL2850	Homo sapiens	Inhibition	%	3.0
	1917499	CHEMBL895142	Inhibition of GSK3-alpha at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	32.0	CHEMBL2850	Homo sapiens	Inhibition	%	32.0
	2025144	CHEMBL886971	Inhibition of human GSK3alpha relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	3.0	CHEMBL2850	Homo sapiens	Inhibition	%	3.0
	2025324	CHEMBL886971	Inhibition of human GSK3alpha relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	4.0	CHEMBL2850	Homo sapiens	Inhibition	%	4.0
	2025325	CHEMBL886971	Inhibition of human GSK3alpha relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	Inhibition	%	9.0
	2025326	CHEMBL886971	Inhibition of human GSK3alpha relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	4.0	CHEMBL2850	Homo sapiens	Inhibition	%	4.0
	2051572	CHEMBL942713	Inhibition of GSK3 alpha	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	911.0	CHEMBL2850	Homo sapiens	Ki	uM	0.911
Not Active	2058391	CHEMBL926492	Inhibition of recombinant GSKalpha	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233		Activity			CHEMBL2850	Homo sapiens	Activity		
	2081794	CHEMBL928817	Inhibition of GSK3-alpha at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2850	Homo sapiens	Inhibition	%	20.0
	2136795	CHEMBL937185	Binding affinity to GSK3alpha	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	nM	5.0
	2136895	CHEMBL937656	Inhibition of GSK3alpha	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	1500.0	CHEMBL2850	Homo sapiens	IC50	nM	1500.0
	2147274	CHEMBL921864	Activity of human GSK3-alpha kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL2850	Homo sapiens	Activity	%	110.0
	2172850	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	CC(C)(C)n1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL404689	=	Inhibition	%	88.0	CHEMBL2850	Homo sapiens	Inhibition	%	88.0
	2172853	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=C(O)c1cccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)c1		CHEMBL257401	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	Inhibition	%	1.0
	2172854	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=C(O)c1ccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)cc1		CHEMBL257562	=	Inhibition	%	93.0	CHEMBL2850	Homo sapiens	Inhibition	%	93.0
	2172855	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	CCCCOC(=O)c1ccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)cc1		CHEMBL257564	=	Inhibition	%	6.0	CHEMBL2850	Homo sapiens	Inhibition	%	6.0
	2172856	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=c1[nH]c2cnc(Nc3ccccc3)nc2n1-c1ccccc1		CHEMBL402529	=	Inhibition	%	-7.0	CHEMBL2850	Homo sapiens	Inhibition	%	-7.0
	2172857	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=c1n(-c2ccccc2)c2nc(Nc3ccccc3)ncc2n1C1CCCCC1		CHEMBL404049	=	Inhibition	%	16.0	CHEMBL2850	Homo sapiens	Inhibition	%	16.0
	2172858	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	Cn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256139	=	Inhibition	%	94.0	CHEMBL2850	Homo sapiens	Inhibition	%	94.0
	2172859	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	CCn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256346	=	Inhibition	%	73.0	CHEMBL2850	Homo sapiens	Inhibition	%	73.0
	2172873	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL257188	=	IC50	nM	270.0	CHEMBL2850	Homo sapiens	IC50	uM	0.27
	2172883	CHEMBL928211	Inhibition of GSK3alpha	B	O=C1CN(c2ccccc2)c2nc(Nc3ccc(C(=O)O)cc3)ncc2N1		CHEMBL403856	=	IC50	nM	6700.0	CHEMBL2850	Homo sapiens	IC50	uM	6.7
	2172884	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc3c(Cl)nn(-c4ccccc4)c3n2)cc1		CHEMBL253740	=	IC50	nM	350.0	CHEMBL2850	Homo sapiens	IC50	uM	0.35
	2172885	CHEMBL928211	Inhibition of GSK3alpha	B	COc1nn(-c2ccccc2)c2nc(Nc3ccc(C(=O)O)cc3)ncc12		CHEMBL253533	=	IC50	nM	1900.0	CHEMBL2850	Homo sapiens	IC50	uM	1.9
	2172886	CHEMBL928211	Inhibition of GSK3alpha	B	Cn1c(=O)c2cnc(Nc3ccc(C(=O)O)cc3)nc2n1-c1ccccc1		CHEMBL401918	=	IC50	nM	1020.0	CHEMBL2850	Homo sapiens	IC50	uM	1.02
	2172887	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1		CHEMBL256307	=	IC50	nM	3760.0	CHEMBL2850	Homo sapiens	IC50	uM	3.76
	2172888	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3)n2)cc1		CHEMBL256306	=	IC50	nM	750.0	CHEMBL2850	Homo sapiens	IC50	uM	0.75
	2172889	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc(C3C=NN=N3)c(Nc3ccccc3)n2)cc1		CHEMBL428596	=	IC50	nM	2850.0	CHEMBL2850	Homo sapiens	IC50	uM	2.85
	2172890	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc(-c3ccncc3)c(Nc3ccccc3)n2)cc1		CHEMBL256987	=	IC50	nM	1870.0	CHEMBL2850	Homo sapiens	IC50	uM	1.87
	2172891	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=C(O)c1ccc(Nc2ncc(Br)c(Nc3ccccc3)n2)cc1		CHEMBL404687	=	Inhibition	%	82.0	CHEMBL2850	Homo sapiens	Inhibition	%	82.0
	2172914	CHEMBL928211	Inhibition of GSK3alpha	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1F)(C3)C2		CHEMBL254587	=	IC50	nM	1499.0	CHEMBL2850	Homo sapiens	IC50	nM	1499.0
	2172915	CHEMBL928211	Inhibition of GSK3alpha	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Cl)(C3)C2		CHEMBL257370	=	IC50	nM	133.0	CHEMBL2850	Homo sapiens	IC50	nM	133.0
	2172916	CHEMBL928211	Inhibition of GSK3alpha	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Br)(C3)C2		CHEMBL403385	=	IC50	nM	91.0	CHEMBL2850	Homo sapiens	IC50	nM	91.0
	2172917	CHEMBL928211	Inhibition of GSK3alpha	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1C(F)(F)F)(C3)C2		CHEMBL255905	=	IC50	nM	61.0	CHEMBL2850	Homo sapiens	IC50	nM	61.0
	2172918	CHEMBL928211	Inhibition of GSK3alpha	B	OC12CC3CC(C1)CC(n1nnc4cnc(N[C@H]5CC[C@H](O)CC5)nc41)(C3)C2		CHEMBL254155	=	IC50	nM	444.0	CHEMBL2850	Homo sapiens	IC50	nM	444.0
	2172919	CHEMBL928211	Inhibition of GSK3alpha	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1NC12CC3CC(CC(O)(C3)C1)C2		CHEMBL404174	=	IC50	nM	123.0	CHEMBL2850	Homo sapiens	IC50	nM	123.0
	2172920	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)COc1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL254350	=	IC50	nM	96.0	CHEMBL2850	Homo sapiens	IC50	nM	96.0
	2172921	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)CCc1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL404175	=	IC50	nM	38.0	CHEMBL2850	Homo sapiens	IC50	nM	38.0
	2172922	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL257575	=	IC50	nM	66.0	CHEMBL2850	Homo sapiens	IC50	nM	66.0
	2172923	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(O)(C5)C3)C4)n2)cc1		CHEMBL402902	=	IC50	nM	4.5	CHEMBL2850	Homo sapiens	IC50	nM	4.5
	2172924	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(C6)C4)C5)c3n2)cc1		CHEMBL257577	=	IC50	nM	80.0	CHEMBL2850	Homo sapiens	IC50	nM	80.0
	2172925	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL253748	=	IC50	nM	34.0	CHEMBL2850	Homo sapiens	IC50	nM	34.0
	2172926	CHEMBL928211	Inhibition of GSK3alpha	B	O=C1OC(Nc2ncc3nnn(-c4ccccc4)c3n2)c2ccccc21		CHEMBL253956	=	IC50	nM	23.0	CHEMBL2850	Homo sapiens	IC50	nM	23.0
	2172927	CHEMBL928211	Inhibition of GSK3alpha	B	COC(=O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404242	=	IC50	nM	204.0	CHEMBL2850	Homo sapiens	IC50	nM	204.0
Not Determined	2172928	CHEMBL928211	Inhibition of GSK3alpha	B	COC(=O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL253958		IC50			CHEMBL2850	Homo sapiens	IC50		
	2172929	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402541	=	IC50	nM	9.0	CHEMBL2850	Homo sapiens	IC50	nM	9.0
	2172930	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL402969	=	IC50	nM	74.0	CHEMBL2850	Homo sapiens	IC50	nM	74.0
	2172931	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)/C=C\c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL255735	=	IC50	nM	13.0	CHEMBL2850	Homo sapiens	IC50	nM	13.0
	2172932	CHEMBL928211	Inhibition of GSK3alpha	B	O[C@H]1CC[C@H](Nc2ncc3nnn(-c4ccccc4)c3n2)CC1		CHEMBL255948	=	IC50	nM	123.0	CHEMBL2850	Homo sapiens	IC50	nM	123.0
	2172933	CHEMBL928211	Inhibition of GSK3alpha	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1Nc1ccccc1		CHEMBL256517	=	IC50	nM	172.0	CHEMBL2850	Homo sapiens	IC50	nM	172.0
	2172934	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)CCc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404565	=	IC50	nM	20.0	CHEMBL2850	Homo sapiens	IC50	nM	20.0
	2172935	CHEMBL928211	Inhibition of GSK3alpha	B	O=C(O)c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402932	=	IC50	nM	32.0	CHEMBL2850	Homo sapiens	IC50	nM	32.0
	2172936	CHEMBL928211	Inhibition of GSK3alpha	B	c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL256518	=	IC50	nM	330.0	CHEMBL2850	Homo sapiens	IC50	nM	330.0
	2172937	CHEMBL928208	Inhibition of GSK3-alpha at 10 uM	B	O=[N+]([O-])c1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL256366	=	Inhibition	%	52.0	CHEMBL2850	Homo sapiens	Inhibition	%	52.0
	2251041	CHEMBL1011065	Inhibition of GSK3alpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	16.0	CHEMBL2850	Homo sapiens	INH	%	16.0
	2470237	CHEMBL984523	Inhibition of GSK3A at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2850	Homo sapiens	INH	%	10.0
Not Evaluated	2476756	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2478595	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2478798	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2850	Homo sapiens	Activity		
	2479653	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.8	CHEMBL2850	Homo sapiens	Activity	%	0.8
Not Evaluated	2479856	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL2850	Homo sapiens	Activity		
	2480653	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.85	CHEMBL2850	Homo sapiens	Activity	%	0.85
Not Evaluated	2480855	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2850	Homo sapiens	Activity		
	2486598	CHEMBL994965	Inhibition of GSK3alpha	B	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	=	Ki	nM	1110.0	CHEMBL2850	Homo sapiens	Ki	uM	1.11
	2572351	CHEMBL985653	Inhibition of GSK3alpha	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	25000.0	CHEMBL2850	Homo sapiens	IC50	uM	25.0
	2577274	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	2.0	CHEMBL2850	Homo sapiens	Activity	%	2.0
Not Evaluated	2577477	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2850	Homo sapiens	Activity		
	2593682	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	30.35	CHEMBL2850	Homo sapiens	Activity	%	30.35
	2593948	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	17.1	CHEMBL2850	Homo sapiens	Activity	%	17.1
Not Evaluated	2594151	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2594891	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2595094	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2596291	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2850	Homo sapiens	Activity		
Active	2596494	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2850	Homo sapiens	Activity		
Not Evaluated	2597763	CHEMBL983554	Binding affinity to human GSK3A at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2850	Homo sapiens	Activity		
	2721619	CHEMBL1057447	Inhibition of GSK3alpha at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	2893543	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893544	CHEMBL1061900	Binding constant for full-length GSK3A	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893545	CHEMBL1061900	Binding constant for full-length GSK3A	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893546	CHEMBL1061900	Binding constant for full-length GSK3A	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893547	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893548	CHEMBL1061900	Binding constant for full-length GSK3A	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	28.0	CHEMBL2850	Homo sapiens	Kd	nM	28.0
	2893549	CHEMBL1061900	Binding constant for full-length GSK3A	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893550	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893551	CHEMBL1061900	Binding constant for full-length GSK3A	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893552	CHEMBL1061900	Binding constant for full-length GSK3A	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893553	CHEMBL1061900	Binding constant for full-length GSK3A	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893554	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893555	CHEMBL1061900	Binding constant for full-length GSK3A	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893556	CHEMBL1061900	Binding constant for full-length GSK3A	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893557	CHEMBL1061900	Binding constant for full-length GSK3A	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1300.0	CHEMBL2850	Homo sapiens	Kd	nM	1300.0
	2893558	CHEMBL1061900	Binding constant for full-length GSK3A	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893559	CHEMBL1061900	Binding constant for full-length GSK3A	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893560	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893561	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893562	CHEMBL1061900	Binding constant for full-length GSK3A	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	160.0	CHEMBL2850	Homo sapiens	Kd	nM	160.0
	2893563	CHEMBL1061900	Binding constant for full-length GSK3A	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893564	CHEMBL1061900	Binding constant for full-length GSK3A	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893565	CHEMBL1061900	Binding constant for full-length GSK3A	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893566	CHEMBL1061900	Binding constant for full-length GSK3A	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893567	CHEMBL1061900	Binding constant for full-length GSK3A	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893568	CHEMBL1061900	Binding constant for full-length GSK3A	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2500.0	CHEMBL2850	Homo sapiens	Kd	nM	2500.0
	2893569	CHEMBL1061900	Binding constant for full-length GSK3A	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893570	CHEMBL1061900	Binding constant for full-length GSK3A	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893571	CHEMBL1061900	Binding constant for full-length GSK3A	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893572	CHEMBL1061900	Binding constant for full-length GSK3A	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893573	CHEMBL1061900	Binding constant for full-length GSK3A	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893574	CHEMBL1061900	Binding constant for full-length GSK3A	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893575	CHEMBL1061900	Binding constant for full-length GSK3A	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	140.0	CHEMBL2850	Homo sapiens	Kd	nM	140.0
	2893576	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893577	CHEMBL1061900	Binding constant for full-length GSK3A	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893578	CHEMBL1061900	Binding constant for full-length GSK3A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893579	CHEMBL1061900	Binding constant for full-length GSK3A	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2893580	CHEMBL1061900	Binding constant for full-length GSK3A	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	2921320	CHEMBL1053745	Inhibition of GSK3A assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	3052623	CHEMBL1038409	Residual activity of GSK3alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL2850	Homo sapiens	Residual activity	%	96.0
	3053932	CHEMBL1046824	Residual activity of GSK3alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	27.0	CHEMBL2850	Homo sapiens	Residual activity	%	27.0
	3054184	CHEMBL1040652	Residual activity of GSK3alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL2850	Homo sapiens	Residual activity	%	103.0
	3055471	CHEMBL1038409	Residual activity of GSK3alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	87.0	CHEMBL2850	Homo sapiens	Residual activity	%	87.0
	3056776	CHEMBL1046824	Residual activity of GSK3alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	28.0	CHEMBL2850	Homo sapiens	Residual activity	%	28.0
	3057028	CHEMBL1040652	Residual activity of GSK3alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL2850	Homo sapiens	Residual activity	%	95.0
	3058348	CHEMBL1038409	Residual activity of GSK3alpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	83.0	CHEMBL2850	Homo sapiens	Residual activity	%	83.0
	3058600	CHEMBL1046824	Residual activity of GSK3alpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	62.0	CHEMBL2850	Homo sapiens	Residual activity	%	62.0
	3072946	CHEMBL1040652	Residual activity of GSK3alpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL2850	Homo sapiens	Residual activity	%	104.0
	3084382	CHEMBL1072661	Inhibition of GSK3alpha	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	170.0	CHEMBL2850	Homo sapiens	IC50	uM	0.17
	3203256	CHEMBL1102981	Inhibition of GSK3alpha	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	1.5	CHEMBL2850	Homo sapiens	Kd	uM	0.0015
	3213925	CHEMBL1114881	Inhibition of GSK3alpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-2.0	CHEMBL2850	Homo sapiens	INH	%	-2.0
	3219673	CHEMBL1110424	Inhibition of GSK3alpha at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	8.0	CHEMBL2850	Homo sapiens	INH	%	8.0
	3224836	CHEMBL1100487	Inhibition of GSK3alpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3225086	CHEMBL1100487	Inhibition of GSK3alpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3240808	CHEMBL1109696	Inhibition of GSK3alpha	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	uM	1.0
	3251260	CHEMBL1107915	Inhibition of GSK3alpha	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	10.6	CHEMBL2850	Homo sapiens	IC50	nM	10.6
	3304853	CHEMBL1120002	Inhibition of GSK3alpha	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Ki	nM	10000.0	CHEMBL2850	Homo sapiens	Ki	uM	10.0
	3331962	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3333377	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3334782	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3336202	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3337545	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3337795	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3339129	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3340431	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3340730	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3342146	CHEMBL1169252	Inhibition of GSK3A at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	3358598	CHEMBL1174443	Inhibition of GSK3A at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	3359040	CHEMBL1174443	Inhibition of GSK3A at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	3370934	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	c1cncc(-c2nc3c(OC4CCCC4)ncnc3[nH]2)c1		CHEMBL1210663	=	Activity	%	57.0	CHEMBL2850	Homo sapiens	Activity	%	57.0
	3370935	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12		CHEMBL1210661	=	Activity	%	49.0	CHEMBL2850	Homo sapiens	Activity	%	49.0
	3370936	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1ncnc2[nH]c(-c3cccc(C#N)c3)nc12		CHEMBL1210602	=	Activity	%	79.0	CHEMBL2850	Homo sapiens	Activity	%	79.0
	3370937	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(/C=C/c3ccccc3)nc12)c1cccc(Br)c1		CHEMBL1210598	=	Activity	%	92.0	CHEMBL2850	Homo sapiens	Activity	%	92.0
	3370938	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(C(=O)Nc2ncnc3[nH]c(-c4cccnc4)nc23)cc1		CHEMBL1210541	=	Activity	%	43.0	CHEMBL2850	Homo sapiens	Activity	%	43.0
	3370939	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(C(=O)Nc2ncnc3[nH]c(/C=C/c4ccccc4)nc23)cc1		CHEMBL1210540	=	Activity	%	96.0	CHEMBL2850	Homo sapiens	Activity	%	96.0
	3370940	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12)c1ccccc1		CHEMBL1210539	=	Activity	%	83.0	CHEMBL2850	Homo sapiens	Activity	%	83.0
	3370941	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	N#Cc1cccc(-c2nc3c(NC(=O)c4ccccc4)ncnc3[nH]2)c1		CHEMBL1210538	=	Activity	%	69.0	CHEMBL2850	Homo sapiens	Activity	%	69.0
	3370942	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3cccc(Cl)c3)nc12)c1ccccc1		CHEMBL1210537	=	Activity	%	60.0	CHEMBL2850	Homo sapiens	Activity	%	60.0
	3370943	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3cccnc3)nc12)c1ccccc1		CHEMBL1210480	=	Activity	%	61.0	CHEMBL2850	Homo sapiens	Activity	%	61.0
	3370944	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(/C=C/c3ccccc3)nc12)c1ccccc1		CHEMBL1210479	=	Activity	%	47.0	CHEMBL2850	Homo sapiens	Activity	%	47.0
	3370945	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccccc3)nc12)c1ccccc1		CHEMBL1210478	=	Activity	%	67.0	CHEMBL2850	Homo sapiens	Activity	%	67.0
	3370946	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	CCCCC(=O)Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12		CHEMBL1210477	=	Activity	%	31.0	CHEMBL2850	Homo sapiens	Activity	%	31.0
	3370947	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	CCCCC(=O)Nc1ncnc2[nH]c(-c3cccc(C#N)c3)nc12		CHEMBL1210476	=	Activity	%	34.0	CHEMBL2850	Homo sapiens	Activity	%	34.0
	3370948	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	CCCCC(=O)Nc1ncnc2[nH]c(/C=C/c3ccccc3)nc12		CHEMBL1210410	=	Activity	%	55.0	CHEMBL2850	Homo sapiens	Activity	%	55.0
	3370949	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3cccc(Cl)c3)nc12)C1CC1		CHEMBL1210310	=	Activity	%	17.0	CHEMBL2850	Homo sapiens	Activity	%	17.0
	3370950	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(/C=C/c3ccccc3)nc12)C1CC1		CHEMBL1210309	=	Activity	%	55.0	CHEMBL2850	Homo sapiens	Activity	%	55.0
	3370951	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	OCNc1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210307	=	Activity	%	50.0	CHEMBL2850	Homo sapiens	Activity	%	50.0
	3370952	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	C(=C/c1nc2c(NCc3cccnc3)ncnc2[nH]1)\c1ccccc1		CHEMBL1210305	=	Activity	%	84.0	CHEMBL2850	Homo sapiens	Activity	%	84.0
	3370953	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	N#Cc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL1210236	=	Activity	%	2.0	CHEMBL2850	Homo sapiens	Activity	%	2.0
	3370954	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	C(=C/c1nc2c(Nc3ccccc3)ncnc2[nH]1)\c1ccccc1		CHEMBL1210176	=	Activity	%	58.0	CHEMBL2850	Homo sapiens	Activity	%	58.0
	3370955	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	c1ccc(Nc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210175	=	Activity	%	5.0	CHEMBL2850	Homo sapiens	Activity	%	5.0
	3370956	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	C(=C/c1nc2c(NCCN3CCOCC3)ncnc2[nH]1)\c1ccccc1		CHEMBL1210174	=	Activity	%	99.0	CHEMBL2850	Homo sapiens	Activity	%	99.0
	3370957	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	C(=C/c1nc2c(N3CCCC3)ncnc2[nH]1)\c1ccccc1		CHEMBL1210113	=	Activity	%	87.0	CHEMBL2850	Homo sapiens	Activity	%	87.0
	3370958	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(C(=O)Nc2ncnc3[nH]c(-c4cccc(Cl)c4)nc23)cc1		CHEMBL1210597	=	Activity	%	71.0	CHEMBL2850	Homo sapiens	Activity	%	71.0
	3370959	CHEMBL1211210	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	N#Cc1cccc(-c2nc3c(NC(=O)C4CC4)ncnc3[nH]2)c1		CHEMBL1210405	=	Activity	%	30.0	CHEMBL2850	Homo sapiens	Activity	%	30.0
	3419150	CHEMBL1228780	Inhibition of GSK3alpha	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	3419167	CHEMBL1228780	Inhibition of GSK3alpha	B	NC(=O)c1sc2c([N+](=O)[O-])cc(SC(F)(F)F)cc2[n+]1[O-]		CHEMBL1222044	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	3443411	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	8.0	CHEMBL2850	Homo sapiens	INH	%	8.0
	3443628	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	23.0	CHEMBL2850	Homo sapiens	INH	%	23.0
	3444783	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	INH	%	9.0
	3445137	CHEMBL1244859	Binding affinity to GSK3A	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2300.0	CHEMBL2850	Homo sapiens	Kd	nM	2300.0
	3445407	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	3445624	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	13.0	CHEMBL2850	Homo sapiens	INH	%	13.0
	3445832	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	INH	%	9.0
	3446022	CHEMBL1244444	Inhibition of GSK3alpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	3447571	CHEMBL1249828	Inhibition of GSK3alpha	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	uM	0.004
	3447572	CHEMBL1249828	Inhibition of GSK3alpha	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	IC50	nM	18.0	CHEMBL2850	Homo sapiens	IC50	uM	0.018
	3447573	CHEMBL1249828	Inhibition of GSK3alpha	B	CN(C)CCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL1242556	=	IC50	nM	22.0	CHEMBL2850	Homo sapiens	IC50	uM	0.022
	3447574	CHEMBL1249828	Inhibition of GSK3alpha	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	uM	0.007
	3447575	CHEMBL1249828	Inhibition of GSK3alpha	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	=	IC50	nM	0.65	CHEMBL2850	Homo sapiens	IC50	uM	0.00065
	3447576	CHEMBL1249828	Inhibition of GSK3alpha	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	10.0	CHEMBL2850	Homo sapiens	IC50	uM	0.01
	3447612	CHEMBL1249828	Inhibition of GSK3alpha	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	IC50	nM	76.0	CHEMBL2850	Homo sapiens	IC50	uM	0.076
	3447613	CHEMBL1249828	Inhibition of GSK3alpha	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	78.0	CHEMBL2850	Homo sapiens	IC50	uM	0.078
	3447614	CHEMBL1249828	Inhibition of GSK3alpha	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	34.0	CHEMBL2850	Homo sapiens	IC50	uM	0.034
	3448448	CHEMBL1244859	Binding affinity to GSK3A	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	3448945	CHEMBL1244859	Binding affinity to GSK3A	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2500.0	CHEMBL2850	Homo sapiens	Kd	nM	2500.0
	3449681	CHEMBL1244859	Binding affinity to GSK3A	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	3450091	CHEMBL1244859	Binding affinity to GSK3A	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	3450343	CHEMBL1244859	Binding affinity to GSK3A	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	3451009	CHEMBL1244859	Binding affinity to GSK3A	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	uM	10.0
	3463245	CHEMBL1252433	Inhibition of GSK3A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	84.0	CHEMBL2850	Homo sapiens	INH	%	84.0
	3463789	CHEMBL1252433	Inhibition of GSK3A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	80.0	CHEMBL2850	Homo sapiens	INH	%	80.0
	3464008	CHEMBL1252433	Inhibition of GSK3A at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	69.0	CHEMBL2850	Homo sapiens	INH	%	69.0
	3556510	CHEMBL1285588	Inhibition of GSK3A at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	34.0	CHEMBL2850	Homo sapiens	INH	%	34.0
	5120259	CHEMBL1645979	Inhibition of human GSK3alpha at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	85.0	CHEMBL2850	Homo sapiens	INH	%	85.0
	5203065	CHEMBL1670831	Inhibition of human recombinant GSK3alpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	1900.0	CHEMBL2850	Homo sapiens	IC50	uM	1.9
	5203066	CHEMBL1670831	Inhibition of human recombinant GSK3alpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	5203067	CHEMBL1670831	Inhibition of human recombinant GSK3alpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	6173485	CHEMBL1768224	Inhibition of GSK3alpha at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	16.0	CHEMBL2850	Homo sapiens	INH	%	16.0
	6174999	CHEMBL1767716	Inhibition of human recombinant GSK3A at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1		CHEMBL1738742	=	Inhibition	%	32.0	CHEMBL2850	Homo sapiens	INH	%	32.0
	6175016	CHEMBL1767716	Inhibition of human recombinant GSK3A at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Inhibition	%	13.0	CHEMBL2850	Homo sapiens	INH	%	13.0
	6193922	CHEMBL1777659	Inhibition of GSK3alpha at 10 uM	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	3.5	CHEMBL2850	Homo sapiens	INH	%	3.5
	6193933	CHEMBL1777659	Inhibition of GSK3alpha at 10 uM	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	29.3	CHEMBL2850	Homo sapiens	INH	%	29.3
	6265549	CHEMBL1798258	Inhibition of GSK3A at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	6265653	CHEMBL1798258	Inhibition of GSK3A at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	6340944	CHEMBL1827268	Activity of GSK3A kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	93.0	CHEMBL2850	Homo sapiens	Activity	%	93.0
	6343505	CHEMBL1827976	Inhibition of GSK3alpha at 28 uM by luciferase fragment complementation assay	B	CCOc1ccc(OCC(O)CN(C)Cc2c(C)nn(Cc3ccccc3Cl)c2C)cc1		CHEMBL1223751	>	Inhibition	%	27.0	CHEMBL2850	Homo sapiens	INH	%	27.0
	6343506	CHEMBL1827977	Inhibition of GSK3alpha at 16 uM by luciferase fragment complementation assay	B	Cc1nn(Cc2ccccc2Cl)c(C)c1CN(C)CC(O)COc1ccc(Cl)cc1		CHEMBL1824695	>	Inhibition	%	27.0	CHEMBL2850	Homo sapiens	INH	%	27.0
	6347905	CHEMBL1828473	Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	70000.0	CHEMBL2850	Homo sapiens	IC50	mM	0.07
	6347911	CHEMBL1828473	Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1	Outside typical range	CHEMBL1824539	=	IC50	nM	1120000.0	CHEMBL2850	Homo sapiens	IC50	mM	1.12
	6347917	CHEMBL1828473	Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1	Outside typical range	CHEMBL1824540	=	IC50	nM	220000.0	CHEMBL2850	Homo sapiens	IC50	mM	0.22
	6347923	CHEMBL1828473	Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1	Outside typical range	CHEMBL1824334	=	IC50	nM	370000.0	CHEMBL2850	Homo sapiens	IC50	mM	0.37
	6347929	CHEMBL1828473	Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1	Outside typical range	CHEMBL1824332	=	IC50	nM	130000.0	CHEMBL2850	Homo sapiens	IC50	mM	0.13
	6384464	CHEMBL1837411	Inhibition of human GSK3alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	=	Inhibition	%	93.6	CHEMBL2850	Homo sapiens	INH	%	93.6
	6384465	CHEMBL1837411	Inhibition of human GSK3alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	>	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	6384466	CHEMBL1837411	Inhibition of human GSK3alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	>	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	6384467	CHEMBL1837411	Inhibition of human GSK3alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	=	Inhibition	%	96.7	CHEMBL2850	Homo sapiens	INH	%	96.7
	6384468	CHEMBL1837411	Inhibition of human GSK3alpha in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	>	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
active	6430392	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(CN1C(=O)CCC1=O)Nc1cccc2c1C(=O)NC2=O		CHEMBL1545694	=	AC50	nM	459.0	CHEMBL2850	Homo sapiens	AC50	uM	0.459
active	6430393	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(Nc1ccsc1C(=O)NC1CCCCC1)c1ccc(F)cc1		CHEMBL588859	=	AC50	nM	24900.0	CHEMBL2850	Homo sapiens	AC50	uM	24.9
active	6430394	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOc1ccccc1/C=N/NC(=O)c1nnn(-c2nonc2N)c1CN1CCC(C)CC1		CHEMBL1904855	=	AC50	nM	39.2	CHEMBL2850	Homo sapiens	AC50	uM	0.0392
active	6430395	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccc2nc3c(cc2c1)c(NC(=O)CC(C)C)nn3CC(C)C		CHEMBL1731237	=	AC50	nM	1480.0	CHEMBL2850	Homo sapiens	AC50	uM	1.48
active	6430396	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCNc1nc(N)c(C(=O)c2ccc(Cl)s2)s1		CHEMBL1448605	<	AC50	nM	21.8	CHEMBL2850	Homo sapiens	AC50	uM	0.0218
active	6430397	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O/N=C/c1cn(-c2ccccc2)nc1-c1ccc2c(c1)OCCO2		CHEMBL1896042	=	AC50	nM	984.0	CHEMBL2850	Homo sapiens	AC50	uM	0.984
active	6430398	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CN(C)Cc1c(C(=O)N/N=C/c2ccncc2)nnn1-c1nonc1N		CHEMBL1903171	=	AC50	nM	597.0	CHEMBL2850	Homo sapiens	AC50	uM	0.597
active	6430399	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Fc1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1471916	=	AC50	nM	3370.0	CHEMBL2850	Homo sapiens	AC50	uM	3.37
active	6430400	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	144.0	CHEMBL2850	Homo sapiens	AC50	uM	0.144
active	6430401	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(CSc1ccc2nnc(-c3cccs3)n2n1)N1CCCC1		CHEMBL1344120	=	AC50	nM	2080.0	CHEMBL2850	Homo sapiens	AC50	uM	2.08
active	6430402	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1cc(/C=N/Nc2ccc([N+](=O)[O-])cn2)cc(OC)c1O		CHEMBL1884163	=	AC50	nM	367.0	CHEMBL2850	Homo sapiens	AC50	uM	0.367
active	6430403	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1nnn(-c2nonc2N)c1CSc1nc2ccccc2s1		CHEMBL1310209	=	AC50	nM	4240.0	CHEMBL2850	Homo sapiens	AC50	uM	4.24
active	6430404	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(Nc1cccc(Cl)c1)Nc1ccnc(-c2cccnc2)n1		CHEMBL1341040	=	AC50	nM	3970.0	CHEMBL2850	Homo sapiens	AC50	uM	3.97
active	6430405	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1c2ccccc2-c2onc3ccc(NCCCN4CCNC4)c1c23		CHEMBL1881885	=	AC50	nM	520.0	CHEMBL2850	Homo sapiens	AC50	uM	0.52
active	6430406	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2cccc(Cl)c2)c1[N+](=O)[O-]		CHEMBL1447858	=	AC50	nM	429.0	CHEMBL2850	Homo sapiens	AC50	uM	0.429
active	6430407	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccccc2F)c1-c1cccs1		CHEMBL1896181	=	AC50	nM	422.0	CHEMBL2850	Homo sapiens	AC50	uM	0.422
active	6430408	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOC(=O)c1ccc2ncc(C(=O)OCC)c(Nc3ccc(N4CCOCC4)cc3)c2c1		CHEMBL1300063	=	AC50	nM	3560.0	CHEMBL2850	Homo sapiens	AC50	uM	3.56
active	6430409	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCN(CCC)Cc1c(C(=O)N/N=C/c2ccoc2)nnn1-c1nonc1N		CHEMBL1890348	=	AC50	nM	1240.0	CHEMBL2850	Homo sapiens	AC50	uM	1.24
active	6430410	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccccc1Nc1nc(NCCO)nc(N)c1[N+](=O)[O-]		CHEMBL1369106	=	AC50	nM	276.0	CHEMBL2850	Homo sapiens	AC50	uM	0.276
active	6430411	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	206.0	CHEMBL2850	Homo sapiens	AC50	uM	0.206
active	6430412	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccccc2Cl)c1CN1CCOCC1		CHEMBL1871132	=	AC50	nM	5640.0	CHEMBL2850	Homo sapiens	AC50	uM	5.64
active	6430413	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1ccc(-c2nc(NCCCn3ccnc3)c3ccccc3n2)cc1		CHEMBL1399850	=	AC50	nM	11180.0	CHEMBL2850	Homo sapiens	AC50	uM	11.18
active	6430414	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1cccc(C(=O)c2sc(NC(C)C)nc2N)c1		CHEMBL1464354	=	AC50	nM	288.0	CHEMBL2850	Homo sapiens	AC50	uM	0.288
active	6430415	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(Nc2ccccc2)nc(NC2CCCCC2)c1[N+](=O)[O-]		CHEMBL1538986	=	AC50	nM	2600.0	CHEMBL2850	Homo sapiens	AC50	uM	2.6
active	6430416	CHEMBL1794317	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Cn1c(SCc2nnc(-c3ccc(F)cc3)o2)nnc1C1COc2ccccc2O1		CHEMBL1547186	=	AC50	nM	1330.0	CHEMBL2850	Homo sapiens	AC50	uM	1.33
active	7011202	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2cc(C(=O)NCCN3CCCCCC3)ccc2S/C1=C\c1ccccc1		CHEMBL1431441	=	AC50	nM	63730.0	CHEMBL2850	Homo sapiens	AC50	uM	63.73
active	7011203	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(Nc2cccc(F)c2)nc(NCCO)c1[N+](=O)[O-]		CHEMBL1405580	=	AC50	nM	953.0	CHEMBL2850	Homo sapiens	AC50	uM	0.953
active	7011204	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccc2nc(NC(=O)CCNC(=O)c3ccccc3Cl)sc2c1		CHEMBL1498228	=	AC50	nM	8010.0	CHEMBL2850	Homo sapiens	AC50	uM	8.01
active	7011205	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1ccc2c(CSc3nnc(-c4ccncc4)o3)cccc2c1		CHEMBL1547788	=	AC50	nM	2930.0	CHEMBL2850	Homo sapiens	AC50	uM	2.93
active	7011206	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O/N=C/c1cn(-c2ccccc2)nc1-c1cccnc1		CHEMBL1870845	=	AC50	nM	828.0	CHEMBL2850	Homo sapiens	AC50	uM	0.828
active	7011207	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1ccc(CSc2ccc3nnc(-c4ccc(OC)cc4)n3n2)o1		CHEMBL1585498	=	AC50	nM	6840.0	CHEMBL2850	Homo sapiens	AC50	uM	6.84
active	7011208	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2ccc(F)cc2)c1[N+](=O)[O-]		CHEMBL1382985	=	AC50	nM	1250.0	CHEMBL2850	Homo sapiens	AC50	uM	1.25
active	7011209	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1cncc(-c2nc(NCCCn3cccc3)c3ccccc3n2)c1		CHEMBL1895793	=	AC50	nM	7630.0	CHEMBL2850	Homo sapiens	AC50	uM	7.63
active	7011210	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2cccc(F)c2)c1[N+](=O)[O-]		CHEMBL1521195	=	AC50	nM	698.0	CHEMBL2850	Homo sapiens	AC50	uM	0.698
active	7011211	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCn1nc(NC(=O)c2cccs2)c2cc3cc(OC)ccc3nc21		CHEMBL1534168	=	AC50	nM	9590.0	CHEMBL2850	Homo sapiens	AC50	uM	9.59
active	7011212	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOC(=O)c1nnn(-c2nonc2N)c1CSc1ccc(C)cc1		CHEMBL1580903	=	AC50	nM	8320.0	CHEMBL2850	Homo sapiens	AC50	uM	8.32
active	7011213	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	C=CCNc1nc(N)c([N+](=O)[O-])c(Nc2ccccc2OC)n1		CHEMBL1433424	=	AC50	nM	388.0	CHEMBL2850	Homo sapiens	AC50	uM	0.388
active	7011214	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCn1nc(NC(=O)C(C)C)c2cc3cc(OC)ccc3nc21		CHEMBL1301070	=	AC50	nM	38500.0	CHEMBL2850	Homo sapiens	AC50	uM	38.5
active	7011215	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1700288	=	AC50	nM	1670.0	CHEMBL2850	Homo sapiens	AC50	uM	1.67
active	7011216	CHEMBL1794559	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCCOC(=O)C1C(C)=Nc2ncnn2C1c1cccc(OC)c1OC		CHEMBL1905464	=	AC50	nM	989.0	CHEMBL2850	Homo sapiens	AC50	uM	0.989
	7567532	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7568003	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7568471	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7568903	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7569046	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7569506	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7569978	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7570441	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7570868	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7571022	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7571479	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7571955	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7572418	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7572834	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7573003	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7573460	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7573936	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	380.0	CHEMBL2850	Homo sapiens	Kd	nM	380.0
	7574981	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	430.0	CHEMBL2850	Homo sapiens	Kd	nM	430.0
	7575442	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7575936	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2500.0	CHEMBL2850	Homo sapiens	Kd	nM	2500.0
	7576344	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7576955	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7577414	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7577450	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7577920	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7578325	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7578963	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	3900.0	CHEMBL2850	Homo sapiens	Kd	nM	3900.0
	7579337	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7579819	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7580288	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7580691	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7581709	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1300.0	CHEMBL2850	Homo sapiens	Kd	nM	1300.0
	7582180	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7582644	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7583044	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7583225	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7583622	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7584067	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7584538	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7585000	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	2500.0	CHEMBL2850	Homo sapiens	Kd	nM	2500.0
	7585404	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7585555	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7585963	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	28.0	CHEMBL2850	Homo sapiens	Kd	nM	28.0
	7586409	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7586880	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7587334	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	280.0	CHEMBL2850	Homo sapiens	Kd	nM	280.0
	7587516	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7587935	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7588388	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7588859	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7589310	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7589481	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7589905	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2300.0	CHEMBL2850	Homo sapiens	Kd	nM	2300.0
	7590372	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7590846	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7591454	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7591876	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7592348	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7592832	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7593421	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	8500.0	CHEMBL2850	Homo sapiens	Kd	nM	8500.0
	7593856	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7594359	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7594811	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7595389	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	23.0	CHEMBL2850	Homo sapiens	Kd	nM	23.0
	7595833	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7595865	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	5200.0	CHEMBL2850	Homo sapiens	Kd	nM	5200.0
	7596336	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7596783	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7597361	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7597845	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7598315	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2850	Homo sapiens	Kd	nM	10000.0
	7598757	CHEMBL1908811	Binding constant for GSK3A kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	140.0	CHEMBL2850	Homo sapiens	Kd	nM	140.0
	7931094	CHEMBL1919269	Inhibition of GSK3A relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	8.0	CHEMBL2850	Homo sapiens	INH	%	8.0
	8003404	CHEMBL1944412	Inhibition of human GSK3alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	=	Inhibition	%	95.2	CHEMBL2850	Homo sapiens	INH	%	95.2
	8003405	CHEMBL1944412	Inhibition of human GSK3alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	>	Inhibition	%	99.5	CHEMBL2850	Homo sapiens	INH	%	99.5
	8003406	CHEMBL1944412	Inhibition of human GSK3alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	=	Inhibition	%	94.3	CHEMBL2850	Homo sapiens	INH	%	94.3
	8003407	CHEMBL1944412	Inhibition of human GSK3alpha in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	>	Inhibition	%	99.5	CHEMBL2850	Homo sapiens	INH	%	99.5
	8017823	CHEMBL1948807	Inhibition of GSK3alpha	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	IC50	nM	600.0	CHEMBL2850	Homo sapiens	IC50	uM	0.6
	8017824	CHEMBL1948807	Inhibition of GSK3alpha	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	IC50	nM	990.0	CHEMBL2850	Homo sapiens	IC50	uM	0.99
	8018780	CHEMBL1948830	Inhibition of GSK3alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	39.0	CHEMBL2850	Homo sapiens	Activity	%	39.0
	8018781	CHEMBL1948830	Inhibition of GSK3alpha assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	16.0	CHEMBL2850	Homo sapiens	Activity	%	16.0
	8018782	CHEMBL1948830	Inhibition of GSK3alpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	3.0	CHEMBL2850	Homo sapiens	Activity	%	3.0
	8047315	CHEMBL1960795	Inhibition of GSK3alpha	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	IC50	nM	1260.0	CHEMBL2850	Homo sapiens	IC50	nM	1260.0
	8047316	CHEMBL1960795	Inhibition of GSK3alpha	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21		CHEMBL1956071	=	IC50	nM	9100.0	CHEMBL2850	Homo sapiens	IC50	nM	9100.0
	8061302	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.59	CHEMBL2850	Homo sapiens	Inhibition	%	4.59
	8061479	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	19.61	CHEMBL2850	Homo sapiens	Inhibition	%	19.61
	8061810	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	12.72	CHEMBL2850	Homo sapiens	Inhibition	%	12.72
	8062001	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.33	CHEMBL2850	Homo sapiens	Inhibition	%	4.33
	8062341	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.08	CHEMBL2850	Homo sapiens	Inhibition	%	10.08
	8062503	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	83.24	CHEMBL2850	Homo sapiens	Inhibition	%	83.24
	8062727	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	17.34	CHEMBL2850	Homo sapiens	Inhibition	%	17.34
	8062825	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	7.82	CHEMBL2850	Homo sapiens	Inhibition	%	7.82
	8063181	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	32.55	CHEMBL2850	Homo sapiens	Inhibition	%	32.55
	8063348	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.46	CHEMBL2850	Homo sapiens	Inhibition	%	2.46
	8063680	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.47	CHEMBL2850	Homo sapiens	Inhibition	%	2.47
	8063862	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.22	CHEMBL2850	Homo sapiens	Inhibition	%	12.22
	8064086	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.83	CHEMBL2850	Homo sapiens	Inhibition	%	5.83
	8064201	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	52.06	CHEMBL2850	Homo sapiens	Inhibition	%	52.06
	8064411	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.34	CHEMBL2850	Homo sapiens	Inhibition	%	1.34
	8064635	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	8.31	CHEMBL2850	Homo sapiens	Inhibition	%	8.31
	8064773	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	8.4	CHEMBL2850	Homo sapiens	Inhibition	%	8.4
	8064939	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.98	CHEMBL2850	Homo sapiens	Inhibition	%	3.98
	8065163	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.01	CHEMBL2850	Homo sapiens	Inhibition	%	3.01
	8065279	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.92	CHEMBL2850	Homo sapiens	Inhibition	%	3.92
	8065678	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	22.43	CHEMBL2850	Homo sapiens	Inhibition	%	22.43
	8065793	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	8.94	CHEMBL2850	Homo sapiens	Inhibition	%	8.94
	8066017	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	46.57	CHEMBL2850	Homo sapiens	Inhibition	%	46.57
	8066227	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.44	CHEMBL2850	Homo sapiens	Inhibition	%	0.44
	8066363	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	38.41	CHEMBL2850	Homo sapiens	Inhibition	%	38.41
	8066753	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	8.2	CHEMBL2850	Homo sapiens	Inhibition	%	8.2
	8066877	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.27	CHEMBL2850	Homo sapiens	Inhibition	%	2.27
	8067101	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	5.24	CHEMBL2850	Homo sapiens	Inhibition	%	5.24
	8067276	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.8	CHEMBL2850	Homo sapiens	Inhibition	%	2.8
	8067621	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.02	CHEMBL2850	Homo sapiens	Inhibition	%	1.02
	8067831	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	7.97	CHEMBL2850	Homo sapiens	Inhibition	%	7.97
	8067966	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	49.66	CHEMBL2850	Homo sapiens	Inhibition	%	49.66
	8068190	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	86.83	CHEMBL2850	Homo sapiens	Inhibition	%	86.83
	8068354	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.76	CHEMBL2850	Homo sapiens	Inhibition	%	5.76
	8068703	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.69	CHEMBL2850	Homo sapiens	Inhibition	%	0.69
	8068877	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.37	CHEMBL2850	Homo sapiens	Inhibition	%	7.37
	8069226	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	6.14	CHEMBL2850	Homo sapiens	Inhibition	%	6.14
	8069521	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	71.92	CHEMBL2850	Homo sapiens	Inhibition	%	71.92
	8069682	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	25.59	CHEMBL2850	Homo sapiens	Inhibition	%	25.59
	8070032	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.28	CHEMBL2850	Homo sapiens	Inhibition	%	2.28
	8070204	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.07	CHEMBL2850	Homo sapiens	Inhibition	%	4.07
	8070428	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	11.46	CHEMBL2850	Homo sapiens	Inhibition	%	11.46
	8070553	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.61	CHEMBL2850	Homo sapiens	Inhibition	%	0.61
	8070851	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	94.53	CHEMBL2850	Homo sapiens	Inhibition	%	94.53
	8071008	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8071232	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	6.57	CHEMBL2850	Homo sapiens	Inhibition	%	6.57
	8071358	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.39	CHEMBL2850	Homo sapiens	Inhibition	%	0.39
	8071755	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	36.91	CHEMBL2850	Homo sapiens	Inhibition	%	36.91
	8071880	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.95	CHEMBL2850	Homo sapiens	Inhibition	%	2.95
	8072194	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.75	CHEMBL2850	Homo sapiens	Inhibition	%	1.75
	8072575	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.23	CHEMBL2850	Homo sapiens	Inhibition	%	4.23
	8072700	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.15	CHEMBL2850	Homo sapiens	Inhibition	%	1.15
	8072924	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.04	CHEMBL2850	Homo sapiens	Inhibition	%	0.04
	8073091	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	80.64	CHEMBL2850	Homo sapiens	Inhibition	%	80.64
	8073216	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.71	CHEMBL2850	Homo sapiens	Inhibition	%	0.71
	8073440	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	4.01	CHEMBL2850	Homo sapiens	Inhibition	%	4.01
	8073559	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.1	CHEMBL2850	Homo sapiens	Inhibition	%	4.1
	8073792	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	7.54	CHEMBL2850	Homo sapiens	Inhibition	%	7.54
	8074016	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.1	CHEMBL2850	Homo sapiens	Inhibition	%	5.1
	8074168	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.26	CHEMBL2850	Homo sapiens	Inhibition	%	8.26
	8074522	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.19	CHEMBL2850	Homo sapiens	Inhibition	%	1.19
	8074679	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.87	CHEMBL2850	Homo sapiens	Inhibition	%	1.87
	8075030	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.06	CHEMBL2850	Homo sapiens	Inhibition	%	0.06
	8075141	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	31.34	CHEMBL2850	Homo sapiens	Inhibition	%	31.34
	8075365	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.11	CHEMBL2850	Homo sapiens	Inhibition	%	-0.11
	8075602	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	21.57	CHEMBL2850	Homo sapiens	Inhibition	%	21.57
	8075743	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	32.78	CHEMBL2850	Homo sapiens	Inhibition	%	32.78
	8076109	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.19	CHEMBL2850	Homo sapiens	Inhibition	%	-0.19
	8076257	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.05	CHEMBL2850	Homo sapiens	Inhibition	%	3.05
	8076481	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.82	CHEMBL2850	Homo sapiens	Inhibition	%	0.82
	8076615	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.49	CHEMBL2850	Homo sapiens	Inhibition	%	3.49
	8076941	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	4.21	CHEMBL2850	Homo sapiens	Inhibition	%	4.21
	8077188	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	52.71	CHEMBL2850	Homo sapiens	Inhibition	%	52.71
	8077316	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	77.55	CHEMBL2850	Homo sapiens	Inhibition	%	77.55
	8077540	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.41	CHEMBL2850	Homo sapiens	Inhibition	%	2.41
	8077691	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.58	CHEMBL2850	Homo sapiens	Inhibition	%	4.58
	8078058	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.18	CHEMBL2850	Homo sapiens	Inhibition	%	3.18
	8078197	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.79	CHEMBL2850	Homo sapiens	Inhibition	%	1.79
	8078523	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.4	CHEMBL2850	Homo sapiens	Inhibition	%	1.4
	8078773	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	86.12	CHEMBL2850	Homo sapiens	Inhibition	%	86.12
	8079113	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.82	CHEMBL2850	Homo sapiens	Inhibition	%	4.82
	8079271	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.1	CHEMBL2850	Homo sapiens	Inhibition	%	0.1
	8079637	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.27	CHEMBL2850	Homo sapiens	Inhibition	%	0.27
	8079776	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	23.48	CHEMBL2850	Homo sapiens	Inhibition	%	23.48
	8080000	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.12	CHEMBL2850	Homo sapiens	Inhibition	%	6.12
	8080105	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	5.93	CHEMBL2850	Homo sapiens	Inhibition	%	5.93
	8080357	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	34.75	CHEMBL2850	Homo sapiens	Inhibition	%	34.75
	8080696	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.55	CHEMBL2850	Homo sapiens	Inhibition	%	1.55
	8080860	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.84	CHEMBL2850	Homo sapiens	Inhibition	%	3.84
	8081084	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.13	CHEMBL2850	Homo sapiens	Inhibition	%	0.13
	8081219	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.88	CHEMBL2850	Homo sapiens	Inhibition	%	2.88
	8081587	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.5	CHEMBL2850	Homo sapiens	Inhibition	%	8.5
	8081690	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	30.41	CHEMBL2850	Homo sapiens	Inhibition	%	30.41
	8081942	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	80.56	CHEMBL2850	Homo sapiens	Inhibition	%	80.56
	8082166	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	66.13	CHEMBL2850	Homo sapiens	Inhibition	%	66.13
	8082279	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.44	CHEMBL2850	Homo sapiens	Inhibition	%	4.44
	8082676	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.91	CHEMBL2850	Homo sapiens	Inhibition	%	2.91
	8082799	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.01	CHEMBL2850	Homo sapiens	Inhibition	%	1.01
	8083179	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	40.61	CHEMBL2850	Homo sapiens	Inhibition	%	40.61
	8083278	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	71.27	CHEMBL2850	Homo sapiens	Inhibition	%	71.27
	8083502	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.17	CHEMBL2850	Homo sapiens	Inhibition	%	2.17
	8083756	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	90.76	CHEMBL2850	Homo sapiens	Inhibition	%	90.76
	8083866	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.36	CHEMBL2850	Homo sapiens	Inhibition	%	1.36
	8084090	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.39	CHEMBL2850	Homo sapiens	Inhibition	%	7.39
	8084275	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	55.3	CHEMBL2850	Homo sapiens	Inhibition	%	55.3
	8084393	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.22	CHEMBL2850	Homo sapiens	Inhibition	%	4.22
	8084617	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.84	CHEMBL2850	Homo sapiens	Inhibition	%	1.84
	8084778	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	76.05	CHEMBL2850	Homo sapiens	Inhibition	%	76.05
	8085100	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	10.34	CHEMBL2850	Homo sapiens	Inhibition	%	10.34
	8085356	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.54	CHEMBL2850	Homo sapiens	Inhibition	%	5.54
	8085688	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.08	CHEMBL2850	Homo sapiens	Inhibition	%	3.08
	8085877	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	80.93	CHEMBL2850	Homo sapiens	Inhibition	%	80.93
	8086216	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	5.95	CHEMBL2850	Homo sapiens	Inhibition	%	5.95
	8086378	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	78.23	CHEMBL2850	Homo sapiens	Inhibition	%	78.23
	8086701	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.52	CHEMBL2850	Homo sapiens	Inhibition	%	0.52
	8086912	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-0.55	CHEMBL2850	Homo sapiens	Inhibition	%	-0.55
	8087294	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.84	CHEMBL2850	Homo sapiens	Inhibition	%	1.84
	8087408	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.41	CHEMBL2850	Homo sapiens	Inhibition	%	3.41
	8087632	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.25	CHEMBL2850	Homo sapiens	Inhibition	%	2.25
	8087770	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.93	CHEMBL2850	Homo sapiens	Inhibition	%	3.93
	8088136	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.61	CHEMBL2850	Homo sapiens	Inhibition	%	2.61
	8088284	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.48	CHEMBL2850	Homo sapiens	Inhibition	%	1.48
	8088636	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.02	CHEMBL2850	Homo sapiens	Inhibition	%	3.02
	8088953	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	23.98	CHEMBL2850	Homo sapiens	Inhibition	%	23.98
	8089081	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.45	CHEMBL2850	Homo sapiens	Inhibition	%	3.45
	8089305	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.53	CHEMBL2850	Homo sapiens	Inhibition	%	9.53
	8089453	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	13.85	CHEMBL2850	Homo sapiens	Inhibition	%	13.85
	8089797	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.38	CHEMBL2850	Homo sapiens	Inhibition	%	0.38
	8089977	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.65	CHEMBL2850	Homo sapiens	Inhibition	%	-0.65
	8090142	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.62	CHEMBL2850	Homo sapiens	Inhibition	%	1.62
	8090366	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.06	CHEMBL2850	Homo sapiens	Inhibition	%	2.06
	8090533	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.02	CHEMBL2850	Homo sapiens	Inhibition	%	5.02
	8090896	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.09	CHEMBL2850	Homo sapiens	Inhibition	%	2.09
	8091101	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.32	CHEMBL2850	Homo sapiens	Inhibition	%	2.32
	8091238	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.81	CHEMBL2850	Homo sapiens	Inhibition	%	3.81
	8091462	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.89	CHEMBL2850	Homo sapiens	Inhibition	%	5.89
	8091617	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.42	CHEMBL2850	Homo sapiens	Inhibition	%	3.42
	8091957	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.92	CHEMBL2850	Homo sapiens	Inhibition	%	3.92
	8092094	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.47	CHEMBL2850	Homo sapiens	Inhibition	%	-1.47
	8092318	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.08	CHEMBL2850	Homo sapiens	Inhibition	%	-2.08
	8092469	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.31	CHEMBL2850	Homo sapiens	Inhibition	%	2.31
	8092617	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.56	CHEMBL2850	Homo sapiens	Inhibition	%	3.56
	8092841	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.69	CHEMBL2850	Homo sapiens	Inhibition	%	1.69
	8092970	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.38	CHEMBL2850	Homo sapiens	Inhibition	%	6.38
	8093282	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.04	CHEMBL2850	Homo sapiens	Inhibition	%	7.04
	8093646	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	37.36	CHEMBL2850	Homo sapiens	Inhibition	%	37.36
	8093785	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	53.45	CHEMBL2850	Homo sapiens	Inhibition	%	53.45
	8094129	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.64	CHEMBL2850	Homo sapiens	Inhibition	%	1.64
	8094309	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.36	CHEMBL2850	Homo sapiens	Inhibition	%	0.36
	8094708	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.88	CHEMBL2850	Homo sapiens	Inhibition	%	3.88
	8094864	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	13.06	CHEMBL2850	Homo sapiens	Inhibition	%	13.06
	8095228	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	9.4	CHEMBL2850	Homo sapiens	Inhibition	%	9.4
	8095431	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.44	CHEMBL2850	Homo sapiens	Inhibition	%	3.44
	8095796	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	28.09	CHEMBL2850	Homo sapiens	Inhibition	%	28.09
	8095944	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.71	CHEMBL2850	Homo sapiens	Inhibition	%	4.71
	8096285	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.18	CHEMBL2850	Homo sapiens	Inhibition	%	4.18
	8096648	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.1	CHEMBL2850	Homo sapiens	Inhibition	%	1.1
	8096804	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.97	CHEMBL2850	Homo sapiens	Inhibition	%	2.97
	8097175	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	6.14	CHEMBL2850	Homo sapiens	Inhibition	%	6.14
	8097482	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	18.22	CHEMBL2850	Homo sapiens	Inhibition	%	18.22
	8097856	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	78.49	CHEMBL2850	Homo sapiens	Inhibition	%	78.49
	8097989	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.54	CHEMBL2850	Homo sapiens	Inhibition	%	-2.54
	8098213	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.82	CHEMBL2850	Homo sapiens	Inhibition	%	1.82
	8098333	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.06	CHEMBL2850	Homo sapiens	Inhibition	%	1.06
	8098513	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.72	CHEMBL2850	Homo sapiens	Inhibition	%	0.72
	8098737	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.11	CHEMBL2850	Homo sapiens	Inhibition	%	1.11
	8098922	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.19	CHEMBL2850	Homo sapiens	Inhibition	%	5.19
	8099066	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8099290	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.78	CHEMBL2850	Homo sapiens	Inhibition	%	4.78
	8099432	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.6	CHEMBL2850	Homo sapiens	Inhibition	%	1.6
	8099626	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	5.27	CHEMBL2850	Homo sapiens	Inhibition	%	5.27
	8099850	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	24.26	CHEMBL2850	Homo sapiens	Inhibition	%	24.26
	8099997	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	19.36	CHEMBL2850	Homo sapiens	Inhibition	%	19.36
	8100143	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.57	CHEMBL2850	Homo sapiens	Inhibition	%	6.57
	8100367	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	31.57	CHEMBL2850	Homo sapiens	Inhibition	%	31.57
	8100483	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.44	CHEMBL2850	Homo sapiens	Inhibition	%	3.44
	8100847	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.03	CHEMBL2850	Homo sapiens	Inhibition	%	1.03
	8101007	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.0	CHEMBL2850	Homo sapiens	Inhibition	%	3.0
	8101231	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.53	CHEMBL2850	Homo sapiens	Inhibition	%	4.53
	8101373	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.71	CHEMBL2850	Homo sapiens	Inhibition	%	5.71
	8101558	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.42	CHEMBL2850	Homo sapiens	Inhibition	%	-1.42
	8101782	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	1.7	CHEMBL2850	Homo sapiens	Inhibition	%	1.7
	8101811	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	78.9	CHEMBL2850	Homo sapiens	Inhibition	%	78.9
	8102035	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	83.48	CHEMBL2850	Homo sapiens	Inhibition	%	83.48
	8102190	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	8.87	CHEMBL2850	Homo sapiens	Inhibition	%	8.87
	8102545	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.34	CHEMBL2850	Homo sapiens	Inhibition	%	0.34
	8102665	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	3.48	CHEMBL2850	Homo sapiens	Inhibition	%	3.48
	8103067	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.51	CHEMBL2850	Homo sapiens	Inhibition	%	1.51
	8103263	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	36.81	CHEMBL2850	Homo sapiens	Inhibition	%	36.81
	8103625	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	3.82	CHEMBL2850	Homo sapiens	Inhibition	%	3.82
	8103775	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.73	CHEMBL2850	Homo sapiens	Inhibition	%	3.73
	8104184	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.91	CHEMBL2850	Homo sapiens	Inhibition	%	3.91
	8104332	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	55.65	CHEMBL2850	Homo sapiens	Inhibition	%	55.65
	8104702	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	67.44	CHEMBL2850	Homo sapiens	Inhibition	%	67.44
	8104816	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.66	CHEMBL2850	Homo sapiens	Inhibition	%	1.66
	8105040	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.69	CHEMBL2850	Homo sapiens	Inhibition	%	2.69
	8105180	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.79	CHEMBL2850	Homo sapiens	Inhibition	%	0.79
	8105570	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.18	CHEMBL2850	Homo sapiens	Inhibition	%	-1.18
	8105708	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	34.44	CHEMBL2850	Homo sapiens	Inhibition	%	34.44
	8105988	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.72	CHEMBL2850	Homo sapiens	Inhibition	%	2.72
	8106377	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.87	CHEMBL2850	Homo sapiens	Inhibition	%	2.87
	8106533	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	42.07	CHEMBL2850	Homo sapiens	Inhibition	%	42.07
	8106886	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.7	CHEMBL2850	Homo sapiens	Inhibition	%	2.7
	8107007	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.29	CHEMBL2850	Homo sapiens	Inhibition	%	2.29
	8107231	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.64	CHEMBL2850	Homo sapiens	Inhibition	%	3.64
	8107403	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.61	CHEMBL2850	Homo sapiens	Inhibition	%	1.61
	8107604	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	73.58	CHEMBL2850	Homo sapiens	Inhibition	%	73.58
	8107963	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	21.03	CHEMBL2850	Homo sapiens	Inhibition	%	21.03
	8108121	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.13	CHEMBL2850	Homo sapiens	Inhibition	%	2.13
	8108345	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.93	CHEMBL2850	Homo sapiens	Inhibition	%	5.93
	8108520	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	3.54	CHEMBL2850	Homo sapiens	Inhibition	%	3.54
	8108667	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.39	CHEMBL2850	Homo sapiens	Inhibition	%	4.39
	8108891	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	10.15	CHEMBL2850	Homo sapiens	Inhibition	%	10.15
	8109033	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8109371	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.56	CHEMBL2850	Homo sapiens	Inhibition	%	4.56
	8109501	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.27	CHEMBL2850	Homo sapiens	Inhibition	%	2.27
	8109725	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.92	CHEMBL2850	Homo sapiens	Inhibition	%	1.92
	8109896	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.34	CHEMBL2850	Homo sapiens	Inhibition	%	-0.34
	8110028	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.75	CHEMBL2850	Homo sapiens	Inhibition	%	3.75
	8110252	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	14.55	CHEMBL2850	Homo sapiens	Inhibition	%	14.55
	8110307	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.35	CHEMBL2850	Homo sapiens	Inhibition	%	5.35
	8110531	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.78	CHEMBL2850	Homo sapiens	Inhibition	%	1.78
	8110697	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.76	CHEMBL2850	Homo sapiens	Inhibition	%	7.76
	8110855	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.52	CHEMBL2850	Homo sapiens	Inhibition	%	0.52
	8111079	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	9.28	CHEMBL2850	Homo sapiens	Inhibition	%	9.28
	8111202	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.53	CHEMBL2850	Homo sapiens	Inhibition	%	1.53
	8111553	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	9.78	CHEMBL2850	Homo sapiens	Inhibition	%	9.78
	8111719	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.55	CHEMBL2850	Homo sapiens	Inhibition	%	2.55
	8111924	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.32	CHEMBL2850	Homo sapiens	Inhibition	%	4.32
	8112148	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	12.33	CHEMBL2850	Homo sapiens	Inhibition	%	12.33
	8112285	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.39	CHEMBL2850	Homo sapiens	Inhibition	%	4.39
	8112677	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.06	CHEMBL2850	Homo sapiens	Inhibition	%	3.06
	8112849	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.65	CHEMBL2850	Homo sapiens	Inhibition	%	4.65
	8113225	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.55	CHEMBL2850	Homo sapiens	Inhibition	%	11.55
	8113361	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.63	CHEMBL2850	Homo sapiens	Inhibition	%	5.63
	8113709	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.51	CHEMBL2850	Homo sapiens	Inhibition	%	4.51
	8114049	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.57	CHEMBL2850	Homo sapiens	Inhibition	%	0.57
	8114225	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.81	CHEMBL2850	Homo sapiens	Inhibition	%	2.81
	8114581	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.67	CHEMBL2850	Homo sapiens	Inhibition	%	3.67
	8114857	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.84	CHEMBL2850	Homo sapiens	Inhibition	%	1.84
	8115023	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	7.6	CHEMBL2850	Homo sapiens	Inhibition	%	7.6
	8115412	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.36	CHEMBL2850	Homo sapiens	Inhibition	%	0.36
	8115532	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	4.83	CHEMBL2850	Homo sapiens	Inhibition	%	4.83
	8115889	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	44.41	CHEMBL2850	Homo sapiens	Inhibition	%	44.41
	8116048	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	23.19	CHEMBL2850	Homo sapiens	Inhibition	%	23.19
	8116272	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	65.21	CHEMBL2850	Homo sapiens	Inhibition	%	65.21
	8116475	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	12.32	CHEMBL2850	Homo sapiens	Inhibition	%	12.32
	8116609	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	11.6	CHEMBL2850	Homo sapiens	Inhibition	%	11.6
	8116833	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	4.22	CHEMBL2850	Homo sapiens	Inhibition	%	4.22
	8117005	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.87	CHEMBL2850	Homo sapiens	Inhibition	%	4.87
	8117176	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.47	CHEMBL2850	Homo sapiens	Inhibition	%	5.47
	8117558	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	49.86	CHEMBL2850	Homo sapiens	Inhibition	%	49.86
	8117688	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.58	CHEMBL2850	Homo sapiens	Inhibition	%	1.58
	8117912	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.24	CHEMBL2850	Homo sapiens	Inhibition	%	4.24
	8118050	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.07	CHEMBL2850	Homo sapiens	Inhibition	%	0.07
	8118390	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.76	CHEMBL2850	Homo sapiens	Inhibition	%	1.76
	8118562	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.39	CHEMBL2850	Homo sapiens	Inhibition	%	1.39
	8118922	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.09	CHEMBL2850	Homo sapiens	Inhibition	%	6.09
	8119193	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.24	CHEMBL2850	Homo sapiens	Inhibition	%	-0.24
	8119352	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	17.5	CHEMBL2850	Homo sapiens	Inhibition	%	17.5
	8119576	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	47.68	CHEMBL2850	Homo sapiens	Inhibition	%	47.68
	8119743	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.39	CHEMBL2850	Homo sapiens	Inhibition	%	1.39
	8119862	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.3	CHEMBL2850	Homo sapiens	Inhibition	%	1.3
	8120086	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.03	CHEMBL2850	Homo sapiens	Inhibition	%	3.03
	8120225	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	5.44	CHEMBL2850	Homo sapiens	Inhibition	%	5.44
	8120609	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.95	CHEMBL2850	Homo sapiens	Inhibition	%	1.95
	8120810	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	48.94	CHEMBL2850	Homo sapiens	Inhibition	%	48.94
	8121162	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	16.52	CHEMBL2850	Homo sapiens	Inhibition	%	16.52
	8121334	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.45	CHEMBL2850	Homo sapiens	Inhibition	%	2.45
	8121501	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	49.52	CHEMBL2850	Homo sapiens	Inhibition	%	49.52
	8121725	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	68.0	CHEMBL2850	Homo sapiens	Inhibition	%	68.0
	8121888	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.13	CHEMBL2850	Homo sapiens	Inhibition	%	5.13
	8122233	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.13	CHEMBL2850	Homo sapiens	Inhibition	%	1.13
	8122371	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.94	CHEMBL2850	Homo sapiens	Inhibition	%	2.94
	8122715	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.57	CHEMBL2850	Homo sapiens	Inhibition	%	2.57
	8122882	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.81	CHEMBL2850	Homo sapiens	Inhibition	%	2.81
	8123106	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.76	CHEMBL2850	Homo sapiens	Inhibition	%	3.76
	8123248	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.16	CHEMBL2850	Homo sapiens	Inhibition	%	0.16
	8123526	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.07	CHEMBL2850	Homo sapiens	Inhibition	%	1.07
	8123900	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	79.21	CHEMBL2850	Homo sapiens	Inhibition	%	79.21
	8124067	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.64	CHEMBL2850	Homo sapiens	Inhibition	%	3.64
	8124410	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	60.7	CHEMBL2850	Homo sapiens	Inhibition	%	60.7
	8124549	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	10.47	CHEMBL2850	Homo sapiens	Inhibition	%	10.47
	8124773	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	48.3	CHEMBL2850	Homo sapiens	Inhibition	%	48.3
	8124938	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.19	CHEMBL2850	Homo sapiens	Inhibition	%	3.19
	8125139	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.69	CHEMBL2850	Homo sapiens	Inhibition	%	3.69
	8125493	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	80.54	CHEMBL2850	Homo sapiens	Inhibition	%	80.54
	8125661	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.62	CHEMBL2850	Homo sapiens	Inhibition	%	3.62
	8126049	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	85.34	CHEMBL2850	Homo sapiens	Inhibition	%	85.34
	8126213	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	11.91	CHEMBL2850	Homo sapiens	Inhibition	%	11.91
	8126552	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	6.32	CHEMBL2850	Homo sapiens	Inhibition	%	6.32
	8126688	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	25.23	CHEMBL2850	Homo sapiens	Inhibition	%	25.23
	8126912	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	62.8	CHEMBL2850	Homo sapiens	Inhibition	%	62.8
	8127034	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.97	CHEMBL2850	Homo sapiens	Inhibition	%	2.97
	8127425	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.67	CHEMBL2850	Homo sapiens	Inhibition	%	2.67
	8127567	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	4.9	CHEMBL2850	Homo sapiens	Inhibition	%	4.9
	8127855	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.37	CHEMBL2850	Homo sapiens	Inhibition	%	0.37
	8128231	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.93	CHEMBL2850	Homo sapiens	Inhibition	%	6.93
	8128398	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	34.68	CHEMBL2850	Homo sapiens	Inhibition	%	34.68
	8128741	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	79.45	CHEMBL2850	Homo sapiens	Inhibition	%	79.45
	8129102	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	85.02	CHEMBL2850	Homo sapiens	Inhibition	%	85.02
	8129273	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.52	CHEMBL2850	Homo sapiens	Inhibition	%	-0.52
	8129462	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.13	CHEMBL2850	Homo sapiens	Inhibition	%	7.13
	8129686	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.9	CHEMBL2850	Homo sapiens	Inhibition	%	2.9
	8129825	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	82.37	CHEMBL2850	Homo sapiens	Inhibition	%	82.37
	8129986	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.64	CHEMBL2850	Homo sapiens	Inhibition	%	3.64
	8130210	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	7.01	CHEMBL2850	Homo sapiens	Inhibition	%	7.01
	8130382	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	89.9	CHEMBL2850	Homo sapiens	Inhibition	%	89.9
	8130542	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	24.4	CHEMBL2850	Homo sapiens	Inhibition	%	24.4
	8130766	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	65.75	CHEMBL2850	Homo sapiens	Inhibition	%	65.75
	8130882	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.47	CHEMBL2850	Homo sapiens	Inhibition	%	1.47
	8131245	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.26	CHEMBL2850	Homo sapiens	Inhibition	%	4.26
	8131365	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.77	CHEMBL2850	Homo sapiens	Inhibition	%	2.77
	8131589	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.06	CHEMBL2850	Homo sapiens	Inhibition	%	-1.06
	8131756	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.61	CHEMBL2850	Homo sapiens	Inhibition	%	5.61
	8131897	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	3.15	CHEMBL2850	Homo sapiens	Inhibition	%	3.15
	8132121	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.54	CHEMBL2850	Homo sapiens	Inhibition	%	9.54
	8132183	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.14	CHEMBL2850	Homo sapiens	Inhibition	%	0.14
	8132407	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.99	CHEMBL2850	Homo sapiens	Inhibition	%	-2.99
	8132554	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	10.18	CHEMBL2850	Homo sapiens	Inhibition	%	10.18
	8132722	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.11	CHEMBL2850	Homo sapiens	Inhibition	%	3.11
	8132946	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	8.27	CHEMBL2850	Homo sapiens	Inhibition	%	8.27
	8133067	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.42	CHEMBL2850	Homo sapiens	Inhibition	%	2.42
	8133429	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	88.84	CHEMBL2850	Homo sapiens	Inhibition	%	88.84
	8133601	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.36	CHEMBL2850	Homo sapiens	Inhibition	%	-0.36
	8134005	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.98	CHEMBL2850	Homo sapiens	Inhibition	%	4.98
	8134153	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	5.87	CHEMBL2850	Homo sapiens	Inhibition	%	5.87
	8134537	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	10.99	CHEMBL2850	Homo sapiens	Inhibition	%	10.99
	8134721	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	7.94	CHEMBL2850	Homo sapiens	Inhibition	%	7.94
	8135105	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.73	CHEMBL2850	Homo sapiens	Inhibition	%	5.73
	8135220	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.81	CHEMBL2850	Homo sapiens	Inhibition	%	3.81
	8135444	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.36	CHEMBL2850	Homo sapiens	Inhibition	%	3.36
	8135585	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.7	CHEMBL2850	Homo sapiens	Inhibition	%	7.7
	8135930	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.44	CHEMBL2850	Homo sapiens	Inhibition	%	-1.44
	8136098	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	14.76	CHEMBL2850	Homo sapiens	Inhibition	%	14.76
	8136466	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.07	CHEMBL2850	Homo sapiens	Inhibition	%	2.07
	8136756	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.13	CHEMBL2850	Homo sapiens	Inhibition	%	-1.13
	8136891	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.15	CHEMBL2850	Homo sapiens	Inhibition	%	0.15
	8137278	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	31.91	CHEMBL2850	Homo sapiens	Inhibition	%	31.91
	8137398	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	9.8	CHEMBL2850	Homo sapiens	Inhibition	%	9.8
	8137622	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-2.93	CHEMBL2850	Homo sapiens	Inhibition	%	-2.93
	8137770	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	93.94	CHEMBL2850	Homo sapiens	Inhibition	%	93.94
	8137936	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.74	CHEMBL2850	Homo sapiens	Inhibition	%	-0.74
	8138160	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.03	CHEMBL2850	Homo sapiens	Inhibition	%	0.03
	8138339	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.47	CHEMBL2850	Homo sapiens	Inhibition	%	6.47
	8138487	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	7.92	CHEMBL2850	Homo sapiens	Inhibition	%	7.92
	8138711	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.52	CHEMBL2850	Homo sapiens	Inhibition	%	1.52
	8138869	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.83	CHEMBL2850	Homo sapiens	Inhibition	%	0.83
	8139054	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	19.55	CHEMBL2850	Homo sapiens	Inhibition	%	19.55
	8139278	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.99	CHEMBL2850	Homo sapiens	Inhibition	%	0.99
	8139437	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	12.54	CHEMBL2850	Homo sapiens	Inhibition	%	12.54
	8139775	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.82	CHEMBL2850	Homo sapiens	Inhibition	%	3.82
	8139916	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.26	CHEMBL2850	Homo sapiens	Inhibition	%	3.26
	8140263	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.11	CHEMBL2850	Homo sapiens	Inhibition	%	2.11
	8140422	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	58.14	CHEMBL2850	Homo sapiens	Inhibition	%	58.14
	8140646	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.5	CHEMBL2850	Homo sapiens	Inhibition	%	3.5
	8140789	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.18	CHEMBL2850	Homo sapiens	Inhibition	%	5.18
	8141091	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.35	CHEMBL2850	Homo sapiens	Inhibition	%	0.35
	8141221	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.5	CHEMBL2850	Homo sapiens	Inhibition	%	4.5
	8141445	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	11.53	CHEMBL2850	Homo sapiens	Inhibition	%	11.53
	8141605	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	71.83	CHEMBL2850	Homo sapiens	Inhibition	%	71.83
	8141948	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.82	CHEMBL2850	Homo sapiens	Inhibition	%	-0.82
	8142109	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.99	CHEMBL2850	Homo sapiens	Inhibition	%	0.99
	8142501	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.56	CHEMBL2850	Homo sapiens	Inhibition	%	-0.56
	8142677	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.93	CHEMBL2850	Homo sapiens	Inhibition	%	4.93
	8143050	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	3.31	CHEMBL2850	Homo sapiens	Inhibition	%	3.31
	8143205	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.01	CHEMBL2850	Homo sapiens	Inhibition	%	2.01
	8143616	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.19	CHEMBL2850	Homo sapiens	Inhibition	%	5.19
	8143775	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	22.57	CHEMBL2850	Homo sapiens	Inhibition	%	22.57
	8144113	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.62	CHEMBL2850	Homo sapiens	Inhibition	%	-0.62
	8144252	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.28	CHEMBL2850	Homo sapiens	Inhibition	%	5.28
	8144476	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.66	CHEMBL2850	Homo sapiens	Inhibition	%	2.66
	8144606	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.87	CHEMBL2850	Homo sapiens	Inhibition	%	1.87
	8144983	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.1	CHEMBL2850	Homo sapiens	Inhibition	%	5.1
	8145120	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.49	CHEMBL2850	Homo sapiens	Inhibition	%	3.49
	8145433	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.16	CHEMBL2850	Homo sapiens	Inhibition	%	1.16
	8145781	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	48.87	CHEMBL2850	Homo sapiens	Inhibition	%	48.87
	8145942	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.09	CHEMBL2850	Homo sapiens	Inhibition	%	4.09
	8146286	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.12	CHEMBL2850	Homo sapiens	Inhibition	%	0.12
	8146446	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.53	CHEMBL2850	Homo sapiens	Inhibition	%	2.53
	8146670	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.22	CHEMBL2850	Homo sapiens	Inhibition	%	1.22
	8146837	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.65	CHEMBL2850	Homo sapiens	Inhibition	%	2.65
	8147006	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	80.48	CHEMBL2850	Homo sapiens	Inhibition	%	80.48
	8147372	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	23.54	CHEMBL2850	Homo sapiens	Inhibition	%	23.54
	8147525	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.4	CHEMBL2850	Homo sapiens	Inhibition	%	1.4
	8147749	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.36	CHEMBL2850	Homo sapiens	Inhibition	%	2.36
	8147936	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.38	CHEMBL2850	Homo sapiens	Inhibition	%	9.38
	8148094	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	68.49	CHEMBL2850	Homo sapiens	Inhibition	%	68.49
	8148318	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.96	CHEMBL2850	Homo sapiens	Inhibition	%	4.96
	8148432	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.89	CHEMBL2850	Homo sapiens	Inhibition	%	-0.89
	8148795	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.93	CHEMBL2850	Homo sapiens	Inhibition	%	5.93
	8148933	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.18	CHEMBL2850	Homo sapiens	Inhibition	%	2.18
	8149316	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.48	CHEMBL2850	Homo sapiens	Inhibition	%	-1.48
	8149450	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.1	CHEMBL2850	Homo sapiens	Inhibition	%	4.1
	8149674	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	10.2	CHEMBL2850	Homo sapiens	Inhibition	%	10.2
	8149772	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.71	CHEMBL2850	Homo sapiens	Inhibition	%	1.71
	8150121	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.87	CHEMBL2850	Homo sapiens	Inhibition	%	-1.87
	8150281	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.04	CHEMBL2850	Homo sapiens	Inhibition	%	10.04
	8150505	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.09	CHEMBL2850	Homo sapiens	Inhibition	%	1.09
	8150625	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.68	CHEMBL2850	Homo sapiens	Inhibition	%	0.68
	8151014	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.89	CHEMBL2850	Homo sapiens	Inhibition	%	0.89
	8151177	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.07	CHEMBL2850	Homo sapiens	Inhibition	%	-1.07
	8151354	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	81.69	CHEMBL2850	Homo sapiens	Inhibition	%	81.69
	8151578	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.96	CHEMBL2850	Homo sapiens	Inhibition	%	6.96
	8151716	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	67.78	CHEMBL2850	Homo sapiens	Inhibition	%	67.78
	8152094	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.7	CHEMBL2850	Homo sapiens	Inhibition	%	2.7
	8152282	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	42.94	CHEMBL2850	Homo sapiens	Inhibition	%	42.94
	8152664	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	15.76	CHEMBL2850	Homo sapiens	Inhibition	%	15.76
	8152778	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.43	CHEMBL2850	Homo sapiens	Inhibition	%	2.43
	8153141	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.34	CHEMBL2850	Homo sapiens	Inhibition	%	4.34
	8153278	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.39	CHEMBL2850	Homo sapiens	Inhibition	%	3.39
	8153502	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.98	CHEMBL2850	Homo sapiens	Inhibition	%	2.98
	8153659	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.08	CHEMBL2850	Homo sapiens	Inhibition	%	0.08
	8154016	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	49.73	CHEMBL2850	Homo sapiens	Inhibition	%	49.73
	8154113	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	5.29	CHEMBL2850	Homo sapiens	Inhibition	%	5.29
	8154337	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.32	CHEMBL2850	Homo sapiens	Inhibition	%	3.32
	8154463	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.71	CHEMBL2850	Homo sapiens	Inhibition	%	2.71
	8154846	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.8	CHEMBL2850	Homo sapiens	Inhibition	%	3.8
	8154966	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.99	CHEMBL2850	Homo sapiens	Inhibition	%	0.99
	8155190	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.14	CHEMBL2850	Homo sapiens	Inhibition	%	3.14
	8155366	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.1	CHEMBL2850	Homo sapiens	Inhibition	%	-1.1
	8155527	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.83	CHEMBL2850	Homo sapiens	Inhibition	%	1.83
	8155929	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	9.03	CHEMBL2850	Homo sapiens	Inhibition	%	9.03
	8156067	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	12.08	CHEMBL2850	Homo sapiens	Inhibition	%	12.08
	8156291	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	46.07	CHEMBL2850	Homo sapiens	Inhibition	%	46.07
	8156503	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	12.41	CHEMBL2850	Homo sapiens	Inhibition	%	12.41
	8156653	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	11.35	CHEMBL2850	Homo sapiens	Inhibition	%	11.35
	8157020	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	43.38	CHEMBL2850	Homo sapiens	Inhibition	%	43.38
	8157140	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.5	CHEMBL2850	Homo sapiens	Inhibition	%	6.5
	8157364	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	10.79	CHEMBL2850	Homo sapiens	Inhibition	%	10.79
	8157505	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.88	CHEMBL2850	Homo sapiens	Inhibition	%	2.88
	8157859	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	26.81	CHEMBL2850	Homo sapiens	Inhibition	%	26.81
	8158020	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.34	CHEMBL2850	Homo sapiens	Inhibition	%	0.34
	8158270	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.04	CHEMBL2850	Homo sapiens	Inhibition	%	6.04
	8158494	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.29	CHEMBL2850	Homo sapiens	Inhibition	%	3.29
	8158652	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.65	CHEMBL2850	Homo sapiens	Inhibition	%	5.65
	8158821	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.07	CHEMBL2850	Homo sapiens	Inhibition	%	7.07
	8159045	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	30.37	CHEMBL2850	Homo sapiens	Inhibition	%	30.37
	8159180	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.45	CHEMBL2850	Homo sapiens	Inhibition	%	3.45
	8159524	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.59	CHEMBL2850	Homo sapiens	Inhibition	%	-2.59
	8159655	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.38	CHEMBL2850	Homo sapiens	Inhibition	%	6.38
	8160020	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	5.52	CHEMBL2850	Homo sapiens	Inhibition	%	5.52
	8160157	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	10.59	CHEMBL2850	Homo sapiens	Inhibition	%	10.59
	8160381	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	9.38	CHEMBL2850	Homo sapiens	Inhibition	%	9.38
	8160531	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.95	CHEMBL2850	Homo sapiens	Inhibition	%	0.95
	8160825	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	48.69	CHEMBL2850	Homo sapiens	Inhibition	%	48.69
	8160975	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.05	CHEMBL2850	Homo sapiens	Inhibition	%	4.05
	8161199	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	8.02	CHEMBL2850	Homo sapiens	Inhibition	%	8.02
	8161342	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	75.6	CHEMBL2850	Homo sapiens	Inhibition	%	75.6
	8161691	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	18.98	CHEMBL2850	Homo sapiens	Inhibition	%	18.98
	8161829	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	13.76	CHEMBL2850	Homo sapiens	Inhibition	%	13.76
	8162183	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	69.15	CHEMBL2850	Homo sapiens	Inhibition	%	69.15
	8162343	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.85	CHEMBL2850	Homo sapiens	Inhibition	%	-2.85
	8162567	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.59	CHEMBL2850	Homo sapiens	Inhibition	%	0.59
	8162820	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	19.34	CHEMBL2850	Homo sapiens	Inhibition	%	19.34
	8162968	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	40.41	CHEMBL2850	Homo sapiens	Inhibition	%	40.41
	8163361	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.51	CHEMBL2850	Homo sapiens	Inhibition	%	5.51
	8163495	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.35	CHEMBL2850	Homo sapiens	Inhibition	%	4.35
	8163842	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.28	CHEMBL2850	Homo sapiens	Inhibition	%	1.28
	8163976	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.49	CHEMBL2850	Homo sapiens	Inhibition	%	1.49
	8164200	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8164340	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.97	CHEMBL2850	Homo sapiens	Inhibition	%	1.97
	8164719	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	85.31	CHEMBL2850	Homo sapiens	Inhibition	%	85.31
	8164863	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.67	CHEMBL2850	Homo sapiens	Inhibition	%	5.67
	8165157	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.2	CHEMBL2850	Homo sapiens	Inhibition	%	7.2
	8165522	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	16.4	CHEMBL2850	Homo sapiens	Inhibition	%	16.4
	8165665	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	92.49	CHEMBL2850	Homo sapiens	Inhibition	%	92.49
	8166015	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	61.42	CHEMBL2850	Homo sapiens	Inhibition	%	61.42
	8166153	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.57	CHEMBL2850	Homo sapiens	Inhibition	%	3.57
	8166377	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	7.78	CHEMBL2850	Homo sapiens	Inhibition	%	7.78
	8166507	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.29	CHEMBL2850	Homo sapiens	Inhibition	%	5.29
	8166832	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	17.3	CHEMBL2850	Homo sapiens	Inhibition	%	17.3
	8167144	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	13.95	CHEMBL2850	Homo sapiens	Inhibition	%	13.95
	8167285	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	70.93	CHEMBL2850	Homo sapiens	Inhibition	%	70.93
	8167673	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.65	CHEMBL2850	Homo sapiens	Inhibition	%	6.65
	8167806	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.78	CHEMBL2850	Homo sapiens	Inhibition	%	3.78
	8168030	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.96	CHEMBL2850	Homo sapiens	Inhibition	%	4.96
	8168154	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.66	CHEMBL2850	Homo sapiens	Inhibition	%	-0.66
	8168519	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.74	CHEMBL2850	Homo sapiens	Inhibition	%	3.74
	8168655	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.81	CHEMBL2850	Homo sapiens	Inhibition	%	5.81
	8168879	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.01	CHEMBL2850	Homo sapiens	Inhibition	%	1.01
	8169043	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	89.47	CHEMBL2850	Homo sapiens	Inhibition	%	89.47
	8169185	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.08	CHEMBL2850	Homo sapiens	Inhibition	%	2.08
	8169409	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	7.33	CHEMBL2850	Homo sapiens	Inhibition	%	7.33
	8169489	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	15.62	CHEMBL2850	Homo sapiens	Inhibition	%	15.62
	8169847	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	60.9	CHEMBL2850	Homo sapiens	Inhibition	%	60.9
	8169992	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.22	CHEMBL2850	Homo sapiens	Inhibition	%	1.22
	8170216	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	5.65	CHEMBL2850	Homo sapiens	Inhibition	%	5.65
	8170341	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.97	CHEMBL2850	Homo sapiens	Inhibition	%	3.97
	8170705	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	12.91	CHEMBL2850	Homo sapiens	Inhibition	%	12.91
	8170840	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	14.85	CHEMBL2850	Homo sapiens	Inhibition	%	14.85
	8171064	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	35.58	CHEMBL2850	Homo sapiens	Inhibition	%	35.58
	8171261	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.79	CHEMBL2850	Homo sapiens	Inhibition	%	2.79
	8171478	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	56.53	CHEMBL2850	Homo sapiens	Inhibition	%	56.53
	8171619	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	7.63	CHEMBL2850	Homo sapiens	Inhibition	%	7.63
	8171843	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	21.07	CHEMBL2850	Homo sapiens	Inhibition	%	21.07
	8171996	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	54.49	CHEMBL2850	Homo sapiens	Inhibition	%	54.49
	8172352	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	3.7	CHEMBL2850	Homo sapiens	Inhibition	%	3.7
	8172480	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.33	CHEMBL2850	Homo sapiens	Inhibition	%	-0.33
	8172704	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.15	CHEMBL2850	Homo sapiens	Inhibition	%	1.15
	8172846	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	19.61	CHEMBL2850	Homo sapiens	Inhibition	%	19.61
	8173206	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.15	CHEMBL2850	Homo sapiens	Inhibition	%	3.15
	8173371	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	85.68	CHEMBL2850	Homo sapiens	Inhibition	%	85.68
	8173736	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.28	CHEMBL2850	Homo sapiens	Inhibition	%	4.28
	8173823	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	50.7	CHEMBL2850	Homo sapiens	Inhibition	%	50.7
	8174047	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	86.75	CHEMBL2850	Homo sapiens	Inhibition	%	86.75
	8174179	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.07	CHEMBL2850	Homo sapiens	Inhibition	%	7.07
	8174551	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.5	CHEMBL2850	Homo sapiens	Inhibition	%	1.5
	8174673	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	8.42	CHEMBL2850	Homo sapiens	Inhibition	%	8.42
	8174897	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.4	CHEMBL2850	Homo sapiens	Inhibition	%	3.4
	8175040	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	53.94	CHEMBL2850	Homo sapiens	Inhibition	%	53.94
	8175400	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	76.0	CHEMBL2850	Homo sapiens	Inhibition	%	76.0
	8175656	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	28.23	CHEMBL2850	Homo sapiens	Inhibition	%	28.23
	8175819	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.79	CHEMBL2850	Homo sapiens	Inhibition	%	1.79
	8176196	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	25.57	CHEMBL2850	Homo sapiens	Inhibition	%	25.57
	8176345	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	75.24	CHEMBL2850	Homo sapiens	Inhibition	%	75.24
	8176701	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	14.45	CHEMBL2850	Homo sapiens	Inhibition	%	14.45
	8177055	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.28	CHEMBL2850	Homo sapiens	Inhibition	%	3.28
	8177197	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-2.04	CHEMBL2850	Homo sapiens	Inhibition	%	-2.04
	8177559	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	1.75	CHEMBL2850	Homo sapiens	Inhibition	%	1.75
	8177723	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	90.03	CHEMBL2850	Homo sapiens	Inhibition	%	90.03
	8178087	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	26.14	CHEMBL2850	Homo sapiens	Inhibition	%	26.14
	8178399	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.64	CHEMBL2850	Homo sapiens	Inhibition	%	1.64
	8178526	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	14.34	CHEMBL2850	Homo sapiens	Inhibition	%	14.34
	8178750	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	64.01	CHEMBL2850	Homo sapiens	Inhibition	%	64.01
	8178899	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.17	CHEMBL2850	Homo sapiens	Inhibition	%	3.17
	8179246	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	9.61	CHEMBL2850	Homo sapiens	Inhibition	%	9.61
	8179390	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	35.31	CHEMBL2850	Homo sapiens	Inhibition	%	35.31
	8179751	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.55	CHEMBL2850	Homo sapiens	Inhibition	%	7.55
	8180008	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	79.51	CHEMBL2850	Homo sapiens	Inhibition	%	79.51
	8180162	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.95	CHEMBL2850	Homo sapiens	Inhibition	%	3.95
	8180386	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.13	CHEMBL2850	Homo sapiens	Inhibition	%	-2.13
	8180542	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	66.99	CHEMBL2850	Homo sapiens	Inhibition	%	66.99
	8180690	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	8.28	CHEMBL2850	Homo sapiens	Inhibition	%	8.28
	8180914	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	21.64	CHEMBL2850	Homo sapiens	Inhibition	%	21.64
	8181047	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.64	CHEMBL2850	Homo sapiens	Inhibition	%	2.64
	8181402	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.25	CHEMBL2850	Homo sapiens	Inhibition	%	1.25
	8181542	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.03	CHEMBL2850	Homo sapiens	Inhibition	%	3.03
	8181766	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	6.53	CHEMBL2850	Homo sapiens	Inhibition	%	6.53
	8181905	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.24	CHEMBL2850	Homo sapiens	Inhibition	%	6.24
	8182068	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	12.12	CHEMBL2850	Homo sapiens	Inhibition	%	12.12
	8182292	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	20.83	CHEMBL2850	Homo sapiens	Inhibition	%	20.83
	8182432	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.05	CHEMBL2850	Homo sapiens	Inhibition	%	2.05
	8182748	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.51	CHEMBL2850	Homo sapiens	Inhibition	%	5.51
	8183094	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	87.72	CHEMBL2850	Homo sapiens	Inhibition	%	87.72
	8183243	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.96	CHEMBL2850	Homo sapiens	Inhibition	%	1.96
	8183596	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.66	CHEMBL2850	Homo sapiens	Inhibition	%	6.66
	8183738	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	75.67	CHEMBL2850	Homo sapiens	Inhibition	%	75.67
	8183962	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	17.31	CHEMBL2850	Homo sapiens	Inhibition	%	17.31
	8184098	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	9.2	CHEMBL2850	Homo sapiens	Inhibition	%	9.2
	8184364	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	85.66	CHEMBL2850	Homo sapiens	Inhibition	%	85.66
	8184735	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8184892	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	19.65	CHEMBL2850	Homo sapiens	Inhibition	%	19.65
	8185265	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.24	CHEMBL2850	Homo sapiens	Inhibition	%	3.24
	8185396	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.72	CHEMBL2850	Homo sapiens	Inhibition	%	1.72
	8185620	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.41	CHEMBL2850	Homo sapiens	Inhibition	%	-0.41
	8185751	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	7.04	CHEMBL2850	Homo sapiens	Inhibition	%	7.04
	8186114	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	32.69	CHEMBL2850	Homo sapiens	Inhibition	%	32.69
	8186255	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.2	CHEMBL2850	Homo sapiens	Inhibition	%	3.2
	8186643	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	11.53	CHEMBL2850	Homo sapiens	Inhibition	%	11.53
	8186782	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.32	CHEMBL2850	Homo sapiens	Inhibition	%	4.32
	8187006	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.56	CHEMBL2850	Homo sapiens	Inhibition	%	1.56
	8187104	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.54	CHEMBL2850	Homo sapiens	Inhibition	%	1.54
	8187452	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	28.12	CHEMBL2850	Homo sapiens	Inhibition	%	28.12
	8187600	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	9.4	CHEMBL2850	Homo sapiens	Inhibition	%	9.4
	8187824	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.14	CHEMBL2850	Homo sapiens	Inhibition	%	2.14
	8187953	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.68	CHEMBL2850	Homo sapiens	Inhibition	%	6.68
	8188320	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	61.19	CHEMBL2850	Homo sapiens	Inhibition	%	61.19
	8188455	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	72.74	CHEMBL2850	Homo sapiens	Inhibition	%	72.74
	8188729	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	12.58	CHEMBL2850	Homo sapiens	Inhibition	%	12.58
	8189101	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	6.47	CHEMBL2850	Homo sapiens	Inhibition	%	6.47
	8189257	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	59.74	CHEMBL2850	Homo sapiens	Inhibition	%	59.74
	8189481	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.32	CHEMBL2850	Homo sapiens	Inhibition	%	4.32
	8189630	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	8.35	CHEMBL2850	Homo sapiens	Inhibition	%	8.35
	8189986	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.81	CHEMBL2850	Homo sapiens	Inhibition	%	1.81
	8190118	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.73	CHEMBL2850	Homo sapiens	Inhibition	%	4.73
	8190482	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.97	CHEMBL2850	Homo sapiens	Inhibition	%	3.97
	8190619	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.32	CHEMBL2850	Homo sapiens	Inhibition	%	4.32
	8190843	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.17	CHEMBL2850	Homo sapiens	Inhibition	%	3.17
	8191007	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	42.9	CHEMBL2850	Homo sapiens	Inhibition	%	42.9
	8191369	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.32	CHEMBL2850	Homo sapiens	Inhibition	%	4.32
	8191465	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.08	CHEMBL2850	Homo sapiens	Inhibition	%	4.08
	8191689	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.54	CHEMBL2850	Homo sapiens	Inhibition	%	1.54
	8191811	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	81.14	CHEMBL2850	Homo sapiens	Inhibition	%	81.14
	8192184	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.98	CHEMBL2850	Homo sapiens	Inhibition	%	6.98
	8192313	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.61	CHEMBL2850	Homo sapiens	Inhibition	%	5.61
	8192681	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.39	CHEMBL2850	Homo sapiens	Inhibition	%	5.39
	8192817	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	80.61	CHEMBL2850	Homo sapiens	Inhibition	%	80.61
	8193041	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	9.42	CHEMBL2850	Homo sapiens	Inhibition	%	9.42
	8193089	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.68	CHEMBL2850	Homo sapiens	Inhibition	%	13.68
	8193313	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.24	CHEMBL2850	Homo sapiens	Inhibition	%	1.24
	8193458	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	37.38	CHEMBL2850	Homo sapiens	Inhibition	%	37.38
	8193839	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	19.98	CHEMBL2850	Homo sapiens	Inhibition	%	19.98
	8193988	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.82	CHEMBL2850	Homo sapiens	Inhibition	%	1.82
	8194343	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.81	CHEMBL2850	Homo sapiens	Inhibition	%	4.81
	8194474	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	10.03	CHEMBL2850	Homo sapiens	Inhibition	%	10.03
	8194698	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.79	CHEMBL2850	Homo sapiens	Inhibition	%	3.79
	8194841	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	12.7	CHEMBL2850	Homo sapiens	Inhibition	%	12.7
	8195198	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.09	CHEMBL2850	Homo sapiens	Inhibition	%	5.09
	8195362	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	24.47	CHEMBL2850	Homo sapiens	Inhibition	%	24.47
	8195725	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.15	CHEMBL2850	Homo sapiens	Inhibition	%	2.15
	8196047	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.37	CHEMBL2850	Homo sapiens	Inhibition	%	4.37
	8196164	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.62	CHEMBL2850	Homo sapiens	Inhibition	%	5.62
	8196538	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	9.81	CHEMBL2850	Homo sapiens	Inhibition	%	9.81
	8196666	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	17.89	CHEMBL2850	Homo sapiens	Inhibition	%	17.89
	8196890	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.28	CHEMBL2850	Homo sapiens	Inhibition	%	0.28
	8197031	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	12.28	CHEMBL2850	Homo sapiens	Inhibition	%	12.28
	8197392	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	30.27	CHEMBL2850	Homo sapiens	Inhibition	%	30.27
	8197667	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.03	CHEMBL2850	Homo sapiens	Inhibition	%	1.03
	8197807	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.18	CHEMBL2850	Homo sapiens	Inhibition	%	2.18
	8198031	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.18	CHEMBL2850	Homo sapiens	Inhibition	%	9.18
	8198188	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.87	CHEMBL2850	Homo sapiens	Inhibition	%	-0.87
	8198326	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.77	CHEMBL2850	Homo sapiens	Inhibition	%	4.77
	8198550	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.14	CHEMBL2850	Homo sapiens	Inhibition	%	2.14
	8198680	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	8.57	CHEMBL2850	Homo sapiens	Inhibition	%	8.57
	8199035	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	14.0	CHEMBL2850	Homo sapiens	Inhibition	%	14.0
	8199183	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.41	CHEMBL2850	Homo sapiens	Inhibition	%	2.41
	8199541	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.26	CHEMBL2850	Homo sapiens	Inhibition	%	3.26
	8199704	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	70.06	CHEMBL2850	Homo sapiens	Inhibition	%	70.06
	8199928	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.43	CHEMBL2850	Homo sapiens	Inhibition	%	4.43
	8200066	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.5	CHEMBL2850	Homo sapiens	Inhibition	%	4.5
	8200394	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.79	CHEMBL2850	Homo sapiens	Inhibition	%	1.79
	8200509	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	9.56	CHEMBL2850	Homo sapiens	Inhibition	%	9.56
	8200733	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	9.63	CHEMBL2850	Homo sapiens	Inhibition	%	9.63
	8200883	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	44.81	CHEMBL2850	Homo sapiens	Inhibition	%	44.81
	8201237	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.22	CHEMBL2850	Homo sapiens	Inhibition	%	6.22
	8201372	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.45	CHEMBL2850	Homo sapiens	Inhibition	%	2.45
	8201596	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.95	CHEMBL2850	Homo sapiens	Inhibition	%	4.95
	8201729	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	7.28	CHEMBL2850	Homo sapiens	Inhibition	%	7.28
	8202008	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.48	CHEMBL2850	Homo sapiens	Inhibition	%	1.48
	8202372	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.62	CHEMBL2850	Homo sapiens	Inhibition	%	0.62
	8202539	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.8	CHEMBL2850	Homo sapiens	Inhibition	%	3.8
	8202888	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.16	CHEMBL2850	Homo sapiens	Inhibition	%	2.16
	8203018	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	19.23	CHEMBL2850	Homo sapiens	Inhibition	%	19.23
	8203373	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.44	CHEMBL2850	Homo sapiens	Inhibition	%	-0.44
	8203519	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.97	CHEMBL2850	Homo sapiens	Inhibition	%	4.97
	8203743	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.46	CHEMBL2850	Homo sapiens	Inhibition	%	2.46
	8203877	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.91	CHEMBL2850	Homo sapiens	Inhibition	%	4.91
	8204267	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	8.44	CHEMBL2850	Homo sapiens	Inhibition	%	8.44
	8204404	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.73	CHEMBL2850	Homo sapiens	Inhibition	%	2.73
	8204733	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	12.25	CHEMBL2850	Homo sapiens	Inhibition	%	12.25
	8205072	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	41.73	CHEMBL2850	Homo sapiens	Inhibition	%	41.73
	8205221	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.47	CHEMBL2850	Homo sapiens	Inhibition	%	4.47
	8205445	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	26.35	CHEMBL2850	Homo sapiens	Inhibition	%	26.35
	8205581	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.1	CHEMBL2850	Homo sapiens	Inhibition	%	3.1
	8205944	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.32	CHEMBL2850	Homo sapiens	Inhibition	%	2.32
	8206076	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	15.38	CHEMBL2850	Homo sapiens	Inhibition	%	15.38
	8206352	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.2	CHEMBL2850	Homo sapiens	Inhibition	%	0.2
	8206719	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	4.94	CHEMBL2850	Homo sapiens	Inhibition	%	4.94
	8206899	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.45	CHEMBL2850	Homo sapiens	Inhibition	%	2.45
	8207249	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.74	CHEMBL2850	Homo sapiens	Inhibition	%	3.74
	8207379	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	55.46	CHEMBL2850	Homo sapiens	Inhibition	%	55.46
	8207603	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	82.85	CHEMBL2850	Homo sapiens	Inhibition	%	82.85
	8207735	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	6.37	CHEMBL2850	Homo sapiens	Inhibition	%	6.37
	8208104	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	13.09	CHEMBL2850	Homo sapiens	Inhibition	%	13.09
	8208236	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.67	CHEMBL2850	Homo sapiens	Inhibition	%	3.67
	8208460	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.27	CHEMBL2850	Homo sapiens	Inhibition	%	5.27
	8208626	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.64	CHEMBL2850	Homo sapiens	Inhibition	%	2.64
	8208759	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.51	CHEMBL2850	Homo sapiens	Inhibition	%	6.51
	8208983	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	24.98	CHEMBL2850	Homo sapiens	Inhibition	%	24.98
	8209088	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.37	CHEMBL2850	Homo sapiens	Inhibition	%	2.37
	8209428	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.86	CHEMBL2850	Homo sapiens	Inhibition	%	3.86
	8209802	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.27	CHEMBL2850	Homo sapiens	Inhibition	%	5.27
	8209938	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	10.16	CHEMBL2850	Homo sapiens	Inhibition	%	10.16
	8210303	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.3	CHEMBL2850	Homo sapiens	Inhibition	%	2.3
	8210439	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	46.65	CHEMBL2850	Homo sapiens	Inhibition	%	46.65
	8210663	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	78.26	CHEMBL2850	Homo sapiens	Inhibition	%	78.26
	8210698	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.36	CHEMBL2850	Homo sapiens	Inhibition	%	0.36
	8210922	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	9.75	CHEMBL2850	Homo sapiens	Inhibition	%	9.75
	8211066	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.51	CHEMBL2850	Homo sapiens	Inhibition	%	1.51
	8211236	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	15.1	CHEMBL2850	Homo sapiens	Inhibition	%	15.1
	8211460	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.38	CHEMBL2850	Homo sapiens	Inhibition	%	3.38
	8211583	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	11.19	CHEMBL2850	Homo sapiens	Inhibition	%	11.19
	8211936	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	85.68	CHEMBL2850	Homo sapiens	Inhibition	%	85.68
	8212068	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.97	CHEMBL2850	Homo sapiens	Inhibition	%	1.97
	8212292	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.81	CHEMBL2850	Homo sapiens	Inhibition	%	4.81
	8212433	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.8	CHEMBL2850	Homo sapiens	Inhibition	%	3.8
	8212790	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.33	CHEMBL2850	Homo sapiens	Inhibition	%	4.33
	8212960	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.8	CHEMBL2850	Homo sapiens	Inhibition	%	5.8
	8213313	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	70.22	CHEMBL2850	Homo sapiens	Inhibition	%	70.22
	8213417	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	9.24	CHEMBL2850	Homo sapiens	Inhibition	%	9.24
	8213641	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	21.42	CHEMBL2850	Homo sapiens	Inhibition	%	21.42
	8213754	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	12.8	CHEMBL2850	Homo sapiens	Inhibition	%	12.8
	8214125	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.87	CHEMBL2850	Homo sapiens	Inhibition	%	8.87
	8214262	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.34	CHEMBL2850	Homo sapiens	Inhibition	%	5.34
	8214486	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	19.75	CHEMBL2850	Homo sapiens	Inhibition	%	19.75
	8214620	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.67	CHEMBL2850	Homo sapiens	Inhibition	%	0.67
	8214996	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.19	CHEMBL2850	Homo sapiens	Inhibition	%	5.19
	8215247	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.73	CHEMBL2850	Homo sapiens	Inhibition	%	1.73
	8215400	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.48	CHEMBL2850	Homo sapiens	Inhibition	%	4.48
	8215788	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.08	CHEMBL2850	Homo sapiens	Inhibition	%	6.08
	8215907	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.27	CHEMBL2850	Homo sapiens	Inhibition	%	-1.27
	8216250	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.26	CHEMBL2850	Homo sapiens	Inhibition	%	1.26
	8216610	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.11	CHEMBL2850	Homo sapiens	Inhibition	%	3.11
	8216748	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	14.65	CHEMBL2850	Homo sapiens	Inhibition	%	14.65
	8217106	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	14.78	CHEMBL2850	Homo sapiens	Inhibition	%	14.78
	8217280	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	Inhibition	%	2.0
	8217504	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	5.53	CHEMBL2850	Homo sapiens	Inhibition	%	5.53
	8217635	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.96	CHEMBL2850	Homo sapiens	Inhibition	%	4.96
	8217960	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	72.1	CHEMBL2850	Homo sapiens	Inhibition	%	72.1
	8218075	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.08	CHEMBL2850	Homo sapiens	Inhibition	%	5.08
	8218299	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	9.93	CHEMBL2850	Homo sapiens	Inhibition	%	9.93
	8218426	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	71.92	CHEMBL2850	Homo sapiens	Inhibition	%	71.92
	8218793	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.93	CHEMBL2850	Homo sapiens	Inhibition	%	3.93
	8218924	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	14.87	CHEMBL2850	Homo sapiens	Inhibition	%	14.87
	8219308	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.57	CHEMBL2850	Homo sapiens	Inhibition	%	4.57
	8219558	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.53	CHEMBL2850	Homo sapiens	Inhibition	%	4.53
	8219719	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.73	CHEMBL2850	Homo sapiens	Inhibition	%	2.73
	8219943	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.86	CHEMBL2850	Homo sapiens	Inhibition	%	3.86
	8220112	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.34	CHEMBL2850	Homo sapiens	Inhibition	%	2.34
	8220241	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	0.1	CHEMBL2850	Homo sapiens	Inhibition	%	0.1
	8220465	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.49	CHEMBL2850	Homo sapiens	Inhibition	%	1.49
	8220579	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	7.48	CHEMBL2850	Homo sapiens	Inhibition	%	7.48
	8220941	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	10.49	CHEMBL2850	Homo sapiens	Inhibition	%	10.49
	8221077	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	21.21	CHEMBL2850	Homo sapiens	Inhibition	%	21.21
	8221301	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	63.71	CHEMBL2850	Homo sapiens	Inhibition	%	63.71
	8221434	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	Inhibition	%	5.0
	8221823	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.29	CHEMBL2850	Homo sapiens	Inhibition	%	1.29
	8221954	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	11.32	CHEMBL2850	Homo sapiens	Inhibition	%	11.32
	8222276	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.75	CHEMBL2850	Homo sapiens	Inhibition	%	3.75
	8222634	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	12.87	CHEMBL2850	Homo sapiens	Inhibition	%	12.87
	8222752	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	82.71	CHEMBL2850	Homo sapiens	Inhibition	%	82.71
	8223120	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	17.28	CHEMBL2850	Homo sapiens	Inhibition	%	17.28
	8223249	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.49	CHEMBL2850	Homo sapiens	Inhibition	%	3.49
	8223473	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.16	CHEMBL2850	Homo sapiens	Inhibition	%	8.16
	8223634	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.37	CHEMBL2850	Homo sapiens	Inhibition	%	1.37
	8223884	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.9	CHEMBL2850	Homo sapiens	Inhibition	%	2.9
	8224270	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.33	CHEMBL2850	Homo sapiens	Inhibition	%	1.33
	8224440	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.66	CHEMBL2850	Homo sapiens	Inhibition	%	2.66
	8224799	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.54	CHEMBL2850	Homo sapiens	Inhibition	%	1.54
	8224913	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.24	CHEMBL2850	Homo sapiens	Inhibition	%	0.24
	8225137	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-1.53	CHEMBL2850	Homo sapiens	Inhibition	%	-1.53
	8225271	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.99	CHEMBL2850	Homo sapiens	Inhibition	%	2.99
	8225633	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.93	CHEMBL2850	Homo sapiens	Inhibition	%	1.93
	8225768	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.33	CHEMBL2850	Homo sapiens	Inhibition	%	6.33
	8226150	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.54	CHEMBL2850	Homo sapiens	Inhibition	%	3.54
	8226275	CHEMBL1962042	GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.01	CHEMBL2850	Homo sapiens	Inhibition	%	4.01
	8226499	CHEMBL1962043	GSK_PKIS: GSK3A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	14.3	CHEMBL2850	Homo sapiens	Inhibition	%	14.3
active	9584071	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
active	9584072	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9584073	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9584074	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9584075	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9584076	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9584077	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584078	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9584079	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584080	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
inactive	9584081	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584082	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9584083	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584084	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9584085	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	1.259	CHEMBL2850	Homo sapiens	pKi		8.9
inactive	9584086	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584087	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9584088	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	3.981	CHEMBL2850	Homo sapiens	pKi		8.4
active	9584089	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9584090	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584091	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1nc(N)c(C#N)c(-c2ccc(Cl)cc2Cl)c1C#N		CHEMBL1999778	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9584092	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584093	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9584094	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9584095	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9584096	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	19952.62	CHEMBL2850	Homo sapiens	pKi		4.7
inactive	9584097	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9584098	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9584099	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	=	Ki	nM	5.012	CHEMBL2850	Homo sapiens	pKi		8.3
inactive	9584100	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584101	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9584102	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584103	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9584104	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
active	9584105	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9584106	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9584107	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9584108	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9584109	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584110	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9584111	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	5.012	CHEMBL2850	Homo sapiens	pKi		8.3
inactive	9584112	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584113	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	79432.82	CHEMBL2850	Homo sapiens	pKi		4.1
active	9584114	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
active	9584115	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584116	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9584117	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9584118	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9584119	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9584120	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9584121	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL2850	Homo sapiens	pKi		4.1
inactive	9584122	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584123	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9584124	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9584125	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
active	9584126	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9584127	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9584128	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9584129	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9584130	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9584131	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9584132	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9584133	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587701	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587702	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9587703	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9587704	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9587705	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587706	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
active	9587707	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
inactive	9587708	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	19952.62	CHEMBL2850	Homo sapiens	pKi		4.7
inactive	9587709	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587710	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587711	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587712	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9587713	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587714	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9587715	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9587716	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587717	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9587718	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587719	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
active	9587720	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9587721	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587722	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587723	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587724	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587725	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9587726	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9587727	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587728	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587729	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9587730	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587731	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9587732	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587733	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587734	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587735	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587736	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587737	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9587738	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587739	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587740	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9587741	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9587742	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587743	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
active	9587744	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9587745	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587746	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587747	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1cccc(Br)c1c2=O		CHEMBL1976158	<	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9587748	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587749	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587750	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587751	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587752	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	19952.62	CHEMBL2850	Homo sapiens	pKi		4.7
active	9587753	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9587754	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587755	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587756	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587757	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9587758	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9587759	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
inactive	9587760	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587761	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587762	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	79432.82	CHEMBL2850	Homo sapiens	pKi		4.1
inactive	9587763	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587764	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9587765	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9587766	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587767	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
active	9587768	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9587769	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587770	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587771	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587772	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587773	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(CNC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1C		CHEMBL1994968	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587774	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9587775	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587776	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587777	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587778	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9587779	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587780	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL2850	Homo sapiens	pKi		4.1
active	9587781	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
inactive	9587782	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587783	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9587784	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587785	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587786	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9587787	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587788	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587789	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9587790	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587791	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9587792	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587793	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587794	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587795	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587796	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4cccc(C#N)c4)c3)c12		CHEMBL1985129	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9587797	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587798	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
active	9587799	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587800	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9587801	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587802	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587803	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9587804	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587805	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587806	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9587807	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587808	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587809	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9587810	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587811	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9587812	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9587813	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9587814	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587815	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587816	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9587817	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
inactive	9587818	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587819	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587820	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587821	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
active	9587822	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9587823	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587824	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587825	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587826	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587827	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587828	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587829	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9587830	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9587831	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	=	Ki	nM	12.59	CHEMBL2850	Homo sapiens	pKi		7.9
active	9587832	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
active	9587833	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9587834	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9587835	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587836	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9587837	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587838	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9587839	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
inactive	9587840	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587841	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587842	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
inactive	9587843	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587844	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587845	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587846	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587847	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9587848	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9587849	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587850	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
active	9587851	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9587852	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
inactive	9587853	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587854	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587855	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9587856	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587857	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587858	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	63095.73	CHEMBL2850	Homo sapiens	pKi		4.2
active	9587859	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587860	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587861	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587862	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587863	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587864	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9587865	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9587866	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587867	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587868	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587869	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587870	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
inactive	9587871	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587872	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587873	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	<	Ki	nM	79432.82	CHEMBL2850	Homo sapiens	pKi		4.1
inactive	9587874	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587875	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587876	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9587877	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9587878	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587879	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587880	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9587881	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9587882	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
active	9587883	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9587884	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9587885	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9587886	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
inactive	9587887	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587888	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	=	Ki	nM	25118.86	CHEMBL2850	Homo sapiens	pKi		4.6
inactive	9587889	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587890	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587891	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587892	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587893	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587894	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9587895	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
active	9587896	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9587897	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587898	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
inactive	9587899	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9587900	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587901	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9587902	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
active	9587903	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
inactive	9587904	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587905	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587906	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587907	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587908	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9587909	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	7.943	CHEMBL2850	Homo sapiens	pKi		8.1
active	9587910	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9587911	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9587912	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
inactive	9587913	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587914	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587915	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587916	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587917	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9587918	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9587919	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	19952.62	CHEMBL2850	Homo sapiens	pKi		4.7
inactive	9587920	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587921	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587922	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
active	9587923	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587924	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9587925	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587926	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587927	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9587928	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587929	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587930	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9587931	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9587932	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587933	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587934	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9587935	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	25118.86	CHEMBL2850	Homo sapiens	pKi		4.6
inactive	9587936	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9587937	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9587938	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9587939	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591503	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591504	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591505	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9591506	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591507	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591508	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591509	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591510	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591511	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
active	9591512	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9591513	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591514	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591515	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9591516	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9591517	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591518	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9591519	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591520	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591521	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9591522	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591523	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591524	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591525	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9591526	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9591527	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591528	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591529	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9591530	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9591531	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9591532	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
inactive	9591533	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591534	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591535	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9591536	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
inactive	9591537	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591538	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591539	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591540	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591541	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591542	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591543	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9591544	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	5.012	CHEMBL2850	Homo sapiens	pKi		8.3
inactive	9591545	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591546	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591547	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591548	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9591549	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9591550	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591551	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	12.59	CHEMBL2850	Homo sapiens	pKi		7.9
inactive	9591552	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591553	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591554	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9591555	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591556	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591557	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591558	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591559	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591560	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591561	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
active	9591562	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9591563	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
inactive	9591564	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591565	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591566	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591567	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
active	9591568	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9591569	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591570	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9591571	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591572	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591573	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591574	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Ki	nM	10.0	CHEMBL2850	Homo sapiens	pKi		8.0
inactive	9591575	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591576	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9591577	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
inactive	9591578	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591579	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591580	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9591581	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591582	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
active	9591583	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9591584	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9591585	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9591586	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591587	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9591588	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9591589	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591590	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591591	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591592	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591593	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591594	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
inactive	9591595	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591596	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
active	9591597	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9591598	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591599	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9591600	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
active	9591601	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591602	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591603	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9591604	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
inactive	9591605	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591606	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591607	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591608	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
inactive	9591609	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591610	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591611	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9591612	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9591613	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
inactive	9591614	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591615	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591616	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9591617	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591618	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591619	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
inactive	9591620	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591621	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
inactive	9591622	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591623	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591624	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591625	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591626	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591627	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
inactive	9591628	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591629	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
active	9591630	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9591631	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591632	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
inactive	9591633	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591634	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9591635	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9591636	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9591637	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9591638	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9591639	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591640	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
active	9591641	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
active	9591642	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9591643	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591644	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	=	Ki	nM	12.59	CHEMBL2850	Homo sapiens	pKi		7.9
inactive	9591645	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591646	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9591647	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9591648	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591649	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591650	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
active	9591651	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9591652	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591653	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591654	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591655	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591656	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591657	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9591658	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591659	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591660	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9591661	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9591662	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9591663	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591664	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9591665	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9591666	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591667	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9591668	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591669	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9591670	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591671	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9591672	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9591673	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591674	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591675	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
inactive	9591676	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591677	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591678	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591679	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591680	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9591681	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591682	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591683	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591684	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591685	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1ccc(NC(=O)CC2Nc3ccccc3NC2=O)cc1		CHEMBL1985469	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591686	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9591687	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591688	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591689	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9591690	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
active	9591691	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
active	9591692	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
inactive	9591693	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591694	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9591695	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9591696	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
inactive	9591697	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591698	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591699	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591700	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
active	9591701	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9591702	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9591703	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591704	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9591705	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9591706	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591707	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591708	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591709	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591710	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9591711	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9591712	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9591713	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9591714	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
active	9591715	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
active	9591716	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591717	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	3.162	CHEMBL2850	Homo sapiens	pKi		8.5
active	9591718	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	100000.0	CHEMBL2850	Homo sapiens	pKi		4.0
inactive	9591719	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9591720	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9591721	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591722	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9591723	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	10000.0	CHEMBL2850	Homo sapiens	pKi		5.0
inactive	9591724	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591725	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9591726	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9591727	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591728	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
inactive	9591729	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591730	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9591731	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9591732	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9591733	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591734	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9591735	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9591736	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9591737	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9591738	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9591739	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9591740	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9591741	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
active	9591742	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595304	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9595305	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9595306	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595307	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595308	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595309	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9595310	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595311	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9595312	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595313	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595314	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595315	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595316	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9595317	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9595318	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595319	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
active	9595320	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
inactive	9595321	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595322	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9595323	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9595324	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595325	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595326	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595327	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
active	9595328	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9595329	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3.981	CHEMBL2850	Homo sapiens	pKi		8.4
active	9595330	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9595331	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595332	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
inactive	9595333	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595334	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595335	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9595336	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595337	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595338	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595339	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9595340	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595341	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	79.43	CHEMBL2850	Homo sapiens	pKi		7.1
inactive	9595342	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595343	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595344	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9595345	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9595346	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	31.62	CHEMBL2850	Homo sapiens	pKi		7.5
active	9595347	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9595348	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	63095.73	CHEMBL2850	Homo sapiens	pKi		4.2
inactive	9595349	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595350	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595351	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595352	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595353	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
inactive	9595354	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595355	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595356	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9595357	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595358	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595359	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9595360	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9595361	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595362	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595363	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595364	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9595365	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9595366	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595367	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595368	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9595369	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595370	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595371	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595372	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595373	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2006609	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9595374	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595375	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595376	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595377	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595378	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595379	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595380	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9595381	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595382	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	12589.25	CHEMBL2850	Homo sapiens	pKi		4.9
active	9595383	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9595384	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595385	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595386	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595387	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595388	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
active	9595389	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9595390	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9595391	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
inactive	9595392	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595393	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9595394	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9595395	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
active	9595396	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
active	9595397	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595398	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9595399	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9595400	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
inactive	9595401	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595402	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595403	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595404	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595405	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595406	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595407	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9595408	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9595409	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595410	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595411	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595412	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595413	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595414	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595415	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595416	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9595417	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	63095.73	CHEMBL2850	Homo sapiens	pKi		4.2
inactive	9595418	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595419	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595420	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9595421	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
active	9595422	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
inactive	9595423	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595424	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9595425	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595426	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9595427	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595428	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595429	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595430	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595431	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
active	9595432	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9595433	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
active	9595434	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
active	9595435	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
inactive	9595436	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595437	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9595438	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9595439	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9595440	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595441	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
active	9595442	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595443	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595444	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595445	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9595446	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Ki	nM	125.89	CHEMBL2850	Homo sapiens	pKi		6.9
active	9595447	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1CN=C(c2cccc(Cl)c2)c2c(sc3c2CCCC3)N1		CHEMBL2002470	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595448	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
active	9595449	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595450	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595451	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595452	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	15.85	CHEMBL2850	Homo sapiens	pKi		7.8
active	9595453	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595454	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	Ki	nM	50118.72	CHEMBL2850	Homo sapiens	pKi		4.3
inactive	9595455	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595456	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595457	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595458	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9595459	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595460	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595461	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595462	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595463	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595464	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
inactive	9595465	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595466	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595467	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595468	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595469	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9595470	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9595471	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595472	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9595473	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	199.53	CHEMBL2850	Homo sapiens	pKi		6.7
active	9595474	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9595475	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
active	9595476	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595477	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595478	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595479	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595480	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595481	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595482	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595483	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9595484	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9595485	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595486	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595487	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595488	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
active	9595489	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9595490	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9595491	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	39810.72	CHEMBL2850	Homo sapiens	pKi		4.4
inactive	9595492	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595493	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595494	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9595495	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9595496	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	10.0	CHEMBL2850	Homo sapiens	pKi		8.0
inactive	9595497	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595498	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595499	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9595500	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9595501	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595502	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595503	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595504	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595505	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595506	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595507	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595508	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595509	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595510	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595511	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9595512	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595513	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595514	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595515	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595516	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9595517	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
inactive	9595518	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595519	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9595520	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595521	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595522	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595523	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9595524	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595525	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9595526	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9595527	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595528	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	3.981	CHEMBL2850	Homo sapiens	pKi		8.4
inactive	9595529	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9595530	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595531	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595532	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595533	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9595534	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595535	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595536	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595537	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9595538	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595539	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9595540	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9595541	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
inactive	9595542	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599108	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599109	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
active	9599110	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9599111	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9599112	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599113	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
inactive	9599114	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599115	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9599116	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599117	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599118	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599119	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9599120	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	6.31	CHEMBL2850	Homo sapiens	pKi		8.2
inactive	9599121	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599122	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599123	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9599124	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599125	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9599126	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9599127	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599128	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599129	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9599130	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599131	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599132	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599133	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599134	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599135	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599136	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599137	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	251.19	CHEMBL2850	Homo sapiens	pKi		6.6
active	9599138	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
active	9599139	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
active	9599140	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9599141	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599142	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9599143	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599144	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9599145	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599146	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599147	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599148	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
active	9599149	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9599150	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9599151	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599152	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
inactive	9599153	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599154	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599155	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599156	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
active	9599157	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	398.11	CHEMBL2850	Homo sapiens	pKi		6.4
active	9599158	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
active	9599159	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
active	9599160	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599161	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599162	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599163	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599164	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9599165	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599166	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9599167	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
active	9599168	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	=	Ki	nM	39.81	CHEMBL2850	Homo sapiens	pKi		7.4
inactive	9599169	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599170	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	63.1	CHEMBL2850	Homo sapiens	pKi		7.2
inactive	9599171	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599172	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9599173	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
inactive	9599174	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599175	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Nc1nccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL2002432	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599176	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
active	9599177	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9599178	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	15848.93	CHEMBL2850	Homo sapiens	pKi		4.8
inactive	9599179	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599180	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
inactive	9599181	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599182	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9599183	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9599184	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
active	9599185	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	Ki	nM	5.012	CHEMBL2850	Homo sapiens	pKi		8.3
active	9599186	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	3.981	CHEMBL2850	Homo sapiens	pKi		8.4
active	9599187	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9599188	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599189	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599190	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599191	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599192	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	31622.78	CHEMBL2850	Homo sapiens	pKi		4.5
inactive	9599193	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599194	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599195	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9599196	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599197	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599198	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599199	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	1995.26	CHEMBL2850	Homo sapiens	pKi		5.7
inactive	9599200	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599201	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	3.981	CHEMBL2850	Homo sapiens	pKi		8.4
active	9599202	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	19.95	CHEMBL2850	Homo sapiens	pKi		7.7
active	9599203	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9599204	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599205	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599206	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9599207	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599208	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599209	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	=	Ki	nM	10.0	CHEMBL2850	Homo sapiens	pKi		8.0
active	9599210	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9599211	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599212	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599213	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	100000.0	CHEMBL2850	Homo sapiens	pKi		4.0
active	9599214	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)cc1C		CHEMBL1991874	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599215	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599216	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	1000.0	CHEMBL2850	Homo sapiens	pKi		6.0
inactive	9599217	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9599218	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599219	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	316.23	CHEMBL2850	Homo sapiens	pKi		6.5
active	9599220	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
active	9599221	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9599222	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599223	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599224	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599225	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599226	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599227	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	=	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599228	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599229	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599230	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599231	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	7.943	CHEMBL2850	Homo sapiens	pKi		8.1
inactive	9599232	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599233	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599234	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	25.12	CHEMBL2850	Homo sapiens	pKi		7.6
active	9599235	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
active	9599236	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	=	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
active	9599237	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9599238	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599239	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1584.89	CHEMBL2850	Homo sapiens	pKi		5.8
inactive	9599240	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(CN2CCCCC2)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL202635	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599241	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	=	Ki	nM	10.0	CHEMBL2850	Homo sapiens	pKi		8.0
inactive	9599242	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599243	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599244	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
inactive	9599245	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599246	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	501.19	CHEMBL2850	Homo sapiens	pKi		6.3
inactive	9599247	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599248	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9599249	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599250	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599251	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599252	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599253	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599254	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599255	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599256	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599257	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599258	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599259	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	2511.89	CHEMBL2850	Homo sapiens	pKi		5.6
active	9599260	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	1258.93	CHEMBL2850	Homo sapiens	pKi		5.9
inactive	9599261	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599262	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599263	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599264	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	100.0	CHEMBL2850	Homo sapiens	pKi		7.0
active	9599265	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9599266	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599267	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599268	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	5011.87	CHEMBL2850	Homo sapiens	pKi		5.3
inactive	9599269	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599270	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599271	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599272	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599273	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599274	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599275	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599276	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599277	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9599278	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	=	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
inactive	9599279	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599280	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9599281	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599282	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
active	9599283	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	630.96	CHEMBL2850	Homo sapiens	pKi		6.2
inactive	9599284	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL2850	Homo sapiens	pKi		5.4
inactive	9599285	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	6309.57	CHEMBL2850	Homo sapiens	pKi		5.2
inactive	9599286	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599287	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	7.943	CHEMBL2850	Homo sapiens	pKi		8.1
inactive	9599288	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3162.28	CHEMBL2850	Homo sapiens	pKi		5.5
active	9599289	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	158.49	CHEMBL2850	Homo sapiens	pKi		6.8
active	9599290	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	794.33	CHEMBL2850	Homo sapiens	pKi		6.1
inactive	9599291	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
inactive	9599292	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9599293	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL2850	Homo sapiens	pKi		7.3
inactive	9599294	CHEMBL1963771	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3A	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	7943.28	CHEMBL2850	Homo sapiens	pKi		5.1
active	9720324	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1cccc(OCC(=O)Nc2ccc3c(c2)C(=O)NC3=O)c1		CHEMBL1462726	=	AC50	nM	8000.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	8.0
active	9720325	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1ccc(S(=O)(=O)Nc2c(C(=O)O)[nH]c3ccc(OC)cc23)cc1		CHEMBL1313269	=	AC50	nM	5470.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	5.47
active	9720326	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	121.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.121
active	9720327	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COC(=O)C(C)Sc1ccc2nnc(-c3ccc(F)cc3)n2n1		CHEMBL1426716	=	AC50	nM	5240.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	5.24
active	9720328	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	CCOc1ccccc1/C=N/NC(=O)c1nnn(-c2nonc2N)c1CN1CCCCCC1		CHEMBL1970835	=	AC50	nM	21.9	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.0219
active	9720329	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	281.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.281
active	9720330	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(Nc2ccccc2)sc1C(=O)c1ccccc1		CHEMBL561114	=	AC50	nM	168.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.168
active	9720331	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cccc(/C=C2/Sc3ccc(C(=O)NCCCN4CCCC4)cc3NC2=O)c1		CHEMBL1339810	=	AC50	nM	38910.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	38.91
active	9720332	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	CCOc1cccc(-c2c(C(=O)N/N=C/c3sccc3C)nnn2-c2nonc2N)c1		CHEMBL1996263	=	AC50	nM	474.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.474
active	9720333	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1ccc(-c2nnc(S)n2/N=C/c2ccncc2)cc1		CHEMBL1996315	=	AC50	nM	7710.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	7.71
active	9720334	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Clc1ccc(CSc2nnc(-c3ccncc3)o2)c(Cl)c1		CHEMBL1341221	=	AC50	nM	23970.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	23.97
active	9720335	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc(NC(=O)Cc4cccc5ccccc45)c3)C2)n1		CHEMBL583658	=	AC50	nM	361.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	0.361
active	9720336	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COC(=O)c1ccc(CSc2ccc3nnc(-c4ccc(F)cc4)n3n2)o1		CHEMBL1467011	=	AC50	nM	1870.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	1.87
active	9720337	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]		CHEMBL1343500	=	AC50	nM	1560.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	1.56
active	9720338	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cc(/C=N/n2c(S)nnc2C2CCCCC2)cc(Br)c1O		CHEMBL1978079	=	AC50	nM	10360.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	10.36
active	9720339	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(NCC2CCCO2)nc(Nc2ccc(F)cc2)c1[N+](=O)[O-]		CHEMBL1450439	=	AC50	nM	2420.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	2.42
active	9720340	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cccc(Nc2nc(-c3ccc(O)cc3)cs2)c1		CHEMBL1326359	=	AC50	nM	8210.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	8.21
active	9720341	CHEMBL1963853	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 alpha Activity Measured in Biochemical System Using Microfluidics - 2046-11_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Fc1cccc(Nc2nc(-c3ccncc3)nc3ccccc23)c1		CHEMBL1568626	=	AC50	nM	29720.0	CHEMBL2850	Homo sapiens	AC50_uM	uM	29.72
	10838700	CHEMBL2014926	Inhibition of GSK3a at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	48.0	CHEMBL2850	Homo sapiens	INH	%	48.0
	10850681	CHEMBL2019801	Inhibition of human GSK3alpha at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	10863757	CHEMBL2024912	Inhibition of GSK3alpha by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	nM	10000.0
	10975678	CHEMBL2064932	Inhibition of Gsk3alpha in presence of 10 uM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	IC50	nM	5340.0	CHEMBL2850	Homo sapiens	IC50	nM	5340.0
	10978468	CHEMBL2066239	Inhibition of human recombinant GSK3alpha using ulight-CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 60 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	=	Activity	%	5.0	CHEMBL2850	Homo sapiens	Activity	%	5.0
tde	10978488	CHEMBL2066177	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS404 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978489	CHEMBL2066177	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS404 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978490	CHEMBL2066176	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS404 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978491	CHEMBL2066176	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS404 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978492	CHEMBL2066175	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS396 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978493	CHEMBL2066175	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS396 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978494	CHEMBL2066174	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS396 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978495	CHEMBL2066174	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS396 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978496	CHEMBL2066173	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pT231 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978497	CHEMBL2066172	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pT231 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978498	CHEMBL2066173	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pT231 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978499	CHEMBL2066172	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pT231 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978500	CHEMBL2066171	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS199 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
tde	10978501	CHEMBL2066171	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS199 antibody at 30 to 100 uM by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978502	CHEMBL2066170	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS199 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	10978503	CHEMBL2066170	Inhibition of GSK3alpha in human SH-SY5Y cells assessed as Tau.P301L mutant phosphorylation using pS199 antibody after 6 to 24 hrs by Western blotting analysis	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	10978583	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1cccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)c1		CHEMBL2064516	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	uM	0.015
	10978584	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064517	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	uM	0.015
	10978585	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1cccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)c1		CHEMBL2064518	=	IC50	nM	95.0	CHEMBL2850	Homo sapiens	IC50	uM	0.095
	10978586	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064519	=	IC50	nM	45.0	CHEMBL2850	Homo sapiens	IC50	uM	0.045
	10978587	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064520	=	IC50	nM	12.0	CHEMBL2850	Homo sapiens	IC50	uM	0.012
	10978588	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL2064521	=	IC50	nM	3206.0	CHEMBL2850	Homo sapiens	IC50	uM	3.206
	10978589	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1352577	=	IC50	nM	7379.0	CHEMBL2850	Homo sapiens	IC50	uM	7.379
	10978590	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL40439	=	IC50	nM	2244.0	CHEMBL2850	Homo sapiens	IC50	uM	2.244
	10978591	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	IC50	nM	390.0	CHEMBL2850	Homo sapiens	IC50	uM	0.39
	10978592	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	c1cc(-c2nnn[nH]2)ccc1CSc1nnc(-c2ccc3c(c2)OCO3)o1		CHEMBL2064522	=	IC50	nM	107.0	CHEMBL2850	Homo sapiens	IC50	uM	0.107
	10978593	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064531	=	IC50	nM	9.0	CHEMBL2850	Homo sapiens	IC50	uM	0.009
	10978594	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064532	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	uM	0.002
	10978595	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533	<	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	uM	0.005
	10978596	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	=	IC50	nM	6.0	CHEMBL2850	Homo sapiens	IC50	uM	0.006
	10978597	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534	<	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	uM	0.005
	10978598	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	uM	0.002
	10978599	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2064536	=	IC50	nM	19.0	CHEMBL2850	Homo sapiens	IC50	uM	0.019
	10978600	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	COCC1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064537	=	IC50	nM	54.0	CHEMBL2850	Homo sapiens	IC50	uM	0.054
	10978601	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	COC[C@@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064538	=	IC50	nM	195.0	CHEMBL2850	Homo sapiens	IC50	uM	0.195
	10978602	CHEMBL2066820	Inhibition of human recombinant GSK3alpha	B	COC[C@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064539	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	uM	0.015
	10984767	CHEMBL2072063	Inhibition of human GSK3alpha at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	11018500	CHEMBL2091529	Inhibition of GSK3alpha at 10 uM	B	Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12		CHEMBL2089212	=	Inhibition	%	34.0	CHEMBL2850	Homo sapiens	INH	%	34.0
	12046321	CHEMBL2156651	Inhibition of GSK3alpha at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	INH	%	1.0
	12074636	CHEMBL2161198	Inhibition of GSK3-alpha at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	12076002	CHEMBL2161548	Inhibition of GSK3alpha	B	CCN(CC)S(=O)(=O)c1cc(Nc2nccc(-c3ccnc(-c4ccc(NC(=O)NC)cc4)c3)n2)ccc1Cl		CHEMBL2158866	=	IC50	nM	260.0	CHEMBL2850	Homo sapiens	IC50	nM	260.0
	12141725	CHEMBL2186700	Binding affinity to GSK3A	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	Kd	nM	550.0	CHEMBL2850	Homo sapiens	Kd	nM	550.0
	12141754	CHEMBL2187128	Inhibition of human recombinant GSK3alpha expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	IC50	nM	210.0	CHEMBL2850	Homo sapiens	IC50	uM	0.21
	12141780	CHEMBL2187128	Inhibition of human recombinant GSK3alpha expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053	=	IC50	nM	7700.0	CHEMBL2850	Homo sapiens	IC50	uM	7.7
	12141806	CHEMBL2187128	Inhibition of human recombinant GSK3alpha expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12173591	CHEMBL2213530	Inhibition of GSK3A assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	12183881	CHEMBL2211506	Inhibition of GSK3A	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	pIC50		5.0
	12195445	CHEMBL2210502	Inhibition of recombinant GSK3A after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	21.0	CHEMBL2850	Homo sapiens	Ki	nM	21.0
	12195612	CHEMBL2212861	Inhibition of human recombinant GSK3alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 60 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	103.7	CHEMBL2850	Homo sapiens	Activity	%	103.7
	12225719	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	117.0	CHEMBL2850	Homo sapiens	Residual Activity	%	117.0
	12225720	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	19.0	CHEMBL2850	Homo sapiens	Residual Activity	%	19.0
	12225721	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	107.0	CHEMBL2850	Homo sapiens	Residual Activity	%	107.0
	12225722	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12225723	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12225724	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	117.0	CHEMBL2850	Homo sapiens	Residual Activity	%	117.0
	12225725	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	120.0	CHEMBL2850	Homo sapiens	Residual Activity	%	120.0
	12225726	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12225727	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	136.0	CHEMBL2850	Homo sapiens	Residual Activity	%	136.0
	12225728	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225729	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	129.0	CHEMBL2850	Homo sapiens	Residual Activity	%	129.0
	12225730	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	113.0	CHEMBL2850	Homo sapiens	Residual Activity	%	113.0
	12225731	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	125.0	CHEMBL2850	Homo sapiens	Residual Activity	%	125.0
	12225732	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	116.0	CHEMBL2850	Homo sapiens	Residual Activity	%	116.0
	12225733	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL2850	Homo sapiens	Residual Activity	%	93.0
	12225734	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12225735	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	122.0	CHEMBL2850	Homo sapiens	Residual Activity	%	122.0
	12225736	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	126.0	CHEMBL2850	Homo sapiens	Residual Activity	%	126.0
	12225737	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	121.0	CHEMBL2850	Homo sapiens	Residual Activity	%	121.0
	12225738	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12225739	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL2850	Homo sapiens	Residual Activity	%	111.0
	12225740	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	84.0	CHEMBL2850	Homo sapiens	Residual Activity	%	84.0
	12225741	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	125.0	CHEMBL2850	Homo sapiens	Residual Activity	%	125.0
	12225742	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	118.0	CHEMBL2850	Homo sapiens	Residual Activity	%	118.0
	12225743	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	116.0	CHEMBL2850	Homo sapiens	Residual Activity	%	116.0
	12225744	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12225745	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	85.0	CHEMBL2850	Homo sapiens	Residual Activity	%	85.0
	12225746	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	116.0	CHEMBL2850	Homo sapiens	Residual Activity	%	116.0
	12225747	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225748	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	14.0	CHEMBL2850	Homo sapiens	Residual Activity	%	14.0
	12225749	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	110.0	CHEMBL2850	Homo sapiens	Residual Activity	%	110.0
	12225750	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	107.0	CHEMBL2850	Homo sapiens	Residual Activity	%	107.0
	12225751	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12225752	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	119.0	CHEMBL2850	Homo sapiens	Residual Activity	%	119.0
	12225753	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	120.0	CHEMBL2850	Homo sapiens	Residual Activity	%	120.0
	12225754	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225755	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	115.0	CHEMBL2850	Homo sapiens	Residual Activity	%	115.0
	12225756	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	117.0	CHEMBL2850	Homo sapiens	Residual Activity	%	117.0
	12225757	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	115.0	CHEMBL2850	Homo sapiens	Residual Activity	%	115.0
	12225758	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	113.0	CHEMBL2850	Homo sapiens	Residual Activity	%	113.0
	12225759	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	133.0	CHEMBL2850	Homo sapiens	Residual Activity	%	133.0
	12225760	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	125.0	CHEMBL2850	Homo sapiens	Residual Activity	%	125.0
	12225761	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	20.0	CHEMBL2850	Homo sapiens	Residual Activity	%	20.0
	12225762	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	12.0	CHEMBL2850	Homo sapiens	Residual Activity	%	12.0
	12225763	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	120.0	CHEMBL2850	Homo sapiens	Residual Activity	%	120.0
	12225764	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12225765	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	113.0	CHEMBL2850	Homo sapiens	Residual Activity	%	113.0
	12225766	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	106.0	CHEMBL2850	Homo sapiens	Residual Activity	%	106.0
	12225767	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12225768	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL2850	Homo sapiens	Residual Activity	%	111.0
	12225769	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	15.0	CHEMBL2850	Homo sapiens	Residual Activity	%	15.0
	12225770	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225771	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12225772	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	115.0	CHEMBL2850	Homo sapiens	Residual Activity	%	115.0
	12225773	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	107.0	CHEMBL2850	Homo sapiens	Residual Activity	%	107.0
	12225774	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12225775	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	114.0	CHEMBL2850	Homo sapiens	Residual Activity	%	114.0
	12225776	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	102.0	CHEMBL2850	Homo sapiens	Residual Activity	%	102.0
	12225777	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12225778	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225779	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL2850	Homo sapiens	Residual Activity	%	75.0
	12225780	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	17.0	CHEMBL2850	Homo sapiens	Residual Activity	%	17.0
	12225781	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225782	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL2850	Homo sapiens	Residual Activity	%	91.0
	12225783	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL2850	Homo sapiens	Residual Activity	%	98.0
	12225784	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225785	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225786	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12225787	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	90.0	CHEMBL2850	Homo sapiens	Residual Activity	%	90.0
	12225788	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	91.0	CHEMBL2850	Homo sapiens	Residual Activity	%	91.0
	12225789	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225790	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	94.0	CHEMBL2850	Homo sapiens	Residual Activity	%	94.0
	12225791	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	18.0	CHEMBL2850	Homo sapiens	Residual Activity	%	18.0
	12225792	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225793	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12225794	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12225795	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225796	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225797	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	102.0	CHEMBL2850	Homo sapiens	Residual Activity	%	102.0
	12225798	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12225799	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225800	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	11.0	CHEMBL2850	Homo sapiens	Residual Activity	%	11.0
	12225801	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	92.0	CHEMBL2850	Homo sapiens	Residual Activity	%	92.0
	12225802	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	75.0	CHEMBL2850	Homo sapiens	Residual Activity	%	75.0
	12225803	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	97.0	CHEMBL2850	Homo sapiens	Residual Activity	%	97.0
	12225804	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12225805	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12225806	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	86.0	CHEMBL2850	Homo sapiens	Residual Activity	%	86.0
	12225807	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	86.0	CHEMBL2850	Homo sapiens	Residual Activity	%	86.0
	12225808	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	5.0	CHEMBL2850	Homo sapiens	Residual Activity	%	5.0
	12225809	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225810	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	77.0	CHEMBL2850	Homo sapiens	Residual Activity	%	77.0
	12225811	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	9.0	CHEMBL2850	Homo sapiens	Residual Activity	%	9.0
	12225812	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL2850	Homo sapiens	Residual Activity	%	99.0
	12225813	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	89.0	CHEMBL2850	Homo sapiens	Residual Activity	%	89.0
	12225814	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL2850	Homo sapiens	Residual Activity	%	97.0
	12225815	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12225816	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	115.0	CHEMBL2850	Homo sapiens	Residual Activity	%	115.0
	12225817	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	119.0	CHEMBL2850	Homo sapiens	Residual Activity	%	119.0
	12225818	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225819	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	7.0	CHEMBL2850	Homo sapiens	Residual Activity	%	7.0
	12225820	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	14.0	CHEMBL2850	Homo sapiens	Residual Activity	%	14.0
	12225821	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL2850	Homo sapiens	Residual Activity	%	114.0
	12225822	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	15.0	CHEMBL2850	Homo sapiens	Residual Activity	%	15.0
	12225823	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12225824	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12225825	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	95.0	CHEMBL2850	Homo sapiens	Residual Activity	%	95.0
	12225826	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	107.0	CHEMBL2850	Homo sapiens	Residual Activity	%	107.0
	12225827	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12225828	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	5.0	CHEMBL2850	Homo sapiens	Residual Activity	%	5.0
	12225829	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL2850	Homo sapiens	Residual Activity	%	99.0
	12225830	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	92.0	CHEMBL2850	Homo sapiens	Residual Activity	%	92.0
	12225831	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12225832	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12225833	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12225834	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL2850	Homo sapiens	Residual Activity	%	95.0
	12225835	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	64.0	CHEMBL2850	Homo sapiens	Residual Activity	%	64.0
	12225836	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225837	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL2850	Homo sapiens	Residual Activity	%	92.0
	12225838	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	88.0	CHEMBL2850	Homo sapiens	Residual Activity	%	88.0
	12225839	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	62.0	CHEMBL2850	Homo sapiens	Residual Activity	%	62.0
	12225840	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12225841	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	98.0	CHEMBL2850	Homo sapiens	Residual Activity	%	98.0
	12225842	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	32.0	CHEMBL2850	Homo sapiens	Residual Activity	%	32.0
	12225843	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12225844	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12225845	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225846	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	97.0	CHEMBL2850	Homo sapiens	Residual Activity	%	97.0
	12225847	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	46.0	CHEMBL2850	Homo sapiens	Residual Activity	%	46.0
	12225848	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12225849	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	74.0	CHEMBL2850	Homo sapiens	Residual Activity	%	74.0
	12225850	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	7.0	CHEMBL2850	Homo sapiens	Residual Activity	%	7.0
	12225851	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	54.0	CHEMBL2850	Homo sapiens	Residual Activity	%	54.0
	12225852	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12225853	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	27.0	CHEMBL2850	Homo sapiens	Residual Activity	%	27.0
	12225854	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	80.0	CHEMBL2850	Homo sapiens	Residual Activity	%	80.0
	12225855	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	81.0	CHEMBL2850	Homo sapiens	Residual Activity	%	81.0
	12225856	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	72.0	CHEMBL2850	Homo sapiens	Residual Activity	%	72.0
	12225857	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	-1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	-1.0
	12225858	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	86.0	CHEMBL2850	Homo sapiens	Residual Activity	%	86.0
	12225859	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	89.0	CHEMBL2850	Homo sapiens	Residual Activity	%	89.0
	12225860	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	104.0	CHEMBL2850	Homo sapiens	Residual Activity	%	104.0
	12225861	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL2850	Homo sapiens	Residual Activity	%	98.0
	12225862	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	100.0	CHEMBL2850	Homo sapiens	Residual Activity	%	100.0
	12225863	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL2850	Homo sapiens	Residual Activity	%	106.0
	12225864	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	66.0	CHEMBL2850	Homo sapiens	Residual Activity	%	66.0
	12225865	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12225866	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228406	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	98.0	CHEMBL2850	Homo sapiens	Residual Activity	%	98.0
	12228407	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL2850	Homo sapiens	Residual Activity	%	106.0
	12228408	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	21.0	CHEMBL2850	Homo sapiens	Residual Activity	%	21.0
	12228409	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	93.0	CHEMBL2850	Homo sapiens	Residual Activity	%	93.0
	12228410	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	99.0	CHEMBL2850	Homo sapiens	Residual Activity	%	99.0
	12228411	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	6.0	CHEMBL2850	Homo sapiens	Residual Activity	%	6.0
	12228412	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	84.0	CHEMBL2850	Homo sapiens	Residual Activity	%	84.0
	12228413	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	94.0	CHEMBL2850	Homo sapiens	Residual Activity	%	94.0
	12228414	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	95.0	CHEMBL2850	Homo sapiens	Residual Activity	%	95.0
	12228415	CHEMBL2219094	Millipore: Percentage of residual kinase activity of GSK3A at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	46.0	CHEMBL2850	Homo sapiens	Residual Activity	%	46.0
	12228416	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	74.0	CHEMBL2850	Homo sapiens	Residual Activity	%	74.0
	12228417	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12228418	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	102.0	CHEMBL2850	Homo sapiens	Residual Activity	%	102.0
	12228419	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	148.0	CHEMBL2850	Homo sapiens	Residual Activity	%	148.0
	12228420	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	91.0	CHEMBL2850	Homo sapiens	Residual Activity	%	91.0
	12228421	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	140.0	CHEMBL2850	Homo sapiens	Residual Activity	%	140.0
	12228422	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	87.0	CHEMBL2850	Homo sapiens	Residual Activity	%	87.0
	12228423	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	121.0	CHEMBL2850	Homo sapiens	Residual Activity	%	121.0
	12228424	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12228425	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12228426	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	125.0	CHEMBL2850	Homo sapiens	Residual Activity	%	125.0
	12228427	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	116.0	CHEMBL2850	Homo sapiens	Residual Activity	%	116.0
	12228428	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	142.0	CHEMBL2850	Homo sapiens	Residual Activity	%	142.0
	12228429	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	130.0	CHEMBL2850	Homo sapiens	Residual Activity	%	130.0
	12228430	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	42.0	CHEMBL2850	Homo sapiens	Residual Activity	%	42.0
	12228431	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	129.0	CHEMBL2850	Homo sapiens	Residual Activity	%	129.0
	12228432	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	142.0	CHEMBL2850	Homo sapiens	Residual Activity	%	142.0
	12228433	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12228434	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	105.0	CHEMBL2850	Homo sapiens	Residual Activity	%	105.0
	12228435	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	127.0	CHEMBL2850	Homo sapiens	Residual Activity	%	127.0
	12228436	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	125.0	CHEMBL2850	Homo sapiens	Residual Activity	%	125.0
	12228437	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	40.0	CHEMBL2850	Homo sapiens	Residual Activity	%	40.0
	12228438	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	113.0	CHEMBL2850	Homo sapiens	Residual Activity	%	113.0
	12228439	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	130.0	CHEMBL2850	Homo sapiens	Residual Activity	%	130.0
	12228440	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	136.0	CHEMBL2850	Homo sapiens	Residual Activity	%	136.0
	12228441	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	115.0	CHEMBL2850	Homo sapiens	Residual Activity	%	115.0
	12228442	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	26.0	CHEMBL2850	Homo sapiens	Residual Activity	%	26.0
	12228443	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12228444	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	146.0	CHEMBL2850	Homo sapiens	Residual Activity	%	146.0
	12228445	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228446	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	135.0	CHEMBL2850	Homo sapiens	Residual Activity	%	135.0
	12228447	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12228448	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12228449	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	80.0	CHEMBL2850	Homo sapiens	Residual Activity	%	80.0
	12228450	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	119.0	CHEMBL2850	Homo sapiens	Residual Activity	%	119.0
	12228451	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	135.0	CHEMBL2850	Homo sapiens	Residual Activity	%	135.0
	12228452	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12228453	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	193.0	CHEMBL2850	Homo sapiens	Residual Activity	%	193.0
	12228454	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	144.0	CHEMBL2850	Homo sapiens	Residual Activity	%	144.0
	12228455	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	122.0	CHEMBL2850	Homo sapiens	Residual Activity	%	122.0
	12228456	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	124.0	CHEMBL2850	Homo sapiens	Residual Activity	%	124.0
	12228457	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL2850	Homo sapiens	Residual Activity	%	121.0
	12228458	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	19.0	CHEMBL2850	Homo sapiens	Residual Activity	%	19.0
	12228459	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL2850	Homo sapiens	Residual Activity	%	2.0
	12228460	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	147.0	CHEMBL2850	Homo sapiens	Residual Activity	%	147.0
	12228461	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	135.0	CHEMBL2850	Homo sapiens	Residual Activity	%	135.0
	12228462	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	148.0	CHEMBL2850	Homo sapiens	Residual Activity	%	148.0
	12228463	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	124.0	CHEMBL2850	Homo sapiens	Residual Activity	%	124.0
	12228464	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	120.0	CHEMBL2850	Homo sapiens	Residual Activity	%	120.0
	12228465	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	127.0	CHEMBL2850	Homo sapiens	Residual Activity	%	127.0
	12228466	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	-1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	-1.0
	12228467	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	112.0	CHEMBL2850	Homo sapiens	Residual Activity	%	112.0
	12228468	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228469	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	114.0	CHEMBL2850	Homo sapiens	Residual Activity	%	114.0
	12228470	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	121.0	CHEMBL2850	Homo sapiens	Residual Activity	%	121.0
	12228471	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	111.0	CHEMBL2850	Homo sapiens	Residual Activity	%	111.0
	12228472	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	118.0	CHEMBL2850	Homo sapiens	Residual Activity	%	118.0
	12228473	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	142.0	CHEMBL2850	Homo sapiens	Residual Activity	%	142.0
	12228474	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	80.0	CHEMBL2850	Homo sapiens	Residual Activity	%	80.0
	12228475	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL2850	Homo sapiens	Residual Activity	%	88.0
	12228476	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	30.0	CHEMBL2850	Homo sapiens	Residual Activity	%	30.0
	12228477	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	14.0	CHEMBL2850	Homo sapiens	Residual Activity	%	14.0
	12228478	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12228479	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	121.0	CHEMBL2850	Homo sapiens	Residual Activity	%	121.0
	12228480	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	82.0	CHEMBL2850	Homo sapiens	Residual Activity	%	82.0
	12228481	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	108.0	CHEMBL2850	Homo sapiens	Residual Activity	%	108.0
	12228482	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	109.0	CHEMBL2850	Homo sapiens	Residual Activity	%	109.0
	12228483	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	123.0	CHEMBL2850	Homo sapiens	Residual Activity	%	123.0
	12228484	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	51.0	CHEMBL2850	Homo sapiens	Residual Activity	%	51.0
	12228485	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	178.0	CHEMBL2850	Homo sapiens	Residual Activity	%	178.0
	12228486	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	130.0	CHEMBL2850	Homo sapiens	Residual Activity	%	130.0
	12228487	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	67.0	CHEMBL2850	Homo sapiens	Residual Activity	%	67.0
	12228488	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	2.0	CHEMBL2850	Homo sapiens	Residual Activity	%	2.0
	12228489	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	160.0	CHEMBL2850	Homo sapiens	Residual Activity	%	160.0
	12228490	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	133.0	CHEMBL2850	Homo sapiens	Residual Activity	%	133.0
	12228491	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	187.0	CHEMBL2850	Homo sapiens	Residual Activity	%	187.0
	12228492	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	92.0	CHEMBL2850	Homo sapiens	Residual Activity	%	92.0
	12228493	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	84.0	CHEMBL2850	Homo sapiens	Residual Activity	%	84.0
	12228494	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	110.0	CHEMBL2850	Homo sapiens	Residual Activity	%	110.0
	12228495	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL2850	Homo sapiens	Residual Activity	%	-2.0
	12228496	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12228497	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12228498	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	30.0	CHEMBL2850	Homo sapiens	Residual Activity	%	30.0
	12228499	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	68.0	CHEMBL2850	Homo sapiens	Residual Activity	%	68.0
	12228500	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL2850	Homo sapiens	Residual Activity	%	94.0
	12228501	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	84.0	CHEMBL2850	Homo sapiens	Residual Activity	%	84.0
	12228502	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	96.0	CHEMBL2850	Homo sapiens	Residual Activity	%	96.0
	12228503	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	49.0	CHEMBL2850	Homo sapiens	Residual Activity	%	49.0
	12228504	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	35.0	CHEMBL2850	Homo sapiens	Residual Activity	%	35.0
	12228505	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228506	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	85.0	CHEMBL2850	Homo sapiens	Residual Activity	%	85.0
	12228507	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	30.0	CHEMBL2850	Homo sapiens	Residual Activity	%	30.0
	12228508	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12228509	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL2850	Homo sapiens	Residual Activity	%	96.0
	12228510	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	69.0	CHEMBL2850	Homo sapiens	Residual Activity	%	69.0
	12228511	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	102.0	CHEMBL2850	Homo sapiens	Residual Activity	%	102.0
	12228512	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	89.0	CHEMBL2850	Homo sapiens	Residual Activity	%	89.0
	12228513	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	102.0	CHEMBL2850	Homo sapiens	Residual Activity	%	102.0
	12228514	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	106.0	CHEMBL2850	Homo sapiens	Residual Activity	%	106.0
	12228515	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	83.0	CHEMBL2850	Homo sapiens	Residual Activity	%	83.0
	12228516	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	4.0	CHEMBL2850	Homo sapiens	Residual Activity	%	4.0
	12228517	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12228518	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	77.0	CHEMBL2850	Homo sapiens	Residual Activity	%	77.0
	12228519	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12228520	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	2.0	CHEMBL2850	Homo sapiens	Residual Activity	%	2.0
	12228521	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12228522	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	34.0	CHEMBL2850	Homo sapiens	Residual Activity	%	34.0
	12228523	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12228524	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	95.0	CHEMBL2850	Homo sapiens	Residual Activity	%	95.0
	12228525	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	0.0	CHEMBL2850	Homo sapiens	Residual Activity	%	0.0
	12228526	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	84.0	CHEMBL2850	Homo sapiens	Residual Activity	%	84.0
	12228527	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	85.0	CHEMBL2850	Homo sapiens	Residual Activity	%	85.0
	12228528	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	0.0	CHEMBL2850	Homo sapiens	Residual Activity	%	0.0
	12228529	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	89.0	CHEMBL2850	Homo sapiens	Residual Activity	%	89.0
	12228530	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	86.0	CHEMBL2850	Homo sapiens	Residual Activity	%	86.0
	12228531	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL2850	Homo sapiens	Residual Activity	%	101.0
	12228532	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	29.0	CHEMBL2850	Homo sapiens	Residual Activity	%	29.0
	12228533	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	103.0	CHEMBL2850	Homo sapiens	Residual Activity	%	103.0
	12228534	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	50.0	CHEMBL2850	Homo sapiens	Residual Activity	%	50.0
	12228535	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	88.0	CHEMBL2850	Homo sapiens	Residual Activity	%	88.0
	12228536	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	20.0	CHEMBL2850	Homo sapiens	Residual Activity	%	20.0
	12228537	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	119.0	CHEMBL2850	Homo sapiens	Residual Activity	%	119.0
	12228538	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	69.0	CHEMBL2850	Homo sapiens	Residual Activity	%	69.0
	12228539	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	10.0	CHEMBL2850	Homo sapiens	Residual Activity	%	10.0
	12228540	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	0.0	CHEMBL2850	Homo sapiens	Residual Activity	%	0.0
	12228541	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	93.0	CHEMBL2850	Homo sapiens	Residual Activity	%	93.0
	12228542	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	62.0	CHEMBL2850	Homo sapiens	Residual Activity	%	62.0
	12228543	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	88.0	CHEMBL2850	Homo sapiens	Residual Activity	%	88.0
	12228544	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	41.0	CHEMBL2850	Homo sapiens	Residual Activity	%	41.0
	12228545	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL2850	Homo sapiens	Residual Activity	%	2.0
	12228546	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	75.0	CHEMBL2850	Homo sapiens	Residual Activity	%	75.0
	12228547	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228548	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	40.0	CHEMBL2850	Homo sapiens	Residual Activity	%	40.0
	12228549	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	99.0	CHEMBL2850	Homo sapiens	Residual Activity	%	99.0
	12228550	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12228551	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	28.0	CHEMBL2850	Homo sapiens	Residual Activity	%	28.0
	12228552	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	50.0	CHEMBL2850	Homo sapiens	Residual Activity	%	50.0
	12228553	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	15.0	CHEMBL2850	Homo sapiens	Residual Activity	%	15.0
	12228554	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	-1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	-1.0
	12228555	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	74.0	CHEMBL2850	Homo sapiens	Residual Activity	%	74.0
	12228556	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL2850	Homo sapiens	Residual Activity	%	87.0
	12228557	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL2850	Homo sapiens	Residual Activity	%	107.0
	12228558	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	35.0	CHEMBL2850	Homo sapiens	Residual Activity	%	35.0
	12228559	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	76.0	CHEMBL2850	Homo sapiens	Residual Activity	%	76.0
	12228560	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	106.0	CHEMBL2850	Homo sapiens	Residual Activity	%	106.0
	12228561	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	13.0	CHEMBL2850	Homo sapiens	Residual Activity	%	13.0
	12228562	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	0.0	CHEMBL2850	Homo sapiens	Residual Activity	%	0.0
	12228563	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	-1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	-1.0
	12228564	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL2850	Homo sapiens	Residual Activity	%	90.0
	12228565	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	86.0	CHEMBL2850	Homo sapiens	Residual Activity	%	86.0
	12228566	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	1.0	CHEMBL2850	Homo sapiens	Residual Activity	%	1.0
	12228567	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	51.0	CHEMBL2850	Homo sapiens	Residual Activity	%	51.0
	12228568	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	78.0	CHEMBL2850	Homo sapiens	Residual Activity	%	78.0
	12228569	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	3.0	CHEMBL2850	Homo sapiens	Residual Activity	%	3.0
	12228570	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	80.0	CHEMBL2850	Homo sapiens	Residual Activity	%	80.0
	12228571	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	89.0	CHEMBL2850	Homo sapiens	Residual Activity	%	89.0
	12228572	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	42.0	CHEMBL2850	Homo sapiens	Residual Activity	%	42.0
	12228573	CHEMBL2219095	Millipore: Percentage of residual kinase activity of GSK3A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	39.0	CHEMBL2850	Homo sapiens	Residual Activity	%	39.0
	12421519	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOc1ccc(S(=O)(=O)N2CCN(c3ccccc3)CC2)cc1-c1nc2ncccc2c(=O)[nH]1		CHEMBL2234213	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421520	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOc1ccc(S(=O)(=O)N2CCOCC2)cc1-c1nc2ncccc2c(=O)[nH]1		CHEMBL2234212	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421521	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=c1[nH]cnc2c(-c3ccc(Br)cc3)n[nH]c12		CHEMBL2234211	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421522	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=c1[nH]cnc2c(-c3ccccc3)n[nH]c12		CHEMBL2234269	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421523	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Br)cc2)c1N		CHEMBL2234268	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421524	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1N		CHEMBL2234220	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421525	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1/N=N/c1ccccc1		CHEMBL2234219	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421526	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(F)cc2)c1/N=N/c1ccccc1		CHEMBL2234218	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421527	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=C1NN=C(c2ccc(Br)cc2)/C(=N/Nc2ccccc2)C1=O		CHEMBL2234217	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421528	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=C1NN=C(c2ccccc2)/C(=N/Nc2ccccc2)C1=O		CHEMBL2234216	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421529	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccc(Cl)cc1		CHEMBL2234215	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12421530	CHEMBL3061699	Inhibition of GSK3alpha (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccccc1		CHEMBL2234214	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	12621667	CHEMBL2319815	Inhibition of human recombinant GSK-3alpha using GS2 peptide as substrate and [gamma33P]-ATP after 12 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	1621.81	CHEMBL2850	Homo sapiens	pIC50		5.79
	12621690	CHEMBL2319815	Inhibition of human recombinant GSK-3alpha using GS2 peptide as substrate and [gamma33P]-ATP after 12 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	1600.0	CHEMBL2850	Homo sapiens	IC50	uM	1.6
	12628469	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	N#Cc1c(N)nc2sc(C(=O)c3ccc(Cl)cc3)c(N)c2c1-c1ccccc1I		CHEMBL2313821	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	12628470	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	N#Cc1cccc(C(=O)c2sc3nc(N)c(C#N)c(-c4ccccc4Cl)c3c2N)c1		CHEMBL2314101	>	IC50	nM	25000.0	CHEMBL2850	Homo sapiens	IC50	uM	25.0
	12628471	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	12628472	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Br		CHEMBL2313850	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	12628473	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1I		CHEMBL2313844	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	12628474	CHEMBL2321415	Inhibition of human Nt-GST-tagged GSK-3alpha	B	COc1ccccc1-c1c(C#N)c(N)nc2sc(C(=O)c3ccccc3)c(N)c12		CHEMBL2314102	>	IC50	nM	100000.0	CHEMBL2850	Homo sapiens	IC50	uM	100.0
	12693233	CHEMBL2343917	Inhibition of GSK3alpha (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	nM	10000.0
	12728816	CHEMBL2352889	Inhibition of GSK3alpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	48.0	CHEMBL2850	Homo sapiens	Activity	%	48.0
	12729061	CHEMBL2351967	Inhibition of GSK3alpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL2850	Homo sapiens	Activity	%	97.0
	12729943	CHEMBL2352179	Inhibition of GSK3a (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	81.0	CHEMBL2850	Homo sapiens	Activity	%	81.0
	12730204	CHEMBL2352889	Inhibition of GSK3alpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	81.0	CHEMBL2850	Homo sapiens	Activity	%	81.0
	13279232	CHEMBL2380168	Inhibition of human GSK3alpha at 0.1 uM incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay relative to control	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825	=	Inhibition	%	70.0	CHEMBL2850	Homo sapiens	INH	%	70.0
	13327674	CHEMBL2389832	Inhibition of GSK3A (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	6.0	CHEMBL2850	Homo sapiens	INH	%	6.0
	13327675	CHEMBL2389832	Inhibition of GSK3A (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	24.0	CHEMBL2850	Homo sapiens	INH	%	24.0
	13337646	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391098	=	IC50	nM	324.0	CHEMBL2850	Homo sapiens	IC50	uM	0.324
	13337647	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391131	=	IC50	nM	240.0	CHEMBL2850	Homo sapiens	IC50	uM	0.24
	13337651	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391127	=	IC50	nM	195.0	CHEMBL2850	Homo sapiens	IC50	uM	0.195
	13337661	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2390958	=	IC50	nM	77.0	CHEMBL2850	Homo sapiens	IC50	uM	0.077
	13337664	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391099	=	IC50	nM	52.0	CHEMBL2850	Homo sapiens	IC50	uM	0.052
	13337665	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391117	=	IC50	nM	51.0	CHEMBL2850	Homo sapiens	IC50	uM	0.051
	13337666	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391123	=	IC50	nM	51.0	CHEMBL2850	Homo sapiens	IC50	uM	0.051
	13337667	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1		CHEMBL2391132	=	IC50	nM	46.0	CHEMBL2850	Homo sapiens	IC50	uM	0.046
	13337669	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391124	=	IC50	nM	35.0	CHEMBL2850	Homo sapiens	IC50	uM	0.035
	13337673	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391133	=	IC50	nM	27.0	CHEMBL2850	Homo sapiens	IC50	uM	0.027
	13337674	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1		CHEMBL2391100	=	IC50	nM	20.0	CHEMBL2850	Homo sapiens	IC50	uM	0.02
	13337676	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391126	=	IC50	nM	19.0	CHEMBL2850	Homo sapiens	IC50	uM	0.019
	13337678	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1		CHEMBL2391101	=	IC50	nM	17.0	CHEMBL2850	Homo sapiens	IC50	uM	0.017
	13337679	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391120	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	uM	0.015
	13337680	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391128	=	IC50	nM	15.0	CHEMBL2850	Homo sapiens	IC50	uM	0.015
	13337682	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391130	=	IC50	nM	9.0	CHEMBL2850	Homo sapiens	IC50	uM	0.009
	13337683	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2391119	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	uM	0.007
	13337684	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1		CHEMBL2391118	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	uM	0.005
	13337685	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1		CHEMBL2391125	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	uM	0.005
	13337686	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391121	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	uM	0.004
	13337687	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2391129	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	uM	0.004
	13337688	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2391122	=	IC50	nM	3.0	CHEMBL2850	Homo sapiens	IC50	uM	0.003
	13337689	CHEMBL2393655	Inhibition of human recombinant GSK3alpha by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1		CHEMBL2391102	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	uM	0.002
Not Active	13349230	CHEMBL2399725	Inhibition of recombinant GSK3alpha (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Not Active	13349231	CHEMBL2399725	Inhibition of recombinant GSK3alpha (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	13351556	CHEMBL2399990	Inhibition of human GSK3alpha at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	13375848	CHEMBL2405110	Inhibition of GSK3A (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	13439839	CHEMBL2427140	Competitive binding affinity to GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	91.0	CHEMBL2850	Homo sapiens	INH	%	91.0
	13442421	CHEMBL2427140	Competitive binding affinity to GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL2850	Homo sapiens	INH	%	85.0
	13442494	CHEMBL2429311	Binding affinity to GSK3A (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	1300.0	CHEMBL2850	Homo sapiens	Kd	uM	1.3
	13445376	CHEMBL2427140	Competitive binding affinity to GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	97.0	CHEMBL2850	Homo sapiens	INH	%	97.0
	13445672	CHEMBL2427140	Competitive binding affinity to GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	13451659	CHEMBL2427140	Competitive binding affinity to GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	13872133	CHEMBL3101758	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	68.0	CHEMBL2850	Homo sapiens	Activity	%	68.0
	13899603	CHEMBL3112010	Inhibition of human recombinant GSK-3alpha using ATP/Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate at 1 uM after 60 mins by LANCE assay	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	=	Inhibition	%	98.3	CHEMBL2850	Homo sapiens	INH	%	98.3
	13953297	CHEMBL3130696	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	95.0	CHEMBL2850	Homo sapiens	Activity	%	95.0
	13953320	CHEMBL3130696	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	92.0	CHEMBL2850	Homo sapiens	Activity	%	92.0
	13954648	CHEMBL3130696	Inhibition of human GSK3alpha assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	102.0	CHEMBL2850	Homo sapiens	Activity	%	102.0
	14582512	CHEMBL3242364	Inhibition of human GSK3alpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	121.5	CHEMBL2850	Homo sapiens	Activity	%	121.5
	15018608	CHEMBL3366832	Inhibition of GSK3 alpha (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	29.9	CHEMBL2850	Homo sapiens	INH	%	29.9
	15091117	CHEMBL3390654	Inhibition of human recombinant GSK3alpha using CFFKNIVTPRTPPPSQGK-amide substrate after 60 mins incubation by LANCE method	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Inhibition	%	59.0	CHEMBL2850	Homo sapiens	INH	%	59.0
	15091118	CHEMBL3390654	Inhibition of human recombinant GSK3alpha using CFFKNIVTPRTPPPSQGK-amide substrate after 60 mins incubation by LANCE method	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(O)c(Br)c1		CHEMBL3335349	=	Inhibition	%	30.0	CHEMBL2850	Homo sapiens	INH	%	30.0
	15091128	CHEMBL3390654	Inhibition of human recombinant GSK3alpha using CFFKNIVTPRTPPPSQGK-amide substrate after 60 mins incubation by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	28.0	CHEMBL2850	Homo sapiens	IC50	nM	28.0
	15205886	CHEMBL3413912	Inhibition of GSK3alpha (unknown origin)	B	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		CHEMBL3408213	=	IC50	nM	462.0	CHEMBL2850	Homo sapiens	IC50	uM	0.462
	15249283	CHEMBL3428313	Inhibition of human GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	5.1	CHEMBL2850	Homo sapiens	INH	%	5.1
	15463082	CHEMBL3533962	Inhibition of GSK3alpha (unknown origin)	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.5	CHEMBL2850	Homo sapiens	IC50	nM	1.5
	15615809	CHEMBL3584795	Competitive inhibition of full length recombinant human GSK-3alpha expressed in baculovirus infected insect Sf9 cells using GS-2 peptide as substrate assessed as 33P incorporation into substrate peptide after 30 mins by beta scintillation counting analysis in presence of [33P]gamma-ATP	B	[11CH3]n1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL3582401	=	Ki	nM	9.0	CHEMBL2850	Homo sapiens	Ki	nM	9.0
	15615810	CHEMBL3584794	Inhibition of full length recombinant human GSK-3alpha expressed in baculovirus infected insect Sf9 cells using GS-2 peptide as substrate assessed as 33P incorporation into substrate peptide after 30 mins by beta scintillation counting analysis in presence of [33P]gamma-ATP	B	[11CH3]n1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL3582401	=	IC50	nM	34.0	CHEMBL2850	Homo sapiens	IC50	nM	34.0
	15650170	CHEMBL3595490	Inhibition of human GSK3A at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	15651978	CHEMBL3595347	Inhibition of GSK-3alpha (unknown origin) at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	<	Inhibition	%	75.0	CHEMBL2850	Homo sapiens	INH	%	75.0
	15742901	CHEMBL3626288	Inhibition of GSK3A (unknown origin) at 1 uM	B	O=C(C1CC1)n1ccc2c3c(=O)cc(-c4ccccc4)[nH]c3ccc21		CHEMBL3623601	=	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	15756967	CHEMBL3630516	Inhibition of GSK3alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	37.76	CHEMBL2850	Homo sapiens	INH	%	37.76
	15757756	CHEMBL3630516	Inhibition of GSK3alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	98.94	CHEMBL2850	Homo sapiens	INH	%	98.94
	15758735	CHEMBL3630516	Inhibition of GSK3alpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.43	CHEMBL2850	Homo sapiens	INH	%	5.43
	15770161	CHEMBL3635553	Inhibition of human recombinant GSK-3 alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate incubated for 60 mins by LANCE method relative to control	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824	=	IC50	nM	42.0	CHEMBL2850	Homo sapiens	IC50	nM	42.0
	15770162	CHEMBL3635553	Inhibition of human recombinant GSK-3 alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate incubated for 60 mins by LANCE method relative to control	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	=	IC50	nM	230.0	CHEMBL2850	Homo sapiens	IC50	nM	230.0
Active	15770205	CHEMBL3635562	Inhibition of GSK-3 alpha in human HL-60 cells assessed as reduction in GSK-3 alpha Tyr 279 phosphorylation up to 20 uM after 24 hrs by immunoblotting	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770206	CHEMBL3635563	Inhibition of GSK-3 alpha in human NB4 cells assessed as reduction in GSK-3 alpha Tyr 279 phosphorylation up to 20 uM after 24 hrs by immunoblotting	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770209	CHEMBL3635561	Inhibition of GSK-3 alpha in human HL-60 cells assessed as decreased nuclear to cytoplasmic ratio at 5 to 10 uM after 6 days by May-Grunwald Giemsa staining based light microscopy	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770210	CHEMBL3635566	Inhibition of GSK-3 alpha in human NB4 cells assessed as decreased nuclear to cytoplasmic ratio at 5 to 10 uM after 6 days by May-Grunwald Giemsa staining based light microscopy	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770211	CHEMBL3635567	Inhibition of GSK-3 alpha in human HL-60 cells assessed as increased vacuolization at 5 to 10 uM after 6 days by May-Grunwald Giemsa staining based light microscopy	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770212	CHEMBL3635568	Inhibition of GSK-3 alpha in human NB4 cells assessed as increased vacuolization at 5 to 10 uM after 6 days by May-Grunwald Giemsa staining based light microscopy	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770213	CHEMBL3635569	Inhibition of GSK-3 alpha in human HL-60 cells assessed as CD11b expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770214	CHEMBL3635570	Inhibition of GSK-3 alpha in human HL-60 cells assessed as CD11c expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770215	CHEMBL3635571	Inhibition of GSK-3 alpha in human HL-60 cells assessed as CD14 expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770216	CHEMBL3635572	Inhibition of GSK-3 alpha in human NB4 cells assessed as CD11b expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770217	CHEMBL3635573	Inhibition of GSK-3 alpha in human NB4 cells assessed as CD11c expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770218	CHEMBL3635574	Inhibition of GSK-3 alpha in human NB4 cells assessed as CD14 expression at 5 to 10 uM after 6 days by flow cytometry	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770219	CHEMBL3635575	Inhibition of GSK-3 alpha in human HL-60 cells assessed as methylcellulose colony formation impairment at 5 to 10 uM pre-treated for 72 hrs and measured 7 to 10 days growth in methylcellulose	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	15770220	CHEMBL3635731	Inhibition of GSK-3 alpha in human NB4 cells assessed as methylcellulose colony formation impairment at 5 to 10 uM pre-treated for 72 hrs and measured 7 to 10 days growth in methylcellulose	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
244248	16265133	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2c[nH]c3ncc(F)cc23)nc(C23CC4CC(CC(C4)C2)C3)n1		CHEMBL3652549	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	nM	2.0
244243	16271575	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652545	=	IC50	nM	0.5	CHEMBL2850	Homo sapiens	IC50	nM	0.5
244249	16272548	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	CC(C)(O)c1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652550	=	IC50	nM	3.0	CHEMBL2850	Homo sapiens	IC50	nM	3.0
244240	16276513	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(C2CCOCC2)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3652542	=	IC50	nM	30.0	CHEMBL2850	Homo sapiens	IC50	nM	30.0
308359	16282265	CHEMBL3707586	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1		CHEMBL3673435	=	IC50	nM	99.0	CHEMBL2850	Homo sapiens	IC50	nM	99.0
244247	16284589	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc([C@H]2CCCC[C@@H]2C)n1		CHEMBL3652548	=	IC50	nM	1.0	CHEMBL2850	Homo sapiens	IC50	nM	1.0
244238	16285849	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(C2CCCCC2)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3652540	=	IC50	nM	0.7	CHEMBL2850	Homo sapiens	IC50	nM	0.7
251321	16291879	CHEMBL3705327	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Fc1cnc2[nH]nc(Nc3cc(C(F)(F)F)cc(-c4ccccc4Cl)n3)c2c1		CHEMBL3661029	=	IC50	nM	3.0	CHEMBL2850	Homo sapiens	IC50	nM	3.0
244244	16300995	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ccc(F)cc23)nc(C2CCOCC2)n1		CHEMBL3652546	=	IC50	nM	30.0	CHEMBL2850	Homo sapiens	IC50	nM	30.0
251325	16307197	CHEMBL3705327	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2)c1C		CHEMBL3661033	=	IC50	nM	0.6	CHEMBL2850	Homo sapiens	IC50	nM	0.6
244242	16308121	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCC2)n1		CHEMBL3652544	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	nM	2.0
251323	16317758	CHEMBL3705327	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2Cl)c1		CHEMBL3661031	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	nM	2.0
308358	16326337	CHEMBL3707586	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1		CHEMBL3673434	=	IC50	nM	160.0	CHEMBL2850	Homo sapiens	IC50	nM	160.0
244239	16328642	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(Nc2n[nH]c3ncc(F)cc23)cc(C2CCC(F)(F)CC2)n1		CHEMBL3652541	=	IC50	nM	1.0	CHEMBL2850	Homo sapiens	IC50	nM	1.0
244241	16337901	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCCC2)n1		CHEMBL3652543	=	IC50	nM	0.3	CHEMBL2850	Homo sapiens	IC50	nM	0.3
251322	16340145	CHEMBL3705327	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2Cl)c1C		CHEMBL3661030	=	IC50	nM	10.0	CHEMBL2850	Homo sapiens	IC50	nM	10.0
244246	16340474	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCOCC2)n1		CHEMBL3652547	=	IC50	nM	3.0	CHEMBL2850	Homo sapiens	IC50	nM	3.0
318304	16340664	CHEMBL3706098	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C(F)(F)F)c21		CHEMBL3673985	=	IC50	nM	13.0	CHEMBL2850	Homo sapiens	IC50	nM	13.0
251324	16342488	CHEMBL3705327	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(-c2ccccc2Cl)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3661032	=	IC50	nM	30.0	CHEMBL2850	Homo sapiens	IC50	nM	30.0
244250	16352085	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ccc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652551	=	IC50	nM	2.0	CHEMBL2850	Homo sapiens	IC50	nM	2.0
244245	16353775	CHEMBL3705569	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCCC2)n1		CHEMBL3652543	=	IC50	nM	3.0	CHEMBL2850	Homo sapiens	IC50	nM	3.0
318295	16354048	CHEMBL3706098	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1[nH]nc2c1[C@H](c1ccccc1)C1=C(CC(C)(C)CC1=O)N2		CHEMBL3673983	=	IC50	nM	161.0	CHEMBL2850	Homo sapiens	IC50	nM	161.0
	16381047	CHEMBL3736803	Inhibition of human recombinant GSK-3alpha by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	40.0	CHEMBL2850	Homo sapiens	IC50	uM	0.04
	16388243	CHEMBL3737516	Inhibition of GSK3alpha (unknown origin) in presence of 10 uM ATP incubated for 1 hr by Z'Lyte assay	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	IC50	nM	884.0	CHEMBL2850	Homo sapiens	IC50	nM	884.0
	16388301	CHEMBL3737358	Inhibition of GSK3alpha (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	59.0	CHEMBL2850	Homo sapiens	INH	%	59.0
	16413454	CHEMBL3743690	Inhibition of GSK3alpha (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	16425355	CHEMBL3751237	Inhibition of GSK3 alpha (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	7.5	CHEMBL2850	Homo sapiens	INH	%	7.5
	16431852	CHEMBL3748206	Inhibition of human GSK3alpha using [YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL2850	Homo sapiens	IC50	uM	5.0
	16450862	CHEMBL3762718	Inhibition of GSK3aplha (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	30.8	CHEMBL2850	Homo sapiens	INH	%	30.8
	16496009	CHEMBL3779704	Inhibition of N-terminal His6-tagged recombinant human GSK3alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	2.0	CHEMBL2850	Homo sapiens	Activity	%	2.0
	16508196	CHEMBL3779704	Inhibition of N-terminal His6-tagged recombinant human GSK3alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-13.0	CHEMBL2850	Homo sapiens	Activity	%	-13.0
	16509173	CHEMBL3779704	Inhibition of N-terminal His6-tagged recombinant human GSK3alpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-20.0	CHEMBL2850	Homo sapiens	Activity	%	-20.0
	16592304	CHEMBL3807318	Inhibition of recombinant GSK3alpha (unknown origin) at 0.1 uM relative to control	B	Ic1ccc(Oc2cncc3sc(-c4nn[nH]n4)cc23)cc1		CHEMBL498385	>	Inhibition	%	80.0	CHEMBL2850	Homo sapiens	INH	%	80.0
	16592305	CHEMBL3807318	Inhibition of recombinant GSK3alpha (unknown origin) at 0.1 uM relative to control	B	NC(=O)c1ccc(-c2ccc(Oc3cncc4sc(-c5nn[nH]n5)cc34)cc2)cc1		CHEMBL491228	>	Inhibition	%	80.0	CHEMBL2850	Homo sapiens	INH	%	80.0
	16592322	CHEMBL3807327	Inhibition of recombinant GSK3alpha (unknown origin) at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1		CHEMBL118518	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	16592323	CHEMBL3807327	Inhibition of recombinant GSK3alpha (unknown origin) at 1 uM relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1		CHEMBL3805194	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	16614493	CHEMBL3816691	Inhibition of human GSK3alpha at 1 uM using [YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	0.0	CHEMBL2850	Homo sapiens	INH	%	0.0
	16618201	CHEMBL3816353	Inhibition of full length recombinant human N-terminal GST-tagged GSK3-alpha expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	16641944	CHEMBL3826402	Inhibition of GSK3 alpha (unknown origin) at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	43.0	CHEMBL2850	Homo sapiens	INH	%	43.0
	16668169	CHEMBL3854815	Inhibition of GSK-3alpha (unknown origin) at 1 uM relative to control	B	Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12		CHEMBL3903492	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	16668200	CHEMBL3854862	Inhibition of GSK-3alpha (unknown origin)	B	Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12		CHEMBL3903492	=	IC50	nM	691.0	CHEMBL2850	Homo sapiens	IC50	nM	691.0
	16777166	CHEMBL3864828	Competitive binding affinity to full length wild type human GSK3A expressed in bacterial expression system at 10 uM by kinomescan method relative to control	B	C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1		CHEMBL3942186	=	Activity	%	1.4	CHEMBL2850	Homo sapiens	Activity	%	1.4
	16837419	CHEMBL3876090	Inhibition of human full length N-terminal GST-tagged GSK3A expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	3308.0	CHEMBL2850	Homo sapiens	IC50	nM	3308.0
222398	17610993	CHEMBL3706098	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1nccc(-c2ccc(C(=O)N3CCOCC3)c(Cl)c2)c1C#Cc1ccc(N)nc1		CHEMBL3701062	=	IC50	nM	27.0	CHEMBL2850	Homo sapiens	IC50	nM	27.0
277735	17660076	CHEMBL3705607	Enzyme Inhibition Assay: Method 1: The inhibitory activities of the compound of the invention against the GSK 3alpha enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-alpha protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3alpha , and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific). Method 2: This method follows the same steps as Method 1 above, but utilises a shorter period of mixing of the test compound (105 minutes instead of 2 hours) with the GSK3-alpha protein.	B	C#Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)n2)cc(C(=O)NCCOCCOCCOC)c1		CHEMBL3681949	=	IC50	nM	411.0	CHEMBL2850	Homo sapiens	IC50	nM	411.0
304674	17685535	CHEMBL3706163	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of test compounds against the GSK 3alpha enzyme isoform (Invitrogen), were evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-alpha protein (500 ng/mL, 2.5 uL) was mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	>	IC50	nM	17000.0	CHEMBL2850	Homo sapiens	IC50	nM	17000.0
304680	17685541	CHEMBL3706163	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). The inhibitory activities of test compounds against the GSK 3alpha enzyme isoform (Invitrogen), were evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-alpha protein (500 ng/mL, 2.5 uL) was mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	Kd	nM	20000.0	CHEMBL2850	Homo sapiens	Kd	nM	20000.0
363612	17738986	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCC(=O)Nc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc(C)cc3)c3ccccc23)ccn1		CHEMBL3695569	=	IC50	nM	45.0	CHEMBL2850	Homo sapiens	IC50	nM	45.0
363613	17738987	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3897917	>	IC50	nM	1610.0	CHEMBL2850	Homo sapiens	IC50	nM	1610.0
363614	17738988	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)cc1		CHEMBL3972567	>	IC50	nM	15600.0	CHEMBL2850	Homo sapiens	IC50	nM	15600.0
363615	17738989	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)NCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3957923	=	IC50	nM	2330.0	CHEMBL2850	Homo sapiens	IC50	nM	2330.0
363616	17738990	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)ncn5C)n3)c3ccccc23)cc1		CHEMBL3940079	=	IC50	nM	1370.0	CHEMBL2850	Homo sapiens	IC50	nM	1370.0
363617	17738991	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5onc(N)c5c4)n3)c3ccccc23)cc1		CHEMBL3922109	>	IC50	nM	1560.0	CHEMBL2850	Homo sapiens	IC50	nM	1560.0
363618	17738992	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3964537	>	IC50	nM	16000.0	CHEMBL2850	Homo sapiens	IC50	nM	16000.0
363619	17738993	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3894106	>	IC50	nM	1600.0	CHEMBL2850	Homo sapiens	IC50	nM	1600.0
363620	17738994	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C3CCOC3)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3921479	=	IC50	nM	837.0	CHEMBL2850	Homo sapiens	IC50	nM	837.0
363621	17738995	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3943934	>	IC50	nM	15600.0	CHEMBL2850	Homo sapiens	IC50	nM	15600.0
363622	17738996	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(CN5CCCC5=O)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915981	=	IC50	nM	589.0	CHEMBL2850	Homo sapiens	IC50	nM	589.0
363623	17738997	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3933807	=	IC50	nM	848.0	CHEMBL2850	Homo sapiens	IC50	nM	848.0
363624	17738998	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3931027	=	IC50	nM	3890.0	CHEMBL2850	Homo sapiens	IC50	nM	3890.0
363625	17738999	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cn1		CHEMBL3971588	>	IC50	nM	1560.0	CHEMBL2850	Homo sapiens	IC50	nM	1560.0
363626	17739000	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3899497	=	IC50	nM	1090.0	CHEMBL2850	Homo sapiens	IC50	nM	1090.0
363627	17739001	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3933021	=	IC50	nM	1420.0	CHEMBL2850	Homo sapiens	IC50	nM	1420.0
363628	17739002	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ccc45)n3)c3ccccc23)cc1		CHEMBL3928618	>	IC50	nM	16100.0	CHEMBL2850	Homo sapiens	IC50	nM	16100.0
363629	17739003	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cc[nH]c45)n3)c3ccccc23)cc1		CHEMBL3964270	>	IC50	nM	16100.0	CHEMBL2850	Homo sapiens	IC50	nM	16100.0
363630	17739004	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(ccn5C)c4)n3)c3ccccc23)cc1		CHEMBL3955192	=	IC50	nM	7080.0	CHEMBL2850	Homo sapiens	IC50	nM	7080.0
363631	17739005	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5)n3)c3ccccc23)cc1		CHEMBL3946614	=	IC50	nM	1010.0	CHEMBL2850	Homo sapiens	IC50	nM	1010.0
363632	17739006	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CC(=O)N5C)n3)c3ccccc23)cc1		CHEMBL3975927	=	IC50	nM	900.0	CHEMBL2850	Homo sapiens	IC50	nM	900.0
363633	17739007	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5[nH]ncc45)n3)c3ccccc23)cc1		CHEMBL3943340	>	IC50	nM	16000.0	CHEMBL2850	Homo sapiens	IC50	nM	16000.0
363634	17739008	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3935885	>	IC50	nM	16000.0	CHEMBL2850	Homo sapiens	IC50	nM	16000.0
363635	17739009	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3958297	=	IC50	nM	12500.0	CHEMBL2850	Homo sapiens	IC50	nM	12500.0
363636	17739010	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5cn[nH]c5c4)n3)c3ccccc23)cc1		CHEMBL3901815	=	IC50	nM	2180.0	CHEMBL2850	Homo sapiens	IC50	nM	2180.0
363637	17739011	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cccc5cn[nH]c45)n3)c3ccccc23)cc1		CHEMBL3978244	>	IC50	nM	16000.0	CHEMBL2850	Homo sapiens	IC50	nM	16000.0
363638	17739012	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3907109	>	IC50	nM	15700.0	CHEMBL2850	Homo sapiens	IC50	nM	15700.0
363639	17739013	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3956405	>	IC50	nM	1570.0	CHEMBL2850	Homo sapiens	IC50	nM	1570.0
363640	17739014	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(Cl)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3953685	>	IC50	nM	1520.0	CHEMBL2850	Homo sapiens	IC50	nM	1520.0
363641	17739015	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3962324	=	IC50	nM	582.0	CHEMBL2850	Homo sapiens	IC50	nM	582.0
363642	17739016	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]cnc5c4)n3)c3ccccc23)cc1		CHEMBL3919242	=	IC50	nM	301.0	CHEMBL2850	Homo sapiens	IC50	nM	301.0
363643	17739017	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncn(C)c5c4)n3)c3ccccc23)cc1		CHEMBL3960029	=	IC50	nM	1610.0	CHEMBL2850	Homo sapiens	IC50	nM	1610.0
363644	17739018	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cnc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3932522	>	IC50	nM	1600.0	CHEMBL2850	Homo sapiens	IC50	nM	1600.0
363645	17739019	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)cc1		CHEMBL3921959	=	IC50	nM	5140.0	CHEMBL2850	Homo sapiens	IC50	nM	5140.0
363646	17739020	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)cc1		CHEMBL3958914	=	IC50	nM	1620.0	CHEMBL2850	Homo sapiens	IC50	nM	1620.0
363647	17739021	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)cc1		CHEMBL3983442	>	IC50	nM	15600.0	CHEMBL2850	Homo sapiens	IC50	nM	15600.0
363648	17739022	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)cc1		CHEMBL3958384	=	IC50	nM	2100.0	CHEMBL2850	Homo sapiens	IC50	nM	2100.0
363649	17739023	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2ccc(O)cc2)n1		CHEMBL3899975	>	IC50	nM	1600.0	CHEMBL2850	Homo sapiens	IC50	nM	1600.0
363650	17739024	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cc1		CHEMBL3984472	>	IC50	nM	1560.0	CHEMBL2850	Homo sapiens	IC50	nM	1560.0
363651	17739025	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)cc1		CHEMBL3912970	>	IC50	nM	16000.0	CHEMBL2850	Homo sapiens	IC50	nM	16000.0
363652	17739026	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3926692	>	IC50	nM	15600.0	CHEMBL2850	Homo sapiens	IC50	nM	15600.0
363653	17739027	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5C)c4)n3)c3ccccc23)cc1		CHEMBL3935024	>	IC50	nM	15300.0	CHEMBL2850	Homo sapiens	IC50	nM	15300.0
363654	17739028	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)n3)c3ccccc23)cc1		CHEMBL3967247	>	IC50	nM	1530.0	CHEMBL2850	Homo sapiens	IC50	nM	1530.0
363655	17739029	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)cc1		CHEMBL3958953	=	IC50	nM	485.0	CHEMBL2850	Homo sapiens	IC50	nM	485.0
363656	17739030	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3927937	=	IC50	nM	203.0	CHEMBL2850	Homo sapiens	IC50	nM	203.0
363657	17739031	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(OCCN6CCOCC6)c5c4)n3)c3ccccc23)cc1		CHEMBL3950258	=	IC50	nM	407.0	CHEMBL2850	Homo sapiens	IC50	nM	407.0
363658	17739032	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3922538	=	IC50	nM	908.0	CHEMBL2850	Homo sapiens	IC50	nM	908.0
363659	17739033	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N(C)C)c5c4)n3)c3ccccc23)cc1		CHEMBL3975188	=	IC50	nM	472.0	CHEMBL2850	Homo sapiens	IC50	nM	472.0
363660	17739034	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3949262	>	IC50	nM	1420.0	CHEMBL2850	Homo sapiens	IC50	nM	1420.0
363661	17739035	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(CN3CCCC3=O)c2)n1		CHEMBL3966684	=	IC50	nM	1350.0	CHEMBL2850	Homo sapiens	IC50	nM	1350.0
363662	17739036	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3936935	=	IC50	nM	1170.0	CHEMBL2850	Homo sapiens	IC50	nM	1170.0
363663	17739037	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3925985	=	IC50	nM	4900.0	CHEMBL2850	Homo sapiens	IC50	nM	4900.0
363664	17739038	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3965728	=	IC50	nM	4970.0	CHEMBL2850	Homo sapiens	IC50	nM	4970.0
363665	17739039	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3893816	=	IC50	nM	11300.0	CHEMBL2850	Homo sapiens	IC50	nM	11300.0
363666	17739040	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2cccc(OCCN3CCOCC3)c2)n1		CHEMBL3920935	=	IC50	nM	1980.0	CHEMBL2850	Homo sapiens	IC50	nM	1980.0
363667	17739041	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3915395	>	IC50	nM	13500.0	CHEMBL2850	Homo sapiens	IC50	nM	13500.0
363668	17739042	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4cccc(OCCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3898242	>	IC50	nM	13300.0	CHEMBL2850	Homo sapiens	IC50	nM	13300.0
363669	17739043	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COCCOc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(C)c5[nH]ncc5c4)c3)c3ccccc23)c1		CHEMBL3920172	=	IC50	nM	4700.0	CHEMBL2850	Homo sapiens	IC50	nM	4700.0
363670	17739044	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN(C)C)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3892167	=	IC50	nM	1260.0	CHEMBL2850	Homo sapiens	IC50	nM	1260.0
363671	17739045	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CCC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3958095	>	IC50	nM	9230.0	CHEMBL2850	Homo sapiens	IC50	nM	9230.0
363672	17739046	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)COC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3938312	=	IC50	nM	686.0	CHEMBL2850	Homo sapiens	IC50	nM	686.0
363673	17739047	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3898648	=	IC50	nM	1540.0	CHEMBL2850	Homo sapiens	IC50	nM	1540.0
363674	17739048	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5(C)C)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3969828	=	IC50	nM	1700.0	CHEMBL2850	Homo sapiens	IC50	nM	1700.0
363675	17739049	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)C(=O)NC5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3890213	=	IC50	nM	184.0	CHEMBL2850	Homo sapiens	IC50	nM	184.0
363676	17739050	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)CS(=O)(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3914683	=	IC50	nM	437.0	CHEMBL2850	Homo sapiens	IC50	nM	437.0
363677	17739051	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)OCO5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3976445	=	IC50	nM	2840.0	CHEMBL2850	Homo sapiens	IC50	nM	2840.0
363678	17739052	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3905700	=	IC50	nM	2850.0	CHEMBL2850	Homo sapiens	IC50	nM	2850.0
363679	17739053	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)c3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936257	=	IC50	nM	3040.0	CHEMBL2850	Homo sapiens	IC50	nM	3040.0
363680	17739054	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)ccn2)cc2cn[nH]c12		CHEMBL3900304	=	IC50	nM	3040.0	CHEMBL2850	Homo sapiens	IC50	nM	3040.0
363681	17739055	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3891402	=	IC50	nM	1280.0	CHEMBL2850	Homo sapiens	IC50	nM	1280.0
363682	17739056	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3919491	=	IC50	nM	3250.0	CHEMBL2850	Homo sapiens	IC50	nM	3250.0
363683	17739057	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc12		CHEMBL3980630	=	IC50	nM	3440.0	CHEMBL2850	Homo sapiens	IC50	nM	3440.0
363684	17739058	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1n[nH]c2ccc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)cc12		CHEMBL3896872	=	IC50	nM	2290.0	CHEMBL2850	Homo sapiens	IC50	nM	2290.0
363685	17739059	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)cc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3960541	=	IC50	nM	1800.0	CHEMBL2850	Homo sapiens	IC50	nM	1800.0
363686	17739060	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3936603	=	IC50	nM	597.0	CHEMBL2850	Homo sapiens	IC50	nM	597.0
363687	17739061	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1nc2cc(Nc3nccc(Oc4ccc(NC(=O)Nc5cc(C(C)(C)C)nn5-c5ccc(OCCN6CCOCC6)cc5)c5ccccc45)n3)ccc2[nH]1		CHEMBL3924003	=	IC50	nM	4950.0	CHEMBL2850	Homo sapiens	IC50	nM	4950.0
363688	17739062	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5oc(=O)[nH]c5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL4110557	=	IC50	nM	777.0	CHEMBL2850	Homo sapiens	IC50	nM	777.0
363689	17739063	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]c(=O)oc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3918561	=	IC50	nM	2290.0	CHEMBL2850	Homo sapiens	IC50	nM	2290.0
363690	17739064	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5sncc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3984798	=	IC50	nM	2420.0	CHEMBL2850	Homo sapiens	IC50	nM	2420.0
363691	17739065	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5scnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3909641	=	IC50	nM	730.0	CHEMBL2850	Homo sapiens	IC50	nM	730.0
363692	17739066	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5ncsc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3979828	=	IC50	nM	461.0	CHEMBL2850	Homo sapiens	IC50	nM	461.0
363693	17739067	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nnc5c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1		CHEMBL3899391	=	IC50	nM	641.0	CHEMBL2850	Homo sapiens	IC50	nM	641.0
363694	17739068	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ccc5c4)n3)c3ccccc23)cn1		CHEMBL3973916	>	IC50	nM	1560.0	CHEMBL2850	Homo sapiens	IC50	nM	1560.0
363695	17739069	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]nc(C(=O)N6CCOCC6)c5c4)n3)c3ccccc23)cn1		CHEMBL3907174	=	IC50	nM	3780.0	CHEMBL2850	Homo sapiens	IC50	nM	3780.0
363696	17739070	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3cc(Nc4ccc5[nH]ncc5c4)ncn3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3935126	=	IC50	nM	278.0	CHEMBL2850	Homo sapiens	IC50	nM	278.0
363697	17739071	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3912657	=	IC50	nM	2530.0	CHEMBL2850	Homo sapiens	IC50	nM	2530.0
363698	17739072	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCO)c2)n1		CHEMBL3944099	=	IC50	nM	827.0	CHEMBL2850	Homo sapiens	IC50	nM	827.0
363699	17739073	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCO)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3921640	=	IC50	nM	1100.0	CHEMBL2850	Homo sapiens	IC50	nM	1100.0
363700	17739074	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5[nH]ncc5c4)n3)c3ccccc23)n(-c2ccc(=O)n(CCN3CCOCC3)c2)n1		CHEMBL3949420	=	IC50	nM	2430.0	CHEMBL2850	Homo sapiens	IC50	nM	2430.0
363701	17739075	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(=O)n(CCN5CCOCC5)c4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3961674	=	IC50	nM	2780.0	CHEMBL2850	Homo sapiens	IC50	nM	2780.0
363702	17739076	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3986904	=	IC50	nM	267.0	CHEMBL2850	Homo sapiens	IC50	nM	267.0
363703	17739077	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	Cc1cc(Nc2nccc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)nn4-c4ccc(OCCN5CCOCC5)nc4)c4ccccc34)n2)cc2cn[nH]c12		CHEMBL3972709	=	IC50	nM	1210.0	CHEMBL2850	Homo sapiens	IC50	nM	1210.0
363704	17739078	CHEMBL3887921	GSK 3α Enzyme Inhibition Assay: The inhibitory activities of compounds of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(cnn5CCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)nc2)n1		CHEMBL3901628	=	IC50	nM	569.0	CHEMBL2850	Homo sapiens	IC50	nM	569.0
445408	17805116	CHEMBL3889291	Enzyme Inhibition Assay: Method 2: This method follows the same steps as Method 1 above, but utilises a shorter period of mixing of the test compound (105 minutes instead of 2 hours) with the GSK3-α protein. In addition, the concentrations of test compound employed are either 10 ug/mL, 1 ug/mL, 0.1 ug/mL, or 0.01 ug/mL. Method 1: The inhibitory activities of the compound of the invention against the GSK 3α enzyme isoform (Invitrogen), are evaluated by determining the level of activation/phosphorylation of the target peptide. The GSK3-α protein (500 ng/mL, 2.5 uL) is mixed with the test compound (2.5 uL at either 4 ug/mL, 0.4 ug/mL, 0.04 ug/mL, or 0.004 ug/mL) for 2 hr at RT. The FRET peptide (8 uM, 2.5 uL), which is a phosphorylation target for GSK3α, and ATP (40 uM, 2.5 uL) are then added to the enzyme/compound mixture and the resulting mixture incubated for 1 hr. Development reagent (protease, 5 uL) is added for 1 hr prior to detection in a fluorescence microplate reader (Varioskan Flash, ThermoFisher Scientific).	B	COc1cc(Nc2cc(Oc3ccc(NC(=O)Nc4cc(C(C)(C)C)cc(NS(C)(=O)=O)c4OC)c4ccccc34)ccn2)ccc1C(=O)O		CHEMBL3915286	=	IC50	nM	115.0	CHEMBL2850	Homo sapiens	IC50	nM	115.0
Inactive	17905015	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905016	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905017	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905018	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905019	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905020	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905021	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905022	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905023	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905024	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	5188.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	5188.0
Inactive	17905025	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905026	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905027	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905028	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905029	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905030	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	33.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	33.0
Inactive	17905031	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905032	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905033	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905034	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905035	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905036	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905037	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905038	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905039	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905040	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905041	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905042	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905043	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905044	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905045	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905046	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905047	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905048	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905049	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	275.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	275.0
Inactive	17905050	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905051	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905052	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905053	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	13.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	13.0
Inactive	17905054	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905055	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905056	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905057	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905058	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905059	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905060	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905061	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905062	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905063	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905064	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905065	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905066	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905067	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905068	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	5259.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	5259.0
Inactive	17905069	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905070	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905071	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905072	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905073	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905074	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	7206.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	7206.0
Inactive	17905075	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905076	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905077	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905078	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905079	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905080	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	579.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	579.0
Active	17905081	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	845.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	845.0
Inactive	17905082	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905083	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905084	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905085	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905086	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905087	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905088	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905089	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905090	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905091	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905092	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905093	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905094	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905095	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905096	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905097	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905098	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905099	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905100	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905101	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905102	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905103	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905104	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905105	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905106	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905107	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905108	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905109	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905110	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905111	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905112	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	=	Kd	nM	3403.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	3403.0
Active	17905113	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	971.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	971.0
Inactive	17905114	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905115	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905116	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905117	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905118	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905119	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905120	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905121	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905122	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905123	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905124	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905125	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905126	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905127	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905128	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905129	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905130	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905131	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905132	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	193.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	193.0
Inactive	17905133	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905134	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905135	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905136	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905137	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905138	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905139	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	246.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	246.0
Inactive	17905140	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905141	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905142	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905143	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905144	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905145	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905146	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905147	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905148	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905149	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905150	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905151	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905152	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905153	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905154	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905155	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905156	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905157	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905158	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905159	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	1201.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	1201.0
Inactive	17905160	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905161	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905162	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905163	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905164	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905165	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905166	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905167	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905168	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905169	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905170	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905171	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	2088.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	2088.0
Inactive	17905172	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905173	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905174	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905175	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905176	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905177	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905178	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905179	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905180	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905181	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905182	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905183	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905184	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905185	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905186	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905187	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905188	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905189	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905190	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905191	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905192	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905193	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905194	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905195	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905196	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	1462.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	1462.0
Inactive	17905197	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905198	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905199	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905200	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905201	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905202	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905203	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905204	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	2186.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	2186.0
Inactive	17905205	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905206	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905207	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905208	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905209	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905210	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905211	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905212	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905213	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905214	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	1103.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	1103.0
Inactive	17905215	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905216	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905217	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905218	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	29.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	29.0
Inactive	17905219	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905220	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905221	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905222	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	39022.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	39022.0
Active	17905223	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	17301.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	17301.0
Inactive	17905224	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905225	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905226	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905227	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905228	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905229	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905230	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	87.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	87.0
Inactive	17905231	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905232	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905233	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	22543.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	22543.0
Active	17905234	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	6.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	6.0
Inactive	17905235	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905236	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	7.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	7.0
Inactive	17905237	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905238	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905239	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905240	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905241	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905242	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905243	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905244	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905245	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905246	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	55.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	55.0
Inactive	17905247	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905248	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Active	17905249	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	1475.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	1475.0
Inactive	17905250	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905251	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905252	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905253	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905254	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905255	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905256	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905257	CHEMBL3991726	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2850	Homo sapiens	Kd apparent	nM	30000.0
	18031713	CHEMBL4007710	Inhibition of GSK3A (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	18031714	CHEMBL4007710	Inhibition of GSK3A (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	18031715	CHEMBL4007710	Inhibition of GSK3A (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	9360.0	CHEMBL2850	Homo sapiens	IC50	uM	9.36
	18031716	CHEMBL4007710	Inhibition of GSK3A (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	18031717	CHEMBL4007710	Inhibition of GSK3A (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	18052911	CHEMBL4011923	Inhibition of GSK3alpha (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	85.7	CHEMBL2850	Homo sapiens	INH	%	85.7
	18052937	CHEMBL4011950	Inhibition of GSK3alpha (unknown origin) pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	IC50	nM	37.0	CHEMBL2850	Homo sapiens	IC50	nM	37.0
	18105896	CHEMBL4022686	Inhibition of human GSK3alpha using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL3185148	=	IC50	nM	7.0	CHEMBL2850	Homo sapiens	IC50	uM	0.007
	18105897	CHEMBL4022686	Inhibition of human GSK3alpha using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	=	IC50	nM	27.1	CHEMBL2850	Homo sapiens	IC50	uM	0.0271
	18105898	CHEMBL4022686	Inhibition of human GSK3alpha using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	7.8	CHEMBL2850	Homo sapiens	IC50	uM	0.0078
	18114327	CHEMBL4025167	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18115019	CHEMBL4025571	Inhibition of GSK3alpha phosphorylation at Ser21 in human Hep3B cells assessed as ratio of phosphorylated GSK3beta to beta-actin level at 10 uM after 48 hrs by Western blot analysis	B	O=C1COc2ccccc2N1Cc1cn(CCC2OCCO2)nn1		CHEMBL4104878	=	Ratio		0.9	CHEMBL2850	Homo sapiens	Ratio		0.9
	18143854	CHEMBL4031844	Inhibition of GSK3alpha in human PBMC at 1 uM	B	Cc1cccc(-c2cc(N)nc3[nH]cc(C#N)c23)c1		CHEMBL3961632	>	Inhibition	%	35.0	CHEMBL2850	Homo sapiens	INH	%	35.0
	18153312	CHEMBL4034332	Inhibition of GSK3A Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	6.1	CHEMBL2850	Homo sapiens	INH	%	6.1
	18203691	CHEMBL4043978	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18211626	CHEMBL4045688	Inhibition of GSK3A conserved Lys2 (DIKPQNLLVDPDTAVLK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-28.7	CHEMBL2850	Homo sapiens	INH	%	-28.7
	18211833	CHEMBL4045929	Inhibition of GSK3A conserved Lys2 (DIKPQNLLVDPDTAVLK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-47.3	CHEMBL2850	Homo sapiens	INH	%	-47.3
	18218047	CHEMBL4047103	Inhibition of GSK3alpha (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1		CHEMBL4079032	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	18218048	CHEMBL4047103	Inhibition of GSK3alpha (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	-1.0	CHEMBL2850	Homo sapiens	INH	%	-1.0
	18253365	CHEMBL4054966	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	65.0	CHEMBL2850	Homo sapiens	Activity	%	65.0
	18253366	CHEMBL4054966	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18265835	CHEMBL4057285	Inhibition of GSK3-alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL2850	Homo sapiens	INH	%	-1.0
	18266031	CHEMBL4057481	Inhibition of GSK3-alpha (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18274926	CHEMBL4118354	Inhibition of GSK3A in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLVDPDTAVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-2.8	CHEMBL2850	Homo sapiens	INH	%	-2.8
	18274927	CHEMBL4118354	Inhibition of GSK3A in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLVDPDTAVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	15.2	CHEMBL2850	Homo sapiens	INH	%	15.2
	18274928	CHEMBL4118354	Inhibition of GSK3A in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLVDPDTAVLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	4.3	CHEMBL2850	Homo sapiens	INH	%	4.3
Active	18275831	CHEMBL4118791	Binding affinity to GSK3A in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2850	Homo sapiens	Activity		
Active	18275973	CHEMBL4118933	Binding affinity to GSK3A in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL2850	Homo sapiens	Activity		
	18282085	CHEMBL4120040	Inhibition of GSK3alpha (unknown origin) at 1 uM by FRET relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	7.8	CHEMBL2850	Homo sapiens	INH	%	7.8
	18282404	CHEMBL4120040	Inhibition of GSK3alpha (unknown origin) at 1 uM by FRET relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	0.8	CHEMBL2850	Homo sapiens	INH	%	0.8
	18282778	CHEMBL4120363	Inhibition of GSK3-alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL2850	Homo sapiens	INH	%	-1.0
	18283005	CHEMBL4120590	Inhibition of GSK3-alpha (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	1.7	CHEMBL2850	Homo sapiens	INH	%	1.7
	18283229	CHEMBL4120814	Inhibition of GSK3-alpha (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	INH	%	1.0
	18286304	CHEMBL4121539	Inhibition of GSK3alpha (unknown origin) at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	0.0	CHEMBL2850	Homo sapiens	INH	%	0.0
	18384280	CHEMBL4146566	Inhibition of human GSK3alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	0.8	CHEMBL2850	Homo sapiens	IC50	uM	0.0008
	18384294	CHEMBL4146567	Inhibition of human GSK3alpha using biotin-Ahx-AAAKRREILSRRP-S(PO3)YR-amide as substrate after 40 mins in presence of [33gammaP]-ATP by SPA	B	Fc1ccc(/C=N/Nc2ncnc3c2cnn3-c2ccccc2)cc1		CHEMBL303926	=	IC50	nM	6.2	CHEMBL2850	Homo sapiens	IC50	uM	0.0062
	18384295	CHEMBL4146566	Inhibition of human GSK3alpha	B	CCCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL4172418	=	IC50	nM	4.0	CHEMBL2850	Homo sapiens	IC50	uM	0.004
	18384297	CHEMBL4146566	Inhibition of human GSK3alpha	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Cl)cc12)C1CC1		CHEMBL260664	=	IC50	nM	1.0	CHEMBL2850	Homo sapiens	IC50	uM	0.001
	18384298	CHEMBL4146566	Inhibition of human GSK3alpha	B	O=C(Nc1n[nH]c2ncc(-c3ccccc3)cc12)C1CCCC1		CHEMBL258483	=	IC50	nM	5.0	CHEMBL2850	Homo sapiens	IC50	uM	0.005
Active	18409908	CHEMBL4151783	Inhibition of human full length GSK3alpha expressed in bacterial expression system at 1 uM	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	18409909	CHEMBL4151783	Inhibition of human full length GSK3alpha expressed in bacterial expression system at 1 uM	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	18409910	CHEMBL4151783	Inhibition of human full length GSK3alpha expressed in bacterial expression system at 1 uM	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	18409911	CHEMBL4151783	Inhibition of human full length GSK3alpha expressed in bacterial expression system at 1 uM	B	O=C(N[C@H]1CC[C@H](O)CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457177		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	18410261	CHEMBL4151879	Inhibition of human GSK3A expressed in bacterial expression system at 1 uM	B	O=c1ccc2cnc3ccc(-c4cn[nH]c4)cc3c2n1-c1ccc(F)cc1C(F)(F)F		CHEMBL1765714		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	18434114	CHEMBL4156097	Inhibition of GSK3alpha (unknown origin) at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	INH	%	9.0
	18434230	CHEMBL4156097	Inhibition of GSK3alpha (unknown origin) at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	14.0	CHEMBL2850	Homo sapiens	INH	%	14.0
	18434290	CHEMBL4156097	Inhibition of GSK3alpha (unknown origin) at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	3.0	CHEMBL2850	Homo sapiens	INH	%	3.0
	18434362	CHEMBL4156097	Inhibition of GSK3alpha (unknown origin) at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	4.0	CHEMBL2850	Homo sapiens	INH	%	4.0
	18440233	CHEMBL4157057	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	94.0	CHEMBL2850	Homo sapiens	Activity	%	94.0
	18484189	CHEMBL4185836	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18484673	CHEMBL4185836	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18507770	CHEMBL4190992	Inhibition of recombinant human GSK3alpha (2 to end residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE (phospho GS2 peptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	17.0	CHEMBL2850	Homo sapiens	INH	%	17.0
	18653613	CHEMBL4230097	Inhibition of GSK-3-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	18653614	CHEMBL4230097	Inhibition of GSK-3-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	6.0	CHEMBL2850	Homo sapiens	INH	%	6.0
	18655499	CHEMBL4230736	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18751099	CHEMBL4263815	Inhibition of GSK-3-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	18751578	CHEMBL4264325	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	68.0	CHEMBL2850	Homo sapiens	Activity	%	68.0
	18761518	CHEMBL4266571	Inhibition of recombinant human N-terminal His6-tagged GSK3alpha (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	37.0	CHEMBL2850	Homo sapiens	INH	%	37.0
	18761789	CHEMBL4266571	Inhibition of recombinant human N-terminal His6-tagged GSK3alpha (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	0.0	CHEMBL2850	Homo sapiens	INH	%	0.0
	18761952	CHEMBL4266571	Inhibition of recombinant human N-terminal His6-tagged GSK3alpha (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	37.0	CHEMBL2850	Homo sapiens	INH	%	37.0
	18857989	CHEMBL4307835	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	83.0	CHEMBL2850	Homo sapiens	Activity	%	83.0
	18892882	CHEMBL4314848	Inhibition of recombinant human GSK3alpha (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.0	CHEMBL2850	Homo sapiens	Activity	%	102.0
	18895033	CHEMBL4315515	Inhibition of recombinant human N-terminal GST-tagged full length GSK3alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	-3.0	CHEMBL2850	Homo sapiens	Activity	%	-3.0
	18895052	CHEMBL4315515	Inhibition of recombinant human N-terminal GST-tagged full length GSK3alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	-24.0	CHEMBL2850	Homo sapiens	Activity	%	-24.0
	18895071	CHEMBL4315515	Inhibition of recombinant human N-terminal GST-tagged full length GSK3alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	-12.0	CHEMBL2850	Homo sapiens	Activity	%	-12.0
	18895090	CHEMBL4315515	Inhibition of recombinant human N-terminal GST-tagged full length GSK3alpha expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	-1.0	CHEMBL2850	Homo sapiens	Activity	%	-1.0
	18919537	CHEMBL4322893	Binding affinity to recombinant full-length N-terminal His-GST-tagged GSK3A (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	329.0	CHEMBL2850	Homo sapiens	Kd	nM	329.0
	18919725	CHEMBL4322893	Binding affinity to recombinant full-length N-terminal His-GST-tagged GSK3A (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	213.0	CHEMBL2850	Homo sapiens	Kd	nM	213.0
Not Determined	18929788	CHEMBL4325340	Inhibition of kinase tracer 236 binding to N-terminal GST-tagged human full length GSK3alpha expressed in Baculovirus expression system by Lanthascreen Eu kinase binding assay	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133		IC50			CHEMBL2850	Homo sapiens	IC50		
	18929803	CHEMBL4325355	Inhibition of kinase tracer 236 binding to N-terminal GST-tagged human full length GSK3alpha expressed in baculovirus expression system at 1000 nM by Lanthascreen Eu kinase binding assay relative to control	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	Inhibition	%	89.0	CHEMBL2850	Homo sapiens	INH	%	89.0
	18937969	CHEMBL4327711	Inhibition of human GSK3A assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.06	CHEMBL2850	Homo sapiens	Activity	%	99.06
	18937970	CHEMBL4327711	Inhibition of human GSK3A assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.09	CHEMBL2850	Homo sapiens	Activity	%	98.09
	18938555	CHEMBL4328075	Inhibition of human GSK3A assessed as residual activity at 100 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2850	Homo sapiens	Activity	%	65.0
	18938933	CHEMBL4328439	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.4	CHEMBL2850	Homo sapiens	IC50	10'-9M	2.4
	18958902	CHEMBL4333424	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	18963752	CHEMBL4334907	Inhibition of human GSK-3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured in presence of [gamma-33P]ATP by radiometric assay	B	c1ccc(-c2noc(CSc3nnc(-c4ccncc4)o3)n2)cc1		CHEMBL4545000	=	IC50	nM	451.0	CHEMBL2850	Homo sapiens	IC50	nM	451.0
	18963753	CHEMBL4334907	Inhibition of human GSK-3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured in presence of [gamma-33P]ATP by radiometric assay	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.5	CHEMBL2850	Homo sapiens	IC50	nM	1.5
	18963756	CHEMBL4334909	Inhibition of human GSK-3alpha by mobility shift micro-fluidic assay	B	CC[C@@]1(c2ccccc2)C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21		CHEMBL4438334	=	IC50	nM	66.0	CHEMBL2850	Homo sapiens	IC50	nM	66.0
	18963758	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	18963759	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c(Cl)c3)o2)S1		CHEMBL4592453	=	Inhibition	%	80.0	CHEMBL2850	Homo sapiens	INH	%	80.0
	18963760	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC1=NN(c2cccc(C(=O)O)c2)C(=O)/C1=C\c1ccc(-c2ccc3c(c2)C(=O)NC3=O)o1		CHEMBL4532859	=	Inhibition	%	58.0	CHEMBL2850	Homo sapiens	INH	%	58.0
	18963761	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(N/N=C/c1cccc(Cl)c1)c1cc(-c2ccc3c4c(cccc24)CC3)[nH]n1		CHEMBL4574630	=	Inhibition	%	52.0	CHEMBL2850	Homo sapiens	INH	%	52.0
	18963762	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=O)N(c2ccc(Br)cc2)C(=O)/C1=C\NCCc1c[nH]c2ccccc12		CHEMBL4525557	=	Inhibition	%	66.0	CHEMBL2850	Homo sapiens	INH	%	66.0
	18963763	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CN1C(=N)NC(=O)/C1=C\c1ccc(-c2ccc(F)cc2)o1		CHEMBL3437678	=	Inhibition	%	81.0	CHEMBL2850	Homo sapiens	INH	%	81.0
	18963764	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)c(Br)c1		CHEMBL4467604	=	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	18963765	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(O)CCC(=O)N1N=C(c2c(O)nc3ccc(Cl)cc3c2-c2ccccc2)CC1c1ccco1		CHEMBL1518160	=	Inhibition	%	67.0	CHEMBL2850	Homo sapiens	INH	%	67.0
	18963766	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccccc1OCC(=O)Nc1ccc(Oc2ccc3c(c2)C(=O)NC3=O)cc1		CHEMBL1821766	=	Inhibition	%	54.0	CHEMBL2850	Homo sapiens	INH	%	54.0
	18963767	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCOc1c(/C=C2/SC(=O)NC2=O)cccc1OC		CHEMBL4471869	=	Inhibition	%	54.0	CHEMBL2850	Homo sapiens	INH	%	54.0
	18963768	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccco1		CHEMBL4443427	=	Inhibition	%	21.0	CHEMBL2850	Homo sapiens	INH	%	21.0
	18963769	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4539454	=	Inhibition	%	23.0	CHEMBL2850	Homo sapiens	INH	%	23.0
	18963770	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1N/C(=N/Cc2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4589530	=	Inhibition	%	30.0	CHEMBL2850	Homo sapiens	INH	%	30.0
	18963771	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccccc3Cl)o2)S1		CHEMBL4537545	=	Inhibition	%	95.0	CHEMBL2850	Homo sapiens	INH	%	95.0
	18963772	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	NC1=NC(=O)/C(=C\c2ccc(-c3ccccc3[N+](=O)[O-])o2)S1		CHEMBL1878704	=	Inhibition	%	91.0	CHEMBL2850	Homo sapiens	INH	%	91.0
	18963773	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccccc3C(=O)O)o2)S1		CHEMBL4437351	=	Inhibition	%	11.0	CHEMBL2850	Homo sapiens	INH	%	11.0
	18963774	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)S1		CHEMBL4558089	=	Inhibition	%	94.0	CHEMBL2850	Homo sapiens	INH	%	94.0
	18963775	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1cc(C)cc(/N=C2/NC(=O)/C(=C\c3ccc(-c4cccc(Cl)c4)o3)S2)c1		CHEMBL4579205	=	Inhibition	%	10.0	CHEMBL2850	Homo sapiens	INH	%	10.0
	18963776	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Inhibition	%	96.0	CHEMBL2850	Homo sapiens	INH	%	96.0
	18963777	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)S1		CHEMBL4572532	=	Inhibition	%	97.0	CHEMBL2850	Homo sapiens	INH	%	97.0
	18963778	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4575432	=	Inhibition	%	15.0	CHEMBL2850	Homo sapiens	INH	%	15.0
	18963779	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COC(=O)c1ccc(-c2ccc(/C=C3\C(=O)NC(=N)N3C)o2)cc1		CHEMBL3437676	=	Inhibition	%	32.0	CHEMBL2850	Homo sapiens	INH	%	32.0
	18963780	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)S1		CHEMBL4442366	=	Inhibition	%	86.0	CHEMBL2850	Homo sapiens	INH	%	86.0
	18963781	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4577014	=	Inhibition	%	47.0	CHEMBL2850	Homo sapiens	INH	%	47.0
	18963782	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(F)cc3F)o2)S1		CHEMBL4469930	=	Inhibition	%	15.0	CHEMBL2850	Homo sapiens	INH	%	15.0
	18963783	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)S1		CHEMBL4444620	=	Inhibition	%	82.0	CHEMBL2850	Homo sapiens	INH	%	82.0
	18963784	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc([N+](=O)[O-])cc3Cl)o2)S1		CHEMBL4515342	=	Inhibition	%	20.0	CHEMBL2850	Homo sapiens	INH	%	20.0
	18963785	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4467699	=	Inhibition	%	44.0	CHEMBL2850	Homo sapiens	INH	%	44.0
	18963786	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4468449	=	Inhibition	%	29.0	CHEMBL2850	Homo sapiens	INH	%	29.0
	18963787	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL4561377	=	Inhibition	%	85.0	CHEMBL2850	Homo sapiens	INH	%	85.0
	18963788	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(Cl)cc1-c1ccc(/C=C2/S/C(=N\c3ccccc3)NC2=O)o1		CHEMBL4593954	=	Inhibition	%	0.0	CHEMBL2850	Homo sapiens	INH	%	0.0
	18963789	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL4459001	=	Inhibition	%	71.0	CHEMBL2850	Homo sapiens	INH	%	71.0
	18963790	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4463806	=	Inhibition	%	15.0	CHEMBL2850	Homo sapiens	INH	%	15.0
	18963791	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/S/C(=N\C(C)=O)NC2=O)o1		CHEMBL4443667	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	INH	%	9.0
	18963792	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)cc1Cl		CHEMBL4519366	=	Inhibition	%	81.0	CHEMBL2850	Homo sapiens	INH	%	81.0
	18963793	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C)c(Cl)c3)o2)S1		CHEMBL4459906	=	Inhibition	%	21.0	CHEMBL2850	Homo sapiens	INH	%	21.0
	18963794	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c([N+](=O)[O-])c3)o2)S1		CHEMBL4465279	=	Inhibition	%	49.0	CHEMBL2850	Homo sapiens	INH	%	49.0
	18963795	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1c(-c2ccc(/C=C3/SC(=N)NC3=O)o2)ccc([N+](=O)[O-])c1C		CHEMBL4536515	=	Inhibition	%	64.0	CHEMBL2850	Homo sapiens	INH	%	64.0
	18963796	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL4456469	=	Inhibition	%	84.0	CHEMBL2850	Homo sapiens	INH	%	84.0
	18963797	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CN1C(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)N(C)C1=S		CHEMBL4541565	=	Inhibition	%	13.0	CHEMBL2850	Homo sapiens	INH	%	13.0
	18963798	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4526685	=	Inhibition	%	97.0	CHEMBL2850	Homo sapiens	INH	%	97.0
	18963799	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3)o2)NC1=S		CHEMBL4535203	=	Inhibition	%	17.0	CHEMBL2850	Homo sapiens	INH	%	17.0
	18963800	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1		CHEMBL4452978	=	Inhibition	%	97.0	CHEMBL2850	Homo sapiens	INH	%	97.0
	18963801	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCN1C(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)N(CC)C1=S		CHEMBL4541734	=	Inhibition	%	38.0	CHEMBL2850	Homo sapiens	INH	%	38.0
	18963802	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL4566633	=	Inhibition	%	88.0	CHEMBL2850	Homo sapiens	INH	%	88.0
	18963803	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4584696	=	Inhibition	%	23.0	CHEMBL2850	Homo sapiens	INH	%	23.0
	18963804	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)NC1=S		CHEMBL4555724	=	Inhibition	%	26.0	CHEMBL2850	Homo sapiens	INH	%	26.0
	18963805	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2cc([N+](=O)[O-])ccc2Cl)o1		CHEMBL4535815	=	Inhibition	%	22.0	CHEMBL2850	Homo sapiens	INH	%	22.0
	18963806	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)cc1Cl		CHEMBL4519757	=	Inhibition	%	76.0	CHEMBL2850	Homo sapiens	INH	%	76.0
	18963807	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(Cl)c(Cl)c2)o1		CHEMBL4436862	=	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	18963808	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4452888	=	Inhibition	%	88.0	CHEMBL2850	Homo sapiens	INH	%	88.0
	18963809	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Inhibition	%	93.0	CHEMBL2850	Homo sapiens	INH	%	93.0
	18963810	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4444495	=	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	18963811	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)N/C1=C/c1ccc(-c2c(Br)cc([N+](=O)[O-])cc2Br)o1		CHEMBL1408125	=	Inhibition	%	42.0	CHEMBL2850	Homo sapiens	INH	%	42.0
	18963812	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N#Cc1ccccc1-c1ccc(C=C2C(=O)NC(=S)NC2=O)o1		CHEMBL2070563	=	Inhibition	%	14.0	CHEMBL2850	Homo sapiens	INH	%	14.0
	18963813	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(CSc1nc2ccccc2[nH]c1=O)Nc1ccc2c(c1)OCO2		CHEMBL4440259	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18963814	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N#Cc1cn(CCCN2CCN(CCCn3cc(C#N)c(=O)[nH]c3=O)CC2)c(=O)[nH]c1=O		CHEMBL4553913	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18963815	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(O)c1cc(NS(=O)(=O)c2ccc3c4c(cccc24)C(=O)N3)ccc1O		CHEMBL4538480	=	Inhibition	%	15.0	CHEMBL2850	Homo sapiens	INH	%	15.0
	18963816	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	NC(=O)Cc1nc2sc3c(c2c(=O)[nH]1)CCN(Cc1ccccc1)C3		CHEMBL4575294	=	Inhibition	%	-1.0	CHEMBL2850	Homo sapiens	INH	%	-1.0
	18963817	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CCCCCSc1nc2c(c(=O)[nH]c(=O)n2C)n1CC(O)COc1ccccc1		CHEMBL4568389	=	Inhibition	%	25.0	CHEMBL2850	Homo sapiens	INH	%	25.0
	18963818	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1ccc(-c2n[nH]cc2/C=N\NC(=O)c2ccccc2I)cc1OC		CHEMBL4449405	=	Inhibition	%	44.0	CHEMBL2850	Homo sapiens	INH	%	44.0
	18963819	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1ccc(CNc2cc(-c3ccco3)n[nH]2)cc1		CHEMBL4575443	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	INH	%	1.0
	18963820	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1cc(CNc2nn[nH]n2)ccc1OCC(N)=O		CHEMBL4462909	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	INH	%	1.0
	18963821	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(CSc1nnc(CCc2nnc(SCC(=O)c3ccccc3)[nH]2)[nH]1)c1ccccc1		CHEMBL4465709	=	Inhibition	%	25.0	CHEMBL2850	Homo sapiens	INH	%	25.0
	18963822	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	N#CC1=C(N)Oc2[nH]nc(-c3cccnc3)c2/C1=C1\C(=O)Nc2ccc(Br)cc21		CHEMBL4515792	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18963823	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(OCc2n[nH]c(Nc3ccccc3)n2)cc1		CHEMBL4574217	=	Inhibition	%	5.0	CHEMBL2850	Homo sapiens	INH	%	5.0
	18963824	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	NS(=O)(=O)c1ccc(N/C=C2/C(=O)NC(=O)N(c3ccccc3)C2=O)cc1		CHEMBL1496068	=	Inhibition	%	17.0	CHEMBL2850	Homo sapiens	INH	%	17.0
	18963825	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CC(=O)c1cn(CCCCCCCCCCn2cc(C(C)=O)c(=O)[nH]c2=O)c(=O)[nH]c1=O		CHEMBL1408222	=	Inhibition	%	13.0	CHEMBL2850	Homo sapiens	INH	%	13.0
	18963826	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2cc(Cl)ccc2Cl)o1		CHEMBL4446967	=	Inhibition	%	26.0	CHEMBL2850	Homo sapiens	INH	%	26.0
	18963827	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Nc1nc(CCCc2n[nH]c(N)n2)n[nH]1		CHEMBL4467369	=	Inhibition	%	16.0	CHEMBL2850	Homo sapiens	INH	%	16.0
	18963828	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(N/N=C/c1cccnc1)c1cc(-c2cccc3ccccc23)n[nH]1		CHEMBL4446698	=	Inhibition	%	12.0	CHEMBL2850	Homo sapiens	INH	%	12.0
	18963829	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	CN1C(=O)NC(=O)C2C1N=C(N1CCNCC1)N2CCCc1ccccc1		CHEMBL4527194	=	Inhibition	%	13.0	CHEMBL2850	Homo sapiens	INH	%	13.0
	18963830	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1c(Cl)cccc1-c1ccc(CNc2nc[nH]n2)o1		CHEMBL4524944	=	Inhibition	%	8.0	CHEMBL2850	Homo sapiens	INH	%	8.0
	18963831	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1ccc(-c2ccc(CNc3n[nH]c(C)n3)o2)cc1Cl		CHEMBL4458346	=	Inhibition	%	8.0	CHEMBL2850	Homo sapiens	INH	%	8.0
	18963832	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1cc(CNc2ccc(CNc3nc[nH]n3)cc2)ccc1OCC(=O)NC(C)(C)C		CHEMBL1565648	=	Inhibition	%	1.0	CHEMBL2850	Homo sapiens	INH	%	1.0
	18963833	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	COc1cc(/C=C2/C(=O)NC(=O)N(c3ccccc3)C2=O)ccc1O		CHEMBL1312739	=	Inhibition	%	14.0	CHEMBL2850	Homo sapiens	INH	%	14.0
	18963834	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	NC(=O)CSc1nc2c(N)ncnc2n1Cc1ccccc1		CHEMBL4518624	=	Inhibition	%	-10.0	CHEMBL2850	Homo sapiens	INH	%	-10.0
	18963835	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1[nH]nc2c1C(c1ccnc3ccccc13)C(C#N)=C(N)O2		CHEMBL4515202	=	Inhibition	%	6.0	CHEMBL2850	Homo sapiens	INH	%	6.0
	18963836	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	O=C(COC(=O)c1cc(O)nc2ccccc12)c1cccc2ccccc12		CHEMBL4448910	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18963837	CHEMBL4334911	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method relative to control	B	Cc1ccc(SCc2[nH]nc3c2C(c2ccnc4ccccc24)C(C#N)=C(N)O3)cc1		CHEMBL4467550	=	Inhibition	%	2.0	CHEMBL2850	Homo sapiens	INH	%	2.0
	18963838	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.02	CHEMBL2850	Homo sapiens	IC50	nM	1.02
	18963839	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c(Cl)c3)o2)S1		CHEMBL4592453	=	IC50	nM	300.0	CHEMBL2850	Homo sapiens	IC50	uM	0.3
	18963840	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CC1=NN(c2cccc(C(=O)O)c2)C(=O)/C1=C\c1ccc(-c2ccc3c(c2)C(=O)NC3=O)o1		CHEMBL4532859	=	IC50	nM	6150.0	CHEMBL2850	Homo sapiens	IC50	uM	6.15
	18963841	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C(N/N=C/c1cccc(Cl)c1)c1cc(-c2ccc3c4c(cccc24)CC3)[nH]n1		CHEMBL4574630	=	IC50	nM	11210.0	CHEMBL2850	Homo sapiens	IC50	uM	11.21
	18963842	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=O)N(c2ccc(Br)cc2)C(=O)/C1=C\NCCc1c[nH]c2ccccc12		CHEMBL4525557	=	IC50	nM	4600.0	CHEMBL2850	Homo sapiens	IC50	uM	4.6
	18963843	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CN1C(=N)NC(=O)/C1=C\c1ccc(-c2ccc(F)cc2)o1		CHEMBL3437678	=	IC50	nM	1340.0	CHEMBL2850	Homo sapiens	IC50	uM	1.34
	18963844	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)c(Br)c1		CHEMBL4467604	=	IC50	nM	440.0	CHEMBL2850	Homo sapiens	IC50	uM	0.44
	18963845	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C(O)CCC(=O)N1N=C(c2c(O)nc3ccc(Cl)cc3c2-c2ccccc2)CC1c1ccco1		CHEMBL1518160	=	IC50	nM	12980.0	CHEMBL2850	Homo sapiens	IC50	uM	12.98
	18963846	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccccc1OCC(=O)Nc1ccc(Oc2ccc3c(c2)C(=O)NC3=O)cc1		CHEMBL1821766	=	IC50	nM	10160.0	CHEMBL2850	Homo sapiens	IC50	uM	10.16
	18963847	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCOc1c(/C=C2/SC(=O)NC2=O)cccc1OC		CHEMBL4471869	=	IC50	nM	16830.0	CHEMBL2850	Homo sapiens	IC50	uM	16.83
Not Determined	18963848	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccco1		CHEMBL4443427		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963849	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4539454		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963850	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1N/C(=N/Cc2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4589530		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963851	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccccc3Cl)o2)S1		CHEMBL4537545	=	IC50	nM	242.0	CHEMBL2850	Homo sapiens	IC50	nM	242.0
	18963852	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	NC1=NC(=O)/C(=C\c2ccc(-c3ccccc3[N+](=O)[O-])o2)S1		CHEMBL1878704	=	IC50	nM	2804.0	CHEMBL2850	Homo sapiens	IC50	nM	2804.0
Not Determined	18963853	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccccc3C(=O)O)o2)S1		CHEMBL4437351		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963854	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)S1		CHEMBL4558089	=	IC50	nM	282.0	CHEMBL2850	Homo sapiens	IC50	nM	282.0
Not Determined	18963855	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1cc(C)cc(/N=C2/NC(=O)/C(=C\c3ccc(-c4cccc(Cl)c4)o3)S2)c1		CHEMBL4579205		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963856	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	IC50	nM	49.0	CHEMBL2850	Homo sapiens	IC50	nM	49.0
	18963857	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)S1		CHEMBL4572532	=	IC50	nM	207.0	CHEMBL2850	Homo sapiens	IC50	nM	207.0
Not Determined	18963858	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4575432		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963859	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	COC(=O)c1ccc(-c2ccc(/C=C3\C(=O)NC(=N)N3C)o2)cc1		CHEMBL3437676		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963860	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)S1		CHEMBL4442366	=	IC50	nM	557.0	CHEMBL2850	Homo sapiens	IC50	nM	557.0
Not Determined	18963861	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4577014		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963862	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(F)cc3F)o2)S1		CHEMBL4469930		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963863	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)S1		CHEMBL4444620	=	IC50	nM	1879.0	CHEMBL2850	Homo sapiens	IC50	nM	1879.0
Not Determined	18963864	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc([N+](=O)[O-])cc3Cl)o2)S1		CHEMBL4515342		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963865	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4467699		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963866	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	COc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4468449		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963867	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL4561377	=	IC50	nM	162.0	CHEMBL2850	Homo sapiens	IC50	nM	162.0
Not Determined	18963868	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccc(Cl)cc1-c1ccc(/C=C2/S/C(=N\c3ccccc3)NC2=O)o1		CHEMBL4593954		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963869	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL4459001	=	IC50	nM	2676.0	CHEMBL2850	Homo sapiens	IC50	nM	2676.0
Not Determined	18963870	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4463806		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963871	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/S/C(=N\C(C)=O)NC2=O)o1		CHEMBL4443667		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963872	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)cc1Cl		CHEMBL4519366	=	IC50	nM	301.0	CHEMBL2850	Homo sapiens	IC50	nM	301.0
Not Determined	18963873	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C)c(Cl)c3)o2)S1		CHEMBL4459906		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963874	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c([N+](=O)[O-])c3)o2)S1		CHEMBL4465279		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963875	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1c(-c2ccc(/C=C3/SC(=N)NC3=O)o2)ccc([N+](=O)[O-])c1C		CHEMBL4536515	=	IC50	nM	227.0	CHEMBL2850	Homo sapiens	IC50	nM	227.0
	18963876	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL4456469	=	IC50	nM	609.0	CHEMBL2850	Homo sapiens	IC50	nM	609.0
Not Determined	18963877	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CN1C(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)N(C)C1=S		CHEMBL4541565		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963878	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4526685	=	IC50	nM	145.0	CHEMBL2850	Homo sapiens	IC50	nM	145.0
Not Determined	18963879	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3)o2)NC1=S		CHEMBL4535203		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963880	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1		CHEMBL4452978	=	IC50	nM	309.0	CHEMBL2850	Homo sapiens	IC50	nM	309.0
Not Determined	18963881	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCN1C(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)N(CC)C1=S		CHEMBL4541734		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963882	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL4566633	=	IC50	nM	412.0	CHEMBL2850	Homo sapiens	IC50	nM	412.0
Not Determined	18963883	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4584696		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963884	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)NC1=S		CHEMBL4555724		IC50			CHEMBL2850	Homo sapiens	IC50		
Not Determined	18963885	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2cc([N+](=O)[O-])ccc2Cl)o1		CHEMBL4535815		IC50			CHEMBL2850	Homo sapiens	IC50		
	18963886	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)cc1Cl		CHEMBL4519757	=	IC50	nM	904.0	CHEMBL2850	Homo sapiens	IC50	nM	904.0
	18963887	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(Cl)c(Cl)c2)o1		CHEMBL4436862	=	IC50	nM	370.0	CHEMBL2850	Homo sapiens	IC50	nM	370.0
	18963888	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4452888	=	IC50	nM	159.0	CHEMBL2850	Homo sapiens	IC50	nM	159.0
	18963889	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	IC50	nM	33.0	CHEMBL2850	Homo sapiens	IC50	nM	33.0
	18963890	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	CCCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4444495	=	IC50	nM	710.0	CHEMBL2850	Homo sapiens	IC50	nM	710.0
Not Determined	18963891	CHEMBL4334912	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using phospho GS2 peptide as substrate after 40 mins in presence of [gamma-33ATP] by scintillation counting method	B	O=C1NC(=S)N/C1=C/c1ccc(-c2c(Br)cc([N+](=O)[O-])cc2Br)o1		CHEMBL1408125		IC50			CHEMBL2850	Homo sapiens	IC50		
Dose-dependent effect	18964029	CHEMBL4334943	Inhibition of GSK-3alpha phosphorylation at Y279 residue in human HL60 cells after 24 hrs by Western blot analysis	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Dose-dependent effect	18964030	CHEMBL4334944	Inhibition of GSK-3alpha phosphorylation at Y279 residue in human NB4 cells after 24 hrs by Western blot analysis	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	18964333	CHEMBL4335104	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) assessed as residual activity at 1 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	8.0	CHEMBL2850	Homo sapiens	Activity	%	8.0
	18964334	CHEMBL4335104	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) assessed as residual activity at 1 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	10.0	CHEMBL2850	Homo sapiens	Activity	%	10.0
	18971921	CHEMBL4336931	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	79.0	CHEMBL2850	Homo sapiens	Activity	%	79.0
	19030033	CHEMBL4349172	Inhibition of recombinant full length human His-tagged GSK3alpha expressed in baculovirus expression system assessed as enzyme residual activity at 0.4 uM using fluorophore-labeled serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	C=CC(=O)N1CCC(Oc2nc(Nc3ccc(N4CCOCC4)cc3)nc3[nH]cc(-c4cncc(NC)n4)c23)CC1		CHEMBL4443805	=	Activity	%	29.3	CHEMBL2850	Homo sapiens	Activity	%	29.3
Not Active	19039760	CHEMBL4351882	Inhibition of recombinant human GSK3alpha (2 to end residues) at 10 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Active	19041130	CHEMBL4352391	Inhibition of human GSK3A at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	19042444	CHEMBL4352765	ATP competitive inhibition of human GSK3alpha	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	Ki	nM	33.0	CHEMBL2850	Homo sapiens	Ki	nM	33.0
	19059613	CHEMBL4357914	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	19090179	CHEMBL4365753	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2850	Homo sapiens	Activity	%	100.0
	19091948	CHEMBL4366422	Inhibition of human GSK3A at 100 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-8.76	CHEMBL2850	Homo sapiens	INH	%	-8.76
	19118524	CHEMBL4372368	Inhibition of recombinant human N-terminal His6-tagged GSK3alpha (2 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using GSK3 substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	-10.0	CHEMBL2850	Homo sapiens	INH	%	-10.0
	19121966	CHEMBL4373024	Inhibition of GSK3alpha (unknown origin) at 0.1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	23.0	CHEMBL2850	Homo sapiens	INH	%	23.0
	19121974	CHEMBL4373032	Inhibition of GSK3alpha (unknown origin) at 1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	81.0	CHEMBL2850	Homo sapiens	INH	%	81.0
	19144862	CHEMBL4377878	Inhibition of recombinant full-length human GSK3alpha (2 to end residues) S449A mutant at 1 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	17.0	CHEMBL2850	Homo sapiens	INH	%	17.0
	19147872	CHEMBL4379346	Inhibition of human GSK-3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR as substrate after 40 mins by [gamma-33ATP] radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2850	Homo sapiens	IC50	uM	10.0
	19159441	CHEMBL4382545	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	99.0	CHEMBL2850	Homo sapiens	Activity	%	99.0
	19181043	CHEMBL4387254	Inhibition of recombinant full length human GST-tagged GSK3alpha expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	19181269	CHEMBL4387254	Inhibition of recombinant full length human GST-tagged GSK3alpha expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	33.0	CHEMBL2850	Homo sapiens	INH	%	33.0
	19191566	CHEMBL4389264	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	19191927	CHEMBL4389741	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	19200183	CHEMBL4391367	Binding affinity to wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	0.3	CHEMBL2850	Homo sapiens	Activity	%	0.3
	19225394	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4520113	=	IC50	nM	2046.0	CHEMBL2850	Homo sapiens	IC50	nM	2046.0
	19225395	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474903	=	IC50	nM	300.0	CHEMBL2850	Homo sapiens	IC50	nM	300.0
	19225396	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4546015	=	IC50	nM	853.0	CHEMBL2850	Homo sapiens	IC50	nM	853.0
	19225397	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4589431	=	IC50	nM	1337.0	CHEMBL2850	Homo sapiens	IC50	nM	1337.0
	19225398	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	IC50	nM	301.0	CHEMBL2850	Homo sapiens	IC50	nM	301.0
	19225399	CHEMBL4395842	Inhibition of human recombinant full length GSK3alpha using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(Cc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4476724	=	IC50	nM	428.0	CHEMBL2850	Homo sapiens	IC50	nM	428.0
	19230802	CHEMBL4397122	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 5 uM by Kinomescan method relative to control	B	Cc1cc(OCCCC(=O)Nc2ncc(Br)s2)ccc1Cl		CHEMBL4465202	=	Inhibition	%	31.0	CHEMBL2850	Homo sapiens	INH	%	31.0
Not Active	19250388	CHEMBL4401411	Inhibition of human N-terminal His-tagged GSK3alpha expressed in baculovirus expression system assessed as residual activity at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	19250444	CHEMBL4401435	Inhibition of human N-terminal His-tagged GSK3alpha expressed in baculovirus expression system at 1 uM relative to control	B	c1ccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)cc1		CHEMBL4454763	=	Inhibition	%	74.0	CHEMBL2850	Homo sapiens	INH	%	74.0
	19250445	CHEMBL4401435	Inhibition of human N-terminal His-tagged GSK3alpha expressed in baculovirus expression system at 1 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Inhibition	%	12.0	CHEMBL2850	Homo sapiens	INH	%	12.0
	19266444	CHEMBL4405394	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	19276007	CHEMBL4408010	Inhibition of recombinant human GSK3alpha (2 to end residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2850	Homo sapiens	INH	%	0.0
Active	19317091	CHEMBL4417285	Inhibition of GSK3A (unknown origin) at 1000 nM relative to control	B	Cc1c(C(=O)Nc2ccc3ccccc3n2)cnn1-c1ccccc1Br		CHEMBL4555217		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	19476576	CHEMBL4479724	Inhibition of full-length human GST-tagged GSK3A expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	360.0	CHEMBL2850	Homo sapiens	IC50	nM	360.0
	19476676	CHEMBL4479724	Inhibition of full-length human GST-tagged GSK3A expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	130.0	CHEMBL2850	Homo sapiens	IC50	nM	130.0
	19476776	CHEMBL4479724	Inhibition of full-length human GST-tagged GSK3A expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	42.0	CHEMBL2850	Homo sapiens	IC50	nM	42.0
	19476876	CHEMBL4479724	Inhibition of full-length human GST-tagged GSK3A expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	110.0	CHEMBL2850	Homo sapiens	IC50	nM	110.0
	20600438	CHEMBL4603311	Inhibition of recombinant full length GST-tagged human GSK3alpha expressed in baculovirus expression system using Ser/Thr 09 peptide as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	26120.0	CHEMBL2850	Homo sapiens	IC50	uM	26.12
	20601672	CHEMBL4603804	Inhibition of recombinant human N-terminal GST-tagged full length GSK3A expressed in baculovirus expression system using Ser/Thr09 peptide as substrate at 0.6 uM incubated for 1 hr by Z'lyte assay relative to control	B	C=CC(=O)NCCOc1cc(Cc2ccccc2)cc2[nH]c(-c3n[nH]c4cc(C(F)F)ccc34)cc12		CHEMBL4646281	=	Inhibition	%	4.0	CHEMBL2850	Homo sapiens	INH	%	4.0
	20604065	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	99.0	CHEMBL2850	Homo sapiens	INH	%	99.0
	20604066	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	94.0	CHEMBL2850	Homo sapiens	INH	%	94.0
	20604067	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	98.0	CHEMBL2850	Homo sapiens	INH	%	98.0
	20604068	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	101.0	CHEMBL2850	Homo sapiens	INH	%	101.0
	20604069	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	20604070	CHEMBL4604468	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	93.0	CHEMBL2850	Homo sapiens	INH	%	93.0
	20604085	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	IC50	nM	670.0	CHEMBL2850	Homo sapiens	IC50	uM	0.67
	20604086	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	IC50	nM	610.0	CHEMBL2850	Homo sapiens	IC50	uM	0.61
	20604087	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	IC50	nM	710.0	CHEMBL2850	Homo sapiens	IC50	uM	0.71
	20604088	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	IC50	nM	890.0	CHEMBL2850	Homo sapiens	IC50	uM	0.89
	20604100	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	IC50	nM	1000.0	CHEMBL2850	Homo sapiens	IC50	uM	1.0
	20604101	CHEMBL4604475	Inhibition of N-Terminal GST tagged human GSK3A expressed in baculovirus expression system after 1 hr by Z'-LYTE assay	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	IC50	nM	1110.0	CHEMBL2850	Homo sapiens	IC50	uM	1.11
	20635323	CHEMBL4611598	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	CN1CCN(c2ccc(NCCNc3ccc([N+](=O)[O-])c(N)n3)nc2-c2ccc(Cl)cc2Cl)C(=O)C1		CHEMBL1242830	=	Inhibition	%	99.45	CHEMBL2850	Homo sapiens	INH	%	99.45
	20651771	CHEMBL4615951	Inhibition of human recombinant GSK3alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 60 mins in presence of ATP at Km concentration by LANCE assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12		CHEMBL4640019	<	IC50	nM	10.0	CHEMBL2850	Homo sapiens	IC50	uM	0.01
	22392067	CHEMBL4667162	Inhibition of recombinant human GST-tagged full length GSK3alpha expressed in baculovirus expression system using Ser/Thr 09 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	9.0	CHEMBL2850	Homo sapiens	INH	%	9.0
	22399416	CHEMBL4669265	Inhibition of wild type full length human GSK3A (M1 to S483 residues) expressed in bacterial expression assessed as residual activity at 1 uM by Kinomescan method relative to control	B	COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1		CHEMBL552462	=	Activity	%	2.5	CHEMBL2850	Homo sapiens	Activity	%	2.5
	22423575	CHEMBL4674363	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	77.2	CHEMBL2850	Homo sapiens	Activity	%	77.2
	22423576	CHEMBL4674363	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	16.09	CHEMBL2850	Homo sapiens	Activity	%	16.09
	22441939	CHEMBL4678873	Inhibition of kinase tracer 236 binding to N-terminal GST-tagged human full length GSK3alpha expressed in baculovirus expression system by Lanthascreen Eu kinase binding assay	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	96.0	CHEMBL2850	Homo sapiens	INH	%	96.0
	22441960	CHEMBL4678886	Inhibition of human recombinant GSK3alpha using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	100.0	CHEMBL2850	Homo sapiens	INH	%	100.0
	22441961	CHEMBL4678886	Inhibition of human recombinant GSK3alpha using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1		CHEMBL4754081	=	Inhibition	%	101.0	CHEMBL2850	Homo sapiens	INH	%	101.0
	22441962	CHEMBL4678886	Inhibition of human recombinant GSK3alpha using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1		CHEMBL4754399	=	Inhibition	%	101.0	CHEMBL2850	Homo sapiens	INH	%	101.0
	22442115	CHEMBL4678912	Inhibition of GSK3alpha (unknown origin) in presence of 5 mM ATP	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	IC50	nM	187.0	CHEMBL2850	Homo sapiens	IC50	uM	0.187
	22449380	CHEMBL4680600	Inhibition of recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	Cc1ccnc(NC(=O)Cc2ccc3ccccc3c2)c1		CHEMBL4781866	=	IC50	nM	5200.0	CHEMBL2850	Homo sapiens	IC50	nM	5200.0
	22449381	CHEMBL4680600	Inhibition of recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	COc1ccnc(NC(=O)Cc2ccc3ccccc3c2)c1		CHEMBL4744511	=	IC50	nM	4800.0	CHEMBL2850	Homo sapiens	IC50	nM	4800.0
	22449382	CHEMBL4680600	Inhibition of recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(Cl)ccn1		CHEMBL4754904	=	IC50	nM	860.0	CHEMBL2850	Homo sapiens	IC50	nM	860.0
	22449383	CHEMBL4680600	Inhibition of recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	COc1ccc2cc(C(C)C(=O)Nc3cc(C)ccn3)ccc2c1		CHEMBL4749658	=	IC50	nM	1900.0	CHEMBL2850	Homo sapiens	IC50	nM	1900.0
	22449384	CHEMBL4680600	Inhibition of recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	COc1ccc2cc([C@H](C)C(=O)Nc3cc(C)ccn3)ccc2c1		CHEMBL4754518	=	IC50	nM	4500.0	CHEMBL2850	Homo sapiens	IC50	nM	4500.0
	22449398	CHEMBL4680606	Binding affinity to recombinant human GSK3alpha S449A mutant (2 to end residues) using YRRAAVPPSPSLSR peptide as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation analysis	B	Cc1ccnc(NC(=O)Cc2ccc3ccccc3c2)c1		CHEMBL4781866	=	Kd	nM	870.0	CHEMBL2850	Homo sapiens	Kd	nM	870.0
	22485828	CHEMBL4688576	Inhibition of GSK3alpha (unknown origin) by ATP competitive based analysis	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	=	IC50	nM	12.0	CHEMBL2850	Homo sapiens	IC50	nM	12.0
	22758279	CHEMBL4701419	Inhibition of human GSK3alpha	B	COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1		CHEMBL4286578	=	IC50	nM	45.0	CHEMBL2850	Homo sapiens	IC50	nM	45.0
	22798829	CHEMBL4711073	Inhibition of GSK-3alpha (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4789145	=	Inhibition	%	91.06	CHEMBL2850	Homo sapiens	INH	%	91.06
	22840058	CHEMBL4719520	Inhibition of GSK3A (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	IC50	nM	9.11	CHEMBL2850	Homo sapiens	IC50	nM	9.11
	22840059	CHEMBL4719520	Inhibition of GSK3A (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	IC50	nM	7.44	CHEMBL2850	Homo sapiens	IC50	nM	7.44
	22843725	CHEMBL4720711	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.97	CHEMBL2850	Homo sapiens	IC50	10^-9M	3.97
	22844077	CHEMBL4721063	Inhibition of human GSK3A assessed as residual activity using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.11	CHEMBL2850	Homo sapiens	Activity	%	93.11
	22844727	CHEMBL4721402	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	87.77	CHEMBL2850	Homo sapiens	Activity	%	87.77
	22886594	CHEMBL4728297	Inhibition of human GSK3A assessed as residual activity at 1 uM relative to control	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	<	Activity	%	25.0	CHEMBL2850	Homo sapiens	Activity	%	25.0
	22908783	CHEMBL4733715	Inhibition of GSK3alpha (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4749204	=	Inhibition	%	88.94	CHEMBL2850	Homo sapiens	INH	%	88.94
Not Active	22909907	CHEMBL4734063	Inhibition of recombinant human full length GST-tagged GSK3A expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Not Active	22909908	CHEMBL4734063	Inhibition of recombinant human full length GST-tagged GSK3A expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
Not Active	22909909	CHEMBL4734063	Inhibition of recombinant human full length GST-tagged GSK3A expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL2850	Homo sapiens	INH		
	22922121	CHEMBL4736852	Inhibition of GSK3alpha (unknown origin) assessed as enzyme remaining activity at 5 uM relative to control	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5ccc(C(C)=O)cc5)CO[C@H]34)n2)cc1		CHEMBL4758751	>	Activity	%	50.0	CHEMBL2850	Homo sapiens	Activity	%	50.0
	22926814	CHEMBL4737723	Inhibition of human GSKalpha S449A mutant (2 to 3nd residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	22926815	CHEMBL4737723	Inhibition of human GSKalpha S449A mutant (2 to 3nd residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	>	Inhibition	%	50.0	CHEMBL2850	Homo sapiens	INH	%	50.0
	22926820	CHEMBL4737726	Inhibition of human GSKalpha S449A mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		CHEMBL3408213	=	Ki	nM	231.0	CHEMBL2850	Homo sapiens	Ki	uM	0.231
	22926821	CHEMBL4737726	Inhibition of human GSKalpha S449A mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	=	Ki	nM	13.0	CHEMBL2850	Homo sapiens	Ki	uM	0.013000000000000001
	22926822	CHEMBL4737726	Inhibition of human GSKalpha S449A mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	=	Ki	nM	43.0	CHEMBL2850	Homo sapiens	Ki	uM	0.043
	22952856	CHEMBL4766793	Inhibition of human GSK-3alpha (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	102.0	CHEMBL2850	Homo sapiens	Activity	%	102.0
	22967929	CHEMBL4770020	Inhibition of human GSK3alpha by ADP-Glo assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045	=	IC50	nM	70.0	CHEMBL2850	Homo sapiens	IC50	nM	70.0
	23120113	CHEMBL4804312	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	0.0	CHEMBL2850	Homo sapiens	Activity	%	0.0
	23120425	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	91600.0	CHEMBL2850	Homo sapiens	IC50	uM	91.6
	23120426	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	93500.0	CHEMBL2850	Homo sapiens	IC50	uM	93.5
	23120427	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	81100.0	CHEMBL2850	Homo sapiens	IC50	uM	81.1
	23120428	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	85200.0	CHEMBL2850	Homo sapiens	IC50	uM	85.2
	23120429	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	86000.0	CHEMBL2850	Homo sapiens	IC50	uM	86.0
	23120430	CHEMBL4804387	Inhibition of GSK3A in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	97200.0	CHEMBL2850	Homo sapiens	IC50	uM	97.2
	23121464	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	>	Inhibition	%	90.0	CHEMBL2850	Homo sapiens	INH	%	90.0
	23121465	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	Inhibition	%	90.0	CHEMBL2850	Homo sapiens	INH	%	90.0
	23121466	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL2850	Homo sapiens	INH	%	75.0
	23121467	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL2850	Homo sapiens	INH	%	75.0
	23121468	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	75.0	CHEMBL2850	Homo sapiens	INH	%	75.0
	23121469	CHEMBL4804569	Inhibition of GSK3A in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL2850	Homo sapiens	INH	%	90.0
	23122599	CHEMBL4804950	Inhibition of human GSK3A assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL2850	Homo sapiens	Activity	%	94.0
	23123294	CHEMBL4805538	Inhibition of human GSK3A assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	95.0	CHEMBL2850	Homo sapiens	Activity	%	95.0
	23123603	CHEMBL4805847	Inhibition of DNA-tagged human GSK3A assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	85.0	CHEMBL2850	Homo sapiens	Activity	%	85.0
	23124206	CHEMBL4806305	Inhibition of GASK3a (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	IC50	nM	1200.0	CHEMBL2850	Homo sapiens	IC50	nM	1200.0
	23124260	CHEMBL4806333	Inhibition of GASK3a (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	82.0	CHEMBL2850	Homo sapiens	INH	%	82.0
	23124678	CHEMBL4806555	Inhibition of human GSK3A assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	31.0	CHEMBL2850	Homo sapiens	Activity	%	31.0
	23124679	CHEMBL4806555	Inhibition of human GSK3A assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	34.0	CHEMBL2850	Homo sapiens	Activity	%	34.0
	23125249	CHEMBL4806844	Inhibition of human GSK3A at 2000 nM by KINOMEscan assay	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	>	Inhibition	%	65.0	CHEMBL2850	Homo sapiens	INH	%	65.0
	23125260	CHEMBL4806852	Inhibition of human GSK3A by DiscoverX assay	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Kd	nM	5600.0	CHEMBL2850	Homo sapiens	Kd	nM	5600.0
	23128149	CHEMBL4807858	Inhibition of GSK3aplha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2850	Homo sapiens	Activity	%	75.0
	23128150	CHEMBL4807858	Inhibition of GSK3aplha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2850	Homo sapiens	Activity	%	75.0
	23128151	CHEMBL4807858	Inhibition of GSK3aplha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2850	Homo sapiens	Activity	%	75.0
	23161091	CHEMBL4812412	Inhibition of GSK3alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3ccccc3)s1)CC2		CHEMBL4871899	=	Activity	%	62.0	CHEMBL2850	Homo sapiens	Activity	%	62.0
	23161092	CHEMBL4812412	Inhibition of GSK3alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl		CHEMBL4878007	=	Activity	%	61.0	CHEMBL2850	Homo sapiens	Activity	%	61.0
	23213418	CHEMBL4822952	Inhibition of human recombinant GSK3A in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	91.0	CHEMBL2850	Homo sapiens	INH	%	91.0
	23213447	CHEMBL4822981	Inhibition of human wild type GSK-3beta incubated with substrate in presence of ATP measured by serial dilution assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	IC50	nM	370.0	CHEMBL2850	Homo sapiens	IC50	nM	370.0
	23248224	CHEMBL4830409	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	=	IC50	nM	0.6	CHEMBL2850	Homo sapiens	IC50	nM	0.6
	23248225	CHEMBL4830409	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	770.0	CHEMBL2850	Homo sapiens	IC50	nM	770.0
	23248226	CHEMBL4830409	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	414.0	CHEMBL2850	Homo sapiens	IC50	nM	414.0
	23248238	CHEMBL4830415	Inhibition of human GSK3A using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL2850	Homo sapiens	Activity	%	20.0
	23252170	CHEMBL4831320	Inhibition of GSK3alpha (unknown origin) at 0.1 uM in presence of 1 mM ATP relative to control	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	>	Inhibition	%	30.0	CHEMBL2850	Homo sapiens	INH	%	30.0
	23252183	CHEMBL4831333	Inhibition of GSK3alpha (unknown origin) in presence of 1 mM ATP without preincubation	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	=	IC50	nM	189.0	CHEMBL2850	Homo sapiens	IC50	nM	189.0
	23252184	CHEMBL4831334	Inhibition of GSK3alpha (unknown origin) in presence of 1 mM ATP with preincubation	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	=	IC50	nM	251.0	CHEMBL2850	Homo sapiens	IC50	nM	251.0
	23290604	CHEMBL4839413	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Inhibition	%	81.0	CHEMBL2850	Homo sapiens	INH	%	81.0
	23290615	CHEMBL4839424	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Kd	nM	580.0	CHEMBL2850	Homo sapiens	Kd	nM	580.0
	23290872	CHEMBL4839432	Inhibition of GSK3alpha (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	14.0	CHEMBL2850	Homo sapiens	IC50	nM	14.0
	23290873	CHEMBL4839432	Inhibition of GSK3alpha (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	19.0	CHEMBL2850	Homo sapiens	IC50	nM	19.0
	23290874	CHEMBL4839432	Inhibition of GSK3alpha (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.1	CHEMBL2850	Homo sapiens	IC50	nM	5.1
	23290884	CHEMBL4839437	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	Activity	%	12.0	CHEMBL2850	Homo sapiens	Activity	%	12.0
	23290885	CHEMBL4839437	Inhibition of wild-type human full length GSK3A (M1 to S483 residues) expressed in bacterial expression system assessed as residual activity by Kinomescan method relative to control	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	Activity	%	2.3	CHEMBL2850	Homo sapiens	Activity	%	2.3
	23290909	CHEMBL4839448	Inhibition of NanoLuc-fused GSK3A (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	5300.0	CHEMBL2850	Homo sapiens	IC50	uM	5.3
	23290910	CHEMBL4839448	Inhibition of NanoLuc-fused GSK3A (unknown origin) expressed in HEK293T cells after 2 hrs by NanoBRET assay	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	14000.0	CHEMBL2850	Homo sapiens	IC50	uM	14.0
	23299296	CHEMBL4841748	Inhibition of GSK3alpha (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	3.0	CHEMBL2850	Homo sapiens	INH	%	3.0
	23299297	CHEMBL4841748	Inhibition of GSK3alpha (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	20.0	CHEMBL2850	Homo sapiens	INH	%	20.0
Not Active	23317434	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23317902	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23318570	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	62.0	CHEMBL2850	Homo sapiens	% Control	%	62.0
Not Active	23319052	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23319689	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	92.3	CHEMBL2850	Homo sapiens	% Control	%	92.3
Not Active	23320164	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	79.9	CHEMBL2850	Homo sapiens	% Control	%	79.9
Not Active	23320842	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	66.0	CHEMBL2850	Homo sapiens	% Control	%	66.0
Not Active	23321310	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23321940	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	86.0	CHEMBL2850	Homo sapiens	% Control	%	86.0
Not Active	23322408	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23323097	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23323565	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23324023	CHEMBL4880642	GSK3alpha (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-3.0	CHEMBL2850	Homo sapiens	% inhibition	%	-3.0
Not Active	23324419	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23325054	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	74.0	CHEMBL2850	Homo sapiens	% Control	%	74.0
Not Active	23325522	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	93.0	CHEMBL2850	Homo sapiens	% Control	%	93.0
Not Active	23326169	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL2850	Homo sapiens	% Control	%	93.0
Not Active	23326637	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	90.0	CHEMBL2850	Homo sapiens	% Control	%	90.0
Not Active	23327337	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23327805	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23328392	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23328860	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	98.0	CHEMBL2850	Homo sapiens	% Control	%	98.0
Not Active	23329361	CHEMBL4881068	GSK3alpha (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	112.0	CHEMBL2850	Homo sapiens	% residual kinase activity	%	112.0
Not Active	23329806	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23330274	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	85.0	CHEMBL2850	Homo sapiens	% Control	%	85.0
Not Active	23331030	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23331498	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	79.0	CHEMBL2850	Homo sapiens	% Control	%	79.0
Not Active	23332085	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23332551	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23333269	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	95.0	CHEMBL2850	Homo sapiens	% Control	%	95.0
Not Active	23333908	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23334376	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23334900	CHEMBL4881523	GSK3alpha (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	13.0	CHEMBL2850	Homo sapiens	% inhibition	%	13.0
Not Active	23335355	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	95.0	CHEMBL2850	Homo sapiens	% Control	%	95.0
Not Active	23335823	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	99.0	CHEMBL2850	Homo sapiens	% Control	%	99.0
Not Active	23336450	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	99.0	CHEMBL2850	Homo sapiens	% Control	%	99.0
Not Active	23336918	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	82.0	CHEMBL2850	Homo sapiens	% Control	%	82.0
Not Active	23337612	CHEMBL4881983	GSK3A Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	96.0	CHEMBL2850	Homo sapiens	% Ctrl	%	96.0
Not Active	23337999	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23338467	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23339079	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23339547	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23340184	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	70.0	CHEMBL2850	Homo sapiens	% Control	%	70.0
Not Active	23340652	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23341309	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	97.0	CHEMBL2850	Homo sapiens	% Control	%	97.0
Not Active	23341777	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	78.0	CHEMBL2850	Homo sapiens	% Control	%	78.0
Not Active	23342393	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23342861	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	84.0	CHEMBL2850	Homo sapiens	% Control	%	84.0
Not Active	23343491	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23343959	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	61.0	CHEMBL2850	Homo sapiens	% Control	%	61.0
Not Active	23344597	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23345170	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23345638	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23346215	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23346684	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	86.8	CHEMBL2850	Homo sapiens	% Control	%	86.8
Not Active	23347079	CHEMBL4882606	Invitrogen kinase screen (GSK3A)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	µM	0.21	CHEMBL2850	Homo sapiens	IC50	µM	0.21
Not Active	23347287	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	88.0	CHEMBL2850	Homo sapiens	% Control	%	88.0
Not Active	23347775	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23348354	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23348822	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	75.0	CHEMBL2850	Homo sapiens	% Control	%	75.0
Not Active	23349409	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	87.0	CHEMBL2850	Homo sapiens	% Control	%	87.0
Not Active	23350027	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23350495	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	86.0	CHEMBL2850	Homo sapiens	% Control	%	86.0
Not Active	23351100	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	90.0	CHEMBL2850	Homo sapiens	% Control	%	90.0
Not Active	23351568	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23352063	CHEMBL4882754	GSK3A (GSK3 alpha) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.0184	CHEMBL2850	Homo sapiens	% Inhibition	%	0.0184
Not Active	23352592	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23353060	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	86.0	CHEMBL2850	Homo sapiens	% Control	%	86.0
Not Active	23353942	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	99.0	CHEMBL2850	Homo sapiens	% Control	%	99.0
Not Active	23354410	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23355142	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23355610	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23356246	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23356714	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23357323	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23357970	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23358438	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	92.0	CHEMBL2850	Homo sapiens	% Control	%	92.0
Not Active	23359024	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23359622	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	61.0	CHEMBL2850	Homo sapiens	% Control	%	61.0
Not Active	23360090	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	82.0	CHEMBL2850	Homo sapiens	% Control	%	82.0
Not Active	23360675	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL2850	Homo sapiens	% Control	%	95.0
Not Active	23361143	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23361716	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	54.0	CHEMBL2850	Homo sapiens	% Control	%	54.0
Not Active	23362252	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	97.0	CHEMBL2850	Homo sapiens	% Control	%	97.0
Not Active	23362720	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	82.0	CHEMBL2850	Homo sapiens	% Control	%	82.0
Not Active	23364362	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23364830	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23365569	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	89.0	CHEMBL2850	Homo sapiens	% Control	%	89.0
Not Active	23366112	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23366702	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23367170	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23367589	CHEMBL4883942	GSK3-alpha ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	93.0	CHEMBL2850	Homo sapiens	% Residual activity with Skepinone-L	%	93.0
Not Active	23368048	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL2850	Homo sapiens	% Control	%	93.0
Not Active	23368516	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL2850	Homo sapiens	% Control	%	95.0
Not Active	23369115	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23369583	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	75.0	CHEMBL2850	Homo sapiens	% Control	%	75.0
Not Active	23370083	CHEMBL4884327	GSK3α(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	83.0	CHEMBL2850	Homo sapiens	% residual kinase activity	%	83.0
Not Active	23370551	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	90.0	CHEMBL2850	Homo sapiens	% Control	%	90.0
Not Active	23371019	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23371828	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23372296	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
	23373721	CHEMBL4885498	GSK3alpha(GS3ALGK1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2850	Homo sapiens	pIC50		6.0
Not Active	23374991	CHEMBL4885984	GSK3_alpha Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	15.5	CHEMBL2850	Homo sapiens	% Inhibition	%	15.5
Not Active	23375263	CHEMBL4886245	glycogen synthase kinase 3 alpha Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-42.0	CHEMBL2850	Homo sapiens	% inhibition	%	-42.0
Not Active	23375723	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23376191	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23376768	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	82.0	CHEMBL2850	Homo sapiens	% Control	%	82.0
Not Active	23377236	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	73.0	CHEMBL2850	Homo sapiens	% Control	%	73.0
Not Active	23378096	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	99.0	CHEMBL2850	Homo sapiens	% Control	%	99.0
Not Active	23378564	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL2850	Homo sapiens	% Control	%	92.0
Not Active	23379731	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23380199	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	72.0	CHEMBL2850	Homo sapiens	% Control	%	72.0
Not Active	23380893	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	96.0	CHEMBL2850	Homo sapiens	% Control	%	96.0
Not Active	23381541	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23382009	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2850	Homo sapiens	% Control	%	100.0
Not Active	23382633	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	83.0	CHEMBL2850	Homo sapiens	% Control	%	83.0
Not Active	23383101	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	64.0	CHEMBL2850	Homo sapiens	% Control	%	64.0
Not Active	23383808	CHEMBL4887443	GSK3A Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL2850	Homo sapiens	% Ctrl	%	99.0
Not Active	23384291	CHEMBL4887886	GSK3alpha(h Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.47	CHEMBL2850	Homo sapiens	% inhibition	%	5.47
Not Active	23385016	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	86.0	CHEMBL2850	Homo sapiens	% Control	%	86.0
Not Active	23385483	CHEMBL4879740	KinomeScan assay: inhibition of GSK3A	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	94.0	CHEMBL2850	Homo sapiens	% Control	%	94.0
Not Active	23385882	CHEMBL4888355	GSK3alpha Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	-4.0	CHEMBL2850	Homo sapiens	% inhibition	%	-4.0
